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Abstract X 
Abstract 
Osteoarthritis (OA) is the most common and prevalent chronic joint disorder in older adults, 
characterized by progressive deterioration of joint structures. It affects not only the articular 
cartilage and subchondral bone but also other structures of the joint, such as menisci, synovial 
membrane, joint capsule, ligaments, muscles and infrapatellar fat pad (IPFP). IPFP, the biggest 
‘organ’ in the knee and may play an important role in the incidence and progression of knee 
OA. This thesis aims to describe the associations of semi-quantitative and quantitative 
measures of IPFP signal intensity alterations assessed on magnetic resonance imaging (MRI) 
with knee structural and symptomatic changes in older adults or patients with symptomatic 
knee OA. 
This thesis is based on two established studies: Tasmanian Older Adults Cohort (TASOAC) 
study and Vitamin D Effects on Osteoarthritis (VIDEO) study. TASOAC is an ongoing 
prospective, population-based study, aimed at identifying the environmental, genetic, and 
biochemical factors associated with the development and progression of OA (assessed by both 
X-ray and MRI). Baseline measures were conducted from April 2002 to September 2004, and
the first follow-up were conducted from September 2004 to February 2007 (mean 2.7 years, 
range 2.6-3.3 years). Subjects (n=1100) between the age of 50 and 80 years were randomly 
selected from the roll of electors in southern Tasmania (population, 229,000), a comprehensive 
population listing with an equal number of men and women. VIDEO is a multicentre, 
randomized, placebo-controlled double-blind clinical trial. The aim of this study is to compare 
the effects of vitamin D supplementation versus placebo on knee structural and symptomatic 
changes in patients with symptomatic knee OA over a 2-year period. Patients (n = 413) with 
symptomatic knee OA and low 25(OH)D levels were randomized to treatment and control 
groups in Hobart and Melbourne. Outcomes/predictors included knee symptoms assessed by 
Abstract XI 
WOMAC index and visual analogue scale (VAS), knee structural changes assessed by 
radiography or MRI, and serum biomarkers (IL-1, IL-6, TNF-α).  
Chapter 4 describes the associations between semi-quantitative measures of IPFP high signal 
intensity alteration at baseline and knee symptoms and structural changes in older adults. These 
semi-quantitative measures of IPFP high signal intensity alterations at baseline are associated 
with knee structural abnormalities and clinical symptoms cross-sectionally and longitudinally 
in older adults, suggesting that it may serve as an important imaging biomarker in knee OA. 
Chapter 5 investigates the associations between semi-quantitative measures of IPFP 
hypointense signals and knee structural change and symptoms in older adults. These 
hypointense signals in the IPFP are associated primarily with increased knee cartilage defects 
and also with bone marrow lesions (BMLs) and knee symptoms in cross-sectional and 
longitudinal analyses, suggesting the abnormality represented by this signal has a potentially 
important role in OA process. 
Chapter 6 describes the associations between quantitative measures of IPFP high signal 
intensity alteration and knee structural abnormalities in patients with symptomatic knee OA. 
Quantitative measures of increased signal intensity in the IPFP are associated with knee 
structural abnormalities longitudinally, suggesting that these measurements could be used as 
an additional entry criteria in order to enrich for ‘faster progressors’ in studies of knee OA. 
Chapter 7 investigates the associations between serum levels of resistin, IPFP signal intensity 
alterations and other knee structural changes in patients with knee OA. Serum levels of resistin 
Abstract XII 
are significantly and positively associated with IPFP signal intensity alterations and other 
structural abnormalities, suggesting a potential role of resistin in knee OA. 
Chapter 8 describes the natural history of IPFP high signal intensity alteration (quantitative 
measures) and factors affecting its changes over 2 years. IPFP high signal intensity alterations 
were not static in patients with knee OA. Changes of these signal intensity alterations were 
age-related, independent of BMI, predicted by radiographic OA (ROA), cartilage volume and 
effusion-synovitis, as well as associated with changes in neighboring knee structures, 
suggesting therapeutic interventions aimed at these changes could be considered in clinical 
practice. 
In conclusion, age-related signal intensity alterations in the IPFP are associated with greater 
ROA progression, predict symptomatic and structural changes, and are related to neighboring 
knee structural abnormalities. Combined with its associations with pro-inflammatory 
mediators, these signal intensity alterations may represent age-related local adipose tissue 
inflammation, which contributes to the incidence and/or progression of knee OA. Furthermore, 
these signal intensity alterations may be used as imaging biomarkers in clinical research or 
practice. 
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Synopsis 
Osteoarthritis (OA) is one of the most common diseases and is a leading cause of chronic 
disability in older adults, characterized by progressive deterioration of joint structures. It 
affects not only the articular cartilage and subchondral bone but also other structures of the 
joint, such as menisci, synovial membrane, joint capsule, ligaments, muscles and 
infrapatellar fat pad (IPFP),  Although the aetiology and progression of this disease are not 
well understood, it is considered as a multifactorial condition with risk factors including 
genetics, aging, female sex, injury and obesity. Aging and obesity are two prominent risk 
factors for the onset of knee OA, and current studies suggest that age-related adipose tissue 
inflammation may be the underlying mechanism between age, obesity and knee OA. IPFP, 
the biggest intra-articular adipose tissue in the knee, is a source of cytokines, adipokines 
and growth factors, and has similar composition of immune cells as synovium. Despite its 
capabilities of reducing the impact loading and absorbing forces generated through the knee 
joint, it may be an important local source of age-related inflammation and a central 
contributor to the degradation of neighbouring tissues within the knee. The inflammation 
or fibrosis within IPFP may be detected as signal intensity alterations on magnetic 
resonance imaging (MRI). This thesis describes the associations of IPFP signal intensity 
alterations with symptomatic and knee structural changes, as well as pro-inflammatory 
mediators, aiming to examine possible relationships between pathological changes in IPFP 
and knee OA development or progression. Furthermore, it investigates the natural history 
of these signal intensity alterations and factors affecting these alterations. 
 
Chapter 1 gives an introduction to OA, including its definition, symptoms and signs, 
epidemiology and economic burden, currently understanding of aetiology and risk factors, 
diagnostic criteria, and treatments. A brief discussion of the association between 
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inflammation, adipose tissue, IPFP and knee OA is given. An overview of current imaging 
biomarkers in clinical research and practice is provided, with a focus on IPFP signal 
intensity alterations. 
 
Chapter 2 lists the research questions to be addressed in the thesis. 
 
Chapter 3 describes the methodology included in the thesis, including study designs of 
two involved studies: Tasmanian Older Adults Cohort (TASOAC) study and Vitamin D 
Effects on Osteoarthritis (VIDEO) study, protocols for measurements, and statistical 
analyses. 
 
Chapter 4 describes the associations between IPFP high signal intensity alteration at baseline 
and knee symptoms and structural changes in older adults. A total of 874 subjects (mean 62.1 
years, 50.1% female) selected randomly from local community were studied at baseline and 
770 were followed up (only 357 had MRI at follow-up) over 2.6 years.  T1- or T2-weighted fat 
suppressed MRI was utilized to assess IPFP signal intensity alteration (0-3), cartilage volume, 
cartilage defects and BMLs at baseline and 2.6 years later. Knee pain was assessed by self-
administered Western Ontario and McMaster Osteoarthritis Index (WOMAC) questionnaire. 
Radiographic OA was assessed. In cross-sectional analyses, IPFP signal intensity alteration 
was significantly and positively associated with total knee pain as well as knee cartilage defects, 
bone marrow lesions (BMLs) and knee radiographic OA and negatively associated with 
patellar cartilage volume after adjustment for age, sex, BMI and/or radiographic OA. 
Longitudinally, baseline signal intensity alteration within IPFP was significantly and positively 
associated with increases in knee pain when going up/down stairs as well as increases in 
tibiofemoral cartilage defects and BMLs, and negatively associated with change in lateral tibial 
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cartilage volume in multivariable analyses. In conclusion, IPFP signal intensity alteration at 
baseline was associated with knee structural abnormalities and clinical symptoms cross-
sectionally and longitudinally in older adults, suggesting that it may serve as an important 
imaging biomarker in knee OA. 
 
Chapter 5 describes the associations between hypointense signals in the IPFP and knee 
structural change and symptoms in older adults. Participants (n = 874) were selected randomly 
from local community and followed up 2.7 years later (range 2.6-3.3 years). T1- or T2-
weighted fat suppressed MRI was assessed for IPFP hypointense signal, cartilage volume, 
cartilage defects, and BMLs. Knee pain was assessed by self-administered WOMAC 
questionnaire. Radiographic OA was assessed using the Osteoarthritis Research Society 
International (OARSI) atlas. Cross-sectionally, hypointense signals in the IPFP were 
significantly associated with a higher risk of knee cartilage defects at all sites, tibiofemoral 
BMLs and knee pain in multivariable analyses. Longitudinally, baseline signal abnormalities 
were significantly and positively associated with increases in knee cartilage defects (OR: 2.27 
95%CI: 1.61-3.21), BMLs (OR: 1.91, 95%CI: 1.39-2.62), and knee pain (OR: 1.36, 95%CI: 
1.05-1.76) in multivariable analyses. The associations with cartilage defects remained 
significant after adjustment for BMLs, but the associations with BMLs and knee pain decreased 
in magnitude or became non-significant after further adjustment for cartilage defects. In 
conclusion, hypointense signals in the IPFP were associated primarily with increased knee 
cartilage defects and also with BMLs and knee symptoms in cross-sectional and longitudinal 
analyses, suggesting the abnormalities represented by these signals have a potentially important 
role in OA progression. 
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Chapter 6 illustrates the associations between quantitative measures of IPFP high signal 
intensity alteration and knee structural abnormalities in patients with symptomatic knee OA. 
261 participants (mean age 63.0 ± 7.2 years) with symptomatic knee OA were selected from a 
randomized controlled trial with a follow up of 2 years. IPFP signal intensity alterations at 
baseline were quantitatively measured on T2-weighted fat-saturated MRI using MATLAB. 
These quantitative measures included the standard deviation [sDev (IPFP)] of whole IPFP 
signal intensity, the upper quartile value [UQ (H)] of high signal intensity, the ratio of volume 
of high signal intensity alteration to volume of whole IPFP [Percentage (H)] and Clustering 
factor (H) representing the clustering effect of high signal intensity. Cartilage volume and 
defects, and BMLs were assessed using validated measures. Higher baseline sDev (IPFP), UQ 
(H) and Clustering factor (H) were associated with greater loss of tibial cartilage volume and 
larger increases in tibiofemoral cartilage defects over 2 years. Patients with high and medium 
tertiles of Clustering factor (H) had greater loss of cartilage volume compared with those with 
low tertile (4.9% and 4.6% vs 3.3% pa). Baseline Percentage (H) and Clustering factor (H) 
were positively and significantly associated with increases in tibiofemoral BMLs over 2 years. 
In conclusion, quantitative measures of increased signal intensity in the IPFP were associated 
with knee structural abnormalities longitudinally, suggesting that these measurements could be 
used as an additional entry criteria in order to enrich for ‘faster progressors’ in studies of knee 
OA. 
 
Chapter 7 describes the associations between serum levels of resistin, IPFP measures and other 
knee structural changes in patients with knee OA. Patients (n = 200) with symptomatic knee 
OA (mean 63.1 years, range 49-79, female 46.5%) participated in this study and all measures 
were performed at baseline and two years later. Serum levels of resistin were measured using 
enzyme-linked immunosorbent assay. IPFP high signal intensity alteration and effusion-
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synovitis were measured from MRI to represent knee synovitis. Knee structural changes 
including cartilage volume, cartilage defects and BMLs were assessed by MRI semi-
quantitatively or quantitatively. Multilevel mixed-effects liner regression or logistic regression 
analyses were used in the data analyses. Serum levels of resistin were significantly and 
positively associated with the percentage of IPFP high signal intensity alteration volume to 
whole IPFP volume [Percentage (H)] (β: 1.34, 95% CI: 0.38, 2.30) and IPFP high signal 
intensity clustering (as measured by Clustering Factor (H), β: 0.69, 95% CI: 0.0.07, 1.31), as 
well as the presence (OR: 1.06, 95% CI: 1.02, 1.10) and volume (β: 0.77, 95% CI: 0.01, 1.54) 
of effusion-synovitis in multivariable analyses. It was also significantly and positively 
associated with total scores of tibiofemoral cartilage defects (β: 1.92, 95% CI: 0.31, 3.52) and 
BMLs (β: 2.97, 95% CI: 0.79, 5.15) after adjustment for covariates. In conclusion, serum levels 
of resistin were significantly and positively associated with IPFP measures and other knee 
structural abnormalities, suggesting a potential role of resistin in knee OA. 
 
Chapter 8 determines the natural history of IPFP high signal intensity alteration (quantitative 
measures) and factors affecting with its changes over 2 years. A total of 233 patients (mean 
63.0 years, range 49-79, female 42.1%) with symptomatic knee OA participated in this study. 
IPFP high signal intensity alteration, cartilage volume and effusion-synovitis were measured 
quantitatively, while cartilage defects and BMLs were assessed semi-quantitatively, from MRI 
at baseline and at 2 years later. X-ray was used to assess radiographic OA (ROA) at baseline. 
Over 2 years, nearly 90% of participants were with either worsening or improving IPFP high 
signal intensity alterations. In multivariable analyses, baseline age, total ROA scores and 
effusion-synovitis volume were positively and significantly associated with changes in IPFP 
high signal intensity alterations, while baseline cartilage volume was negatively and 
significantly associated with changes in these signal intensity alterations. There were positive 
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and significant associations of changes in cartilage defects, BMLs and effusion synovitis with 
changes in these signal intensity alterations. In conclusion, IPFP high signal intensity 
alterations were not static in patients with knee OA. Changes of these signal intensity 
alterations were age-related, independent of BMI, predicted by radiographic OA, cartilage 
volume and effusion-synovitis, as well as associated with changes in neighboring knee 
structures, suggesting therapeutic interventions aiming at these changes could be considered in 
clinical practice. 
 
Chapter 9 summarises the findings of the thesis and provides a number of potential directions 
for future research. 
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1.1   Overview of osteoarthritis 
 
Osteoarthritis (OA) is the most prevalent form of arthritis, characterized by progressive 
deterioration of joint structures, and mainly affects diarthrodial joints such as the knee, hip and 
hand. To date, it has been considered as a disease of the whole joint, affecting not only articular 
cartilage but also subchondral bone, menisci, ligaments, muscles, capsule and synovium 
(Figure 1.1) [1]. It is a multifactorial condition with risk factors including genetics, aging, 
female sex, injury and obesity. As aging and obesity are two important risk factors for onset of 
knee OA, its societal burden increases with increasing prevalence of obesity and the ageing of 
community.  
 
Clinical symptoms of OA include pain, joint stiffness and dysfunction, which lead to physical 
disability and impaired quality of life. Although routine radiography is considered as the gold 
diagnostic standard in clinical practice due to the ability of revealing joint space loss and 
osteophytes at the joint margin, this method provides only indirect measurements of cartilage 
thickness and it is an insensitive reflection of cartilage loss [2]. Imaging biomarkers assessed 
on magnetic resonance imaging (MRI) are developed in research and clinical fields. Currently, 
there is still no cure for it, and current therapeutic strategies are primarily aimed at symptom-
relief and joint arthroplasty is needed at the end-stage of this disease. Therefore, new 
interventions aiming to retard the progression of OA are urgently required. 
 
1.1.1   Epidemiology and socioeconomic burden 
Due to variations in definitions (pathological, radiographic and clinical) and joint sites (hand, 
knee and hip), prevalence and incidence estimates for OA differ widely. The knee is the most 
common joint affected by OA [3]. About one-third of participants age  60 had radiographic 
OA [4]. The prevalence of knee OA increases with age and is more common in women than 
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men. The age-standardised prevalence of knee OA was 19.2% in adults aged  45 and 37.4% 
in adults aged  60, while rises as high as 40% in adults aged  70 [3, 4]. As not all radiographic 
OA is associated with clinical symptoms, the prevalence of symptomatic knee OA is lower 
than radiographic knee OA. The age-standardised prevalence of symptomatic knee OA was 
4.9% in adults aged  26. Among subjects aged  45, the prevalence of symptomatic knee OA 
was around 6.7% - 16.7%. The gender-standardised prevalence of symptomatic knee OA was 
15.6% in men and 30.5% in women in participants aged  55 [5]. 
 
 
Figure 1.1   Pathogenic features consistent with osteoarthritis [6] 
 
There is an insufficiency of relevant data on the cumulative incidence of developing OA. The 
incidence of radiographic knee OA was 2.5% per year in adults aged  55 [7], suggesting 
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radiographic OA is much common. Another study showed that the incidence of symptomatic 
knee, hip and hand OA were 6.5, 2.1 and 2.4 per 1000 person-year, respectively, lower than 
the incidence of radiographic OA [8]. However, recent systematic review described that 
incident radiographic OA was clinically relevant [9]. The incidence of OA is strongly 
associated with age and gender (Figure 1.2). 
 
 
Figure 1.2   Age- and gender- specific incidence rates (/1000 person-years) of symptomatic 
osteoarthritis.  
Solid: whole population; short dash line: females; long dash line: males. [10] 
 
 
As OA has a high prevalence and incidence, socioeconomic burden of this disease should be 
urgently considered with increasing trends in population ageing, obesity prevalence and joint 
injury in the future. This burden is typically measured in direct, indirect and intangible costs 
[11]. The direct cost includes nonpharmacological treatments, pharmacological treatments, 
surgeries, adverse effects of treatment, long-term care and healthcare provision. In Western 
countries, the direct cost of OA has been estimated to account for between 1% and 2.5% of the 
gross national product of these countries [12]. A study estimated the direct cost of OA is 
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projected to increase from 2.9 billion to 7.6 billion Canadian dollars from 2010 to 2031 in 
Canada [13]. Absenteeism, reduced employment, reduced productivity, caregiver time and 
premature mortality constitute the indirect cost of OA, which could be up to eightfold greater 
than the direct cost and is hard to estimate [13]. The less-defined intangible cost such as pain, 
decreased quality of live, activity limitation and fatigue is also an important ingredient of total 
cost of OA [13]. Consequently, the true burden of OA is often underestimated and further 
studies are needed. 
 
1.1.2  Pathology and pathogenesis 
Knee OA is also characterized by progressive deterioration of joint structures, whereas, the 
specific structures such as meniscus and IPFP are involved in the process of this disease [14, 
15].   
 
The cartilage progressive degradation due to biomechanical and biochemical mechanisms has 
long been considered the crucial pathophysiological changes in knee OA process. However, 
the reasons underlying cartilage degradation are not yet well understood.  Biomechanically, 
increasing focal stress through the joint caused by loss of cartilage in localized areas can lead 
to further cartilage loss, and along with the increasing cartilage loss or bony remodeling, the 
knee develops malalignment which increases further the degree of focal loading [16]. This  
feedback loop between increasing focal stress and cartilage loss could promote the progression 
of knee OA. The early stage of cartilage degradation is a result of failure of the repair process 
of damaged cartilage. This process is regulated by an interplay of anabolic and catabolic 
influences [3]. When this repair process exceeds the system’s ability to compensate as 
biochemical factors such as inflammation and metabolic changes contribute to this process, 
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this process becomes imbalance in favor of degradation [17]. Combining biomechanical and 
biochemical effects, cartilage degradation enters a vicious cycle. 
 
1.1.3   Symptoms and signs 
Pain is the hallmark clinical symptom of OA and the main reason for seeking medical advice. 
Joint pain is typically described as aggravated with activity and relieved with rest, while it may 
occur with rest in advanced disease and result in loss of sleep [18]. There is a discrepancy 
between radiographic joint abnormalities and reporting of pain in OA as there is a poor 
relationship between pain and radiographic OA [19]. Factors differentiating symptomatic OA 
from asymptomatic radiographic OA are largely unknown. One of these may be that 
radiographic measures have limited assessments of joint structure, especially the soft tissue. 
As cartilage is aneural, the pathogenesis of cartilage damage in OA cannot directly generate 
pain. The richly innervated joint structures such as subchondral bone, synovium, joint capsule, 
periosteum, ligaments and muscles could be the source of nociceptive stimuli in OA [20]. 
Patients with OA also experience stiffness, which is short-lived and occurs in the morning, 
after a period of inactivity, or particularly in the evening. This short-lived stiffness generally 
resolves in minutes and the duration is often less than 30 minutes differently from stiffness 
caused by rheumatoid arthritis [21]. Function impairment is another symptom reported by OA 
patients. Pain is the major cause of dysfunction, which includes poor mobility, limited daily 
activities, social isolation and loss of work opportunities [17]. Patients with OA may also 
complain of reduced movement, deformity, swelling and psychological distress [18].  
 
The features on physical examination usually localise the symptomatic joint and vary with the 
severity of disease. The common signs of OA are list in Table 1.1 [18]. 
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Table 1.1   Common signs of OA 
Common signs of OA 
Tenderness, usually located over the joint line 
Crepitus with movement of the joint 
Bony enlargement of the joint 
Restricted joint range of motion 
Pain on passive range of motion 
Deformity 
Instability of the joint 
Altered gait 
Muscle atrophy or weakness 
Joint effusion 
 
1.1.4   Risk factors 
OA is a highly heterogeneous disease comprising various phenotypes that present with 
common clinical and pathological features [22]. The aetiology of this disease is not well 
understood, and recent evidence suggests it is a multifactorial and complex disease affected by 
person-level and joint-level risk factors [23]. Person-level risk factors, also can be called 
systemic risk factors, include ageing, female sex, obesity, inflammation and genetic factors, 
while joint-level risk factors, which alter the biomechanical stability of joint, are local factors 
including joint injury, joint structural abnormalities, synovitis and joint malalignment. 
 
Ageing is one of the most prominent risk factors for the development of OA [24]. Although 
ageing and OA are closely linked, they are independent processes. Otherwise, numerous 
studies describe that the prevalence of radiographic and symptomatic knee, hip, hand and spine 
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OA increase with increasing age [25]. A review also described that the incidence rate of 
symptomatic OA peaked between the age of 50 and 70 [26]. A recent study conducted in Spain 
examined the incidence of clinically diagnosed OA and reported that female hand OA risk 
peaked between the age of 60 and 64, whereas knee and hip OA increased continuously with 
increasing age (Figure 1.2). The mechanistic understanding of how ageing contributes to the 
development of OA is still insufficient. The joint tissue changes with ageing together with other 
OA risk factors such as obesity, genetics and joint injury may contribute to the development of 
OA. The most plausible underlying mechanism may be age-related inflammation which 
increase production of pro-inflammatory mediators, the contributors of OA progression [27]. 
Other age-related factors that contribute to OA development include reduced muscle mass and 
increased fat mass, changes in the extracellular matrix, reduced cell density in the meniscus 
and ligaments, impairment in subchondral bone, as well as oxidative stress [28]. 
 
The prevalence of OA is more frequent among women than men at any given age of >50 years, 
with the sex difference most pronounced for hand and knee OA [23]. Women had higher 
incidence of clinically diagnosed OA in all joint sites (Figure 1.2). The Framingham study also 
described that women is an independent risk factor for knee OA [29]. This sex difference in 
both prevalence and incidence of OA increases with age may be related to endogenous 
oestrogen production and menopause, and further research is needed to reveal the mechanism 
in the future. 
 
Obesity is one of the strongest predictors of OA development. An epidemiological study 
described that a high body mass index (BMI) was independently associated with knee and hand 
OA, but not hip OA [30]. A systematic review also suggested that obesity was the most 
consistent risk factor for onset of knee OA [31]. The underlying mechanism may include 
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abnormal joint loading and inflamed adipose tissue producing adipokines and inflammatory 
mediators which involve in cartilage degradation, synovial inflammation and bone erosions 
[32, 33] (Figure 1.3). Activated adipose tissue increases the synthesis of pro-inflammatory 
cytokines such as IL-1, IL-6, IL-8, TNF-α and IL-18, but decreases anti-inflammatory 
cytokines such as IL-10 [34]. Despite its ability of increasing pro-inflammatory cytokines, 
adipose tissue is a highly metabolic endocrine organ with the capacity to release adipokines 
such as leptin, resistin and adiponectin in spite of the fact that it is considered as a passive 
storage portal of energy [35]. These adipokines were detected in the synovial fluid and plasma 
of patients with OA [36, 37], and patients with OA had higher expression of adipokines than 
healthy controls [38]. Resistin has pro-inflammatory properties and the ability to trigger the 
release of pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α [39, 40], and its 
engagement with inflammatory conditions is rapidly investigated nowadays. Serum levels of 
resistin were correlated with increased synovial inflammation assessed histologically and 
positively associated with N-terminal propeptide of type III procollagen (sPIIINP) and the 
prevalence and incidence of radiographic knee OA [41, 42]. The synovial fluid levels of resistin 
were positively associated with local IL-6 levels in OA patients suggesting there may exhibit 
pro-inflammatory activity [43].  
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Figure 1.3   Pathogeneses of obesity in knee OA [44] 
 
Joint-level risk factors for OA affects joint independently. While some joint-level risk factors 
may be shared by some joint, joint-level risk factors do not increase the risks of OA in all sites 
of the body. Previous joint injury is the main joint-level risk factor for OA. A systematic review 
suggested that a prior knee injury increased the risk of knee OA with pooled odd ratio (OR) of 
2.83 [45]. A large longitudinal study also described that previous joint injury/surgery was an 
independent risk factor for hip and knee OA [46]. Joint injury can directly damage a number 
of joint structural tissues such as cartilage, ligaments and meniscus, which may primarily or 
secondarily contribute to the progression of OA.  Joint shape abnormality is another central 
joint-level risk factor to OA pathogenesis of the joint, especially for hip OA. Overt congenital 
hip dysplasia, which generates progressive insufficient coverage of the femoral head by the 
acetabulum resulting in a concentrated weight-bearing area in the hip, is a well-recognized risk 
factor for hip OA [47]. Other joint-level risk factors such as local structural inflammation, joint 
malalignment, repetitive joint use through occupation and physical activity also contribute to 
the occurrence or progression of OA. 
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1.1.5   Diagnostic criteria 
Routine radiography is considered as the gold diagnostic standard in clinical practice on 
grounds of the ability of revealing joint space loss and osteophytes at the joint margin. The 
radiographic diagnostic criteria for definition of knee OA were introduced in 1957 by Kellgren 
and Lawrence [48]. The Kellgren and Lawrence (K/L) grading system that is traditionally used 
to assess the severity of radiographic knee OA incorporates important radiographic features 
such as joint space narrowing (JSN) and osteophytes into one scale of increasing severity 
(Table 1.3). Although this grading system has limitations (e.g., its individual categories are 
non-isometric from each other) [49], it has been accepted as standard criteria by the World 
Health Organization in 1961 [50] as it is simple and less time consuming.  
 
Although the predisposition to symptoms is related to the extent of radiographic features in OA 
patients, nearly half of patients with radiographic features of OA have no symptoms and vice 
versa [17]. Especially at the earliest stage of OA radiographs are insensitive to the pathological 
features, while with the progression of this disease radiographic features including JSN, 
osteophytes and subchondral bone abnormalities are visible. Hence, the absence of positive 
radiographic findings may not indicate the absence of symptomatic OA. Symptoms are usually 
the main cause that patients seek clinical help. Otherwise, OA has similar symptomatic features 
(i.e. pain) as other conditions such as avascular osteonecrosis, Paget’s disease, complex 
regional pain syndrome, rheumatoid arthritis and stress fractures. Imaging measures including 
radiographs and MRI should be used to rule out other conditions. Thus, the diagnosis of the 
disease should rely on clinical and radiological features. American College of Rheumatology 
(ACR) radiological and clinical criteria for hand, knee and hip OA were developed, and widely 
used in clinical and research practice [21, 51-53]. The ACR criteria for hand, knee and hip OA 
are summarised in Table 1.2 [17]. 
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Table 1.3   Kellgren and Lawrence (K/L) grading system 
Definition grades Description 
Grade 0: Normal No features of osteoarthritis 
Grade 1: Doubtful Possible osteophytic lipping and doubtful significance  
Grade 2: Mild Definite osteophytes and unimpaired joint space 
Grade 3: Moderate Moderate diminution of joint space 
Grade 4: Severe Joint space greatly impaired with sclerosis of subchondral bone 
[54] 
 
1.1.6   Treatment and management 
As we described in Section 1.1.1, OA has high prevalence and severe socioeconomic burden. 
The aims of OA management include pain control, function improvement and disease 
modification [1]. Unfortunately, there are still no identified disease-modifying OA drugs 
(DMOADs) to modify structural progression.  To date, several guidelines for the treatment or 
management of OA have been developed and the recommendations are often divided into three 
main categories such as non-pharmacological, pharmacological and surgical [55-60]. 
Depending on different phenotypes, risk factors, pathological mechanisms and affected sites, 
the modalities should be combined, or used individually. 
 
Table 1.2   American College of Rheumatology (ACR) radiological and clinical criteria 
for hand, knee and hip OA 
Site of joint Criteria 
Hand (clinical) 
Diagnosis if 1, 2, 3, 4 
or 1, 2, 3, 5 are  
1: Hand pain, aching, or stiffness for most days of previous month 
2: Hard tissue enlargement of two or more of ten selected joints 
3: Swelling in two or more metacarpophalangeal joints 
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present 4: Hard tissue enlargement of two or more distal interphalangeal joints 
5: Deformity of two or more of ten selected joint 
Hip (clinical and 
radiographic)                      
Diagnosis if 1, 2, 3 or 1, 2, 
4 or 1, 3, 4 are present 
1: Hip pain for most days of previous month 
2: Erythrocyte sedimentation rate of less than 20 mm in the first hour 
3: Femoral or acetabular osteophytes on radiographs 
4: Hip joint space narrowing on radiographs 
Knee (clinical) 
Diagnosis if 1, 2, 3,4 or 1, 
2, 5 or 1, 4, 5 are present 
1: Knee pain for most days of previous month 
2: Crepitus on active joint motion 
3: Morning stiffness lasting 30 minutes or less 
4: Age 38 years or older 
5: Bony enlargement of the knee on examination 
Knee (clinical and 
radiographic) 
Diagnosis if 1, 2 or 1, 3, 5, 
6 or 1, 4, 5, 6 are present 
1: Knee pain for most days of previous month 
2: Osteophytes at joint margins on radiographs 
3: Synovial fluid typical of OA (laboratory) 
4: Age 40 years or older 
5: Crepitus on active joint motion 
6: Morning stiffness lasting 30 minutes or less 
 
Non-pharmacological treatment 
According to the ACR guideline 2012 [58], modalities are recommended strongly or 
conditionally for different sites of OA. Evaluation of the ability to perform activities of daily 
living (ADLs), instructions in joint protection and use of thermal modalities, assistive device 
and splints are recommended conditionally for hand OA. Aerobic and/or resistance land-based 
exercise, aquatic exercise and weight loss for obese patients are recommended strongly, while 
self-management programs, manual therapy, psychosocial interventions, appropriate 
instructions in joint protection and assistive device are recommended conditionally for knee 
OA. Recommendations for the management of hip OA are similar to those for knee OA. 
However, there are differences in anatomy and biomechanics between hip and knee joint, and 
hip and knee OA have different risk factors and various modalities for local treatments. The 
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effect size of a specific treatment may vary between hip and knee OA. Among the 
recommendations provided by ACR, European League Against Rheumatism (EULAR) and 
OA Research Society International (OARSI), education, change in lifestyles, exercise, and 
weight reduction are recommended consentaneously, and the non-pharmacological 
management of OA should be followed with a patient-centred, multidisciplinary approach 
rather than a discipline-specific approach [55, 58, 60]. 
 
Pharmacological treatment 
The pharmacological treatment for OA include drugs for symptom relief such as 
acetaminophen, oral and topical nonsteroidal anti-inflammatory drugs (NSAIDs), tramadol and 
opioids, and for modifying the process of this disease such as strontium ranelate even they may 
have potential side effects and further randomised clinical trials (RCT) are needed to confirm 
their effects [61, 62]. Pharmacological treatment for OA can be applied site-specifically. 
Topical or oral NASAIDs and tramadol are recommended for hand, knee and hip OA, while 
acetaminophen and intraarticular corticosteroid injections are recommended for knee and hip 
OA but not hand OA [58]. Weak opioids and narcotic analgesics can be used to treat for 
refractory pain for hip and knee OA while other agents are ineffective or contraindicated; 
however, they are not recommended for hand OA [55, 58]. The toxicity or adverse events of 
pharmacological treatments should be considered in the clinical practice. For instance, in 
patients with risk factors of cardiovascular or gastrointestinal events, both non-selective 
NSAIDs and cyclo-oxygenase-2 (COX-2) selective drugs should be used cautiously. 
 
Surgical treatment 
Surgical interventions are generally the last choice for patients with advanced stage of OA 
while other no-surgical managements have failed [1]. The aims of surgical treatment are 
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symptom relief and function improvement to achieve better ADLs. OARSI guideline gives five 
surgical modalities for hip and knee OA: total joint arthroplasty, unicompartmental joint 
arthroplasty for knee OA, osteotomy and joint preserving surgical procedures, arthroscopic 
debridement and lavage in knee OA, and joint fusion when joint arthroplasty had failed [55]. 
There is still low level of evidence for hand OA in surgical treatments. EULAR guideline gives 
the recommendations for surgical management of hand OA based on low level of evidence, 
suggesting that interposition arthroplasty, osteotomy or arthrodesis are effective treatments for 
severe thumb base OA and should be considered when conservative managements are no 
longer effective [63]. The surgical modalities should be utilised based on the proper indications 
individually. For instance, arthroscopic debridement and lavage may improve the function for 
patients with loose bodies or flaps of meniscus or cartilage that causing mechanical symptoms, 
while osteotomy should be considered for patients with joint malalignment [55]. Joint 
arthroplasty is indicated for end-stage OA when conservative managements have failed [55]. 
 
1.2   Association between knee OA and IPFP 
Knee OA is a disease driven by multiple risk factors and has been considered as a whole joint 
disease as it affects not only the articular cartilage and subchondral bone but also other 
structures of the joint, such as menisci, synovial membrane, joint capsule, ligaments, muscles 
and infrapatellar fat pad [1, 64]. Although the pathogeneses of knee OA is still unclear, 
biomechanical and biochemical pathways may both be involved in the incidence or progression 
of knee OA.  IPFP, the local fat around the knee joint with an abundance of adipocytes, immune 
cells, vessels and nerve fibres [65], may have dual contributions to knee OA process. 
Biomechanically, IPFP may reduce the impact loading and absorb forces generated through 
the knee joint. Biochemically, it can produce both pro-inflammatory (deleterious) and anti-
inflammatory (protective) cytokines such as interleukin (IL)- 1β, tumour necrosis factor (TNF) 
Chapter 1. Introduction 
 
22 
α, IL-6, IL-8, basic fibroblast growth factor (bFGF), and vascular endothelial growth factor 
(VEGF), as well as various adipokines such as leptin, resistin and adiponectin, all of which 
play roles in maintenance of cartilage and bone homeostasis [66-69]. An overview of the IPFP 
and its role in knee OA are included in this section. 
 
1.2.1   Infrapatellar fat pad 
IPFP, also known as Hoffa’s fat pad, is  an intracapsular but extrasynovial structure that locates 
in the anterior compartment of the knee [70]. It is richly vascularized and innervated, and may 
play an important role in anterior knee pain. As an important source of inflammation, IPFP 
may also be involved in the progression of knee OA [14]. This section reviews the literature of 
IPFP anatomy, histology, biomechanics, cells and secretory profiles. 
 
1.2.1.1   Anatomy 
IPFP is the biggest adipose structure in the anterior knee joint (Figure 1.4). It is situated beneath 
the patella, behind the patellar tendon and in front of the femoral condyles and tibial plateaus 
plateau [71]. As it is interposed between the joint capsule and the synovial membrane that lines 
its posterior aspect, it has been considered as an intracapsular but extrasynovial structure [70]. 
It attaches to the intercondylar notch of the femur by the plica ligamentum mucosum, as well 
as to the anterior cruciate ligament (ACL) in some subjects [72]. The normal IPFP also 
connects to transverse meniscal ligament, medial and lateral meniscal horns and retinaculum 
[72, 73]. It consists of a central body with medial and lateral extensions, occupying almost the 
whole anterior part of the knee [72]. Two clefts are typically present within the IPFP: one is 
vertical and located at the superior part of the IPFP and the other is horizontal and in a 
posteroinferior position [73].  
 
Chapter 1. Introduction 
 
23 
It is vascularized by a rich anastomotic network. The supromedial and suprolateral geniculate 
arteries provide 2 vertical arteries and are linked horizontally with arteries running distally, 
while the central part of IPFP has low vascularization [74]. IPFP is also richly innervated, with 
an abundance of nerves from a branch of the tibial nerve arising from anterior fibbers of the 
popliteal plexus [75]. There were various nerves, such as a terminal branch of the obturator 
nerve, nerves to the vastus medialis and vastus lateralis, lateral articular and recurrent peroneal 
branches of common peroneal nerve, and the infrapatellar branch of the saphenous nerve, that 
also contribute to the innervation of the IPFP [75]. About one-quarter of the sensory fibres in 
the IPFP are nociceptive fibres targeted by substance P, which causes vasodilation that 
promotes the recruitment of immune cells [76]. As a richly vascularized and innervated 
structure in the knee, IPFP can be considered as an important source of knee pain and stiffness. 
Chapter 1. Introduction 
 
24 
 
Figure 1.4   Anatomy of the infrapatellar fat pad [77] 
 
1.2.1.2   Histology 
The typical IPFP appears yellow and may also include lobules of fat extending from the surface, 
a superior segment extending posteriorly and frond-like projections of the synovium [78]. It is 
structurally similar to subcutaneous adipose tissue [79], comprising of a network of adipocytes, 
fibroblasts, leukocytes and collagen matrix. Otherwise, a recent histotopographic study shows 
that IPFP consists of white adipose tissue, of lobular type, with lobules delimited by thin 
connective septa, and the IPFP lobule area is smaller and the interlobular septa were thicker 
than subcutaneous adipose tissue of the abdomen, while the IPFP lobule area is lager and the 
interlobular septa were thinner than subcutaneous adipose tissue of the knee [80]. An animal 
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study also shows that IPFP contains two specific parts: inner tissue and outer tissue, which 
have different chemical compositions [81]. This study suggests that these two different tissues 
have different functions: the inner tissue is probably subjected to a compressive load, while the 
outer tissue is probably subjected to a tensional load. All these suggest that, unlike systemic 
adipose tissue, IPFP may have its specific functions in the knee joint. 
 
1.2.1.3   Biomechanics 
Along with the knee flexion, the angle between the patellar tendon and the anterior border of 
the tibia decreases, and the IPFP is extruded posteriorly as the space narrows [82]. While with 
the knee extension, it moves away from the anterior tibia [82]. Although the exact function of 
the IPFP is still not well understood, it may be involved in facilitating distribution of synovial 
fluid across the knee joint, providing lubrication [83, 84]. Furthermore, it probably provides 
shock absorbance from mechanical forces (similar to the menisci) and maintains knee stability 
[85-87]. As IPFP is an adaptable structure, its shape, position, pressure and volume vary 
considerably throughout the normal range of motion (ROM) of the knee joint [82, 86]. Thus, 
it could act as a plastic portion aiming to absorbing of pressure variations during knee joint 
activity [80].  
 
1.2.1.4   Cell and secretory profiles 
Adipose tissue was thought to act only as a reservoir for excess calories that are stored as 
triacylglycerol; whereas, it is believed that it could play an active role in physiologic and 
pathologic process in immunology and inflammation [88, 89]. As a specialized form of 
connective tissue, it contains a number of adipocytes, fibroblasts, macrophages, leukocytes, 
and other cells involved in inflammation. IPFP has the typical histological structure and the 
same cell profiles as adipose tissue [90]. The immune cells in IPFP can produce and release 
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inflammatory mediators, while adipocytes are responsible for the production of adipokines 
such as leptin, resistin and adiponectin [88]. Furthermore, it can secrete lipids (i.e. fatty acids) 
in the process of lipolysis. The details of each secretory profiles and their associations with 
knee OA will be discussed in Section 1.2.3. 
 
1.2.2   IPFP and knee OA 
As described previously, IPFP is a large joint structure in the knee. Its histological features 
imply it may have important biomechanical functions in knee joint. The cell and secretory 
profiles of the IPFP indicate that it may be involved in the pathogenesis of knee joint disorders. 
 
1.2.2.1   Biomechanics 
As described in Section 1.2.1.3, IPFP may have the capacity of lubrication and shock 
absorbance, and maintaining joint stability. It may also act as a mechanoreceptor corresponding 
to a tridimensional connective mesh working in the proprioceptive regulation of the joint 
activity [80]. Thus, IPFP abnormalities may contribute to the initiation or progression of knee 
OA. A case-control study compared two groups with or without evidence of oedema in the 
superolateral aspect of the IPFP  and found that there were significant differences in Insall-
Salvati index, patellar translation and patellofemoral angle between groups, suggesting that 
IPFP oedema is associated with patellar maltracking [91]. Another study found similar results 
[92] indicating that superolateral abnormalities in the IPFP may be an important abnormal 
biomechanical factor for patellofemoral joint and may be related to cartilage damage in this 
site. 
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IPFP volume may be related to its biomechanical abilities and be associated with knee OA. 
Recent studies described opposite results due to the different study design, sample size and 
measurements. Our previous study assessed IPFP maximum area in 977 older adults and found 
that this maximum area was significantly and negatively associated with radiographic OA, 
cartilage defect and BMLs, and knee symptoms, while significantly and positively associated 
with tibial and patellar cartilage volume cross-sectionally [93]. After an approximately 2.6 
years follow-up in this study, we found that IPFP maximum area was beneficially associated 
with changes in knee symptoms, tibial cartilage volume and defects in women [94]. Using 
similar measurements in 297 adults without knee OA, Teichtahl et.al. reported that larger IPFP 
maximum area was associated with reduced knee pain, less cartilage volume loss after an 
average 2.3 years follow-up [95]. Another study measured the IPFP volume in 174 patients 
with knee OA and reported that greater IPFP volume was associated with greater cartilage 
volume, fewer cartilage defects, and higher presence of BMLs and osteophytes [96]. One case-
control study showed that IPFP volume was lower in the group with patellar cartilage defects 
than that without [97]. In contrast, one cross-sectional study compared IPFP volume between 
participants with  (n = 35) and without (n = 11) patellofemoral joint OA and reported that IPFP 
volume was greater in group with OA and associated with worse pain [98]. Variations in 
sample size, measurements and disease severity could explain the inconsistent results. At early 
stage of knee OA, IPFP volume may be increased as inflammation would induce hypertrophy 
of adipocytes and immune cells. At end stage of knee OA, IPFP volume may be reduced due 
to the necrosis and fibrosis. Further well-designed studies are needed for determining the 
associations between IPFP volume and knee OA. 
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1.2.2.2   Inflammatory cytokines 
One underlying link between IPFP and knee OA may be the inflammatory cytokines. Although 
the trigger of IPFP inflammation is still unclear, it might be induced by obesity [99]. Figure 
1.5 shows that there are more macrophages that are infiltrated in inflamed IPFP induced by 
obesity compared to unaffected IPFP. Another study described that inflammatory infiltrations 
were present within the IPFP in 36% patients with end-stage of knee OA [100]. Some studies 
have shown that the infiltration of immune cells in the synovium could contribute to the process 
of OA disease by the production of pro-inflammatory and/or pro-fibrotic cytokines [101-103]. 
Inflamed IPFP with a high infiltration of immune cells may also play important roles in OA 
progression. The high infiltrating immune cells in IPFP may be due to the high rates of nerve 
fibres staining positive for substance P [76] that has the ability of causing vasodilation leading 
to extravasation of immune cells.  
 
In the pathogenesis of knee OA, the probable neurophysiological approach may elevate the 
release of substance P that activates related nerve fibres, generating a high infiltration of 
immune cells in IPFP. This high infiltration of immune cells within IPFP may affect knee OA 
processes by the production of pro-inflammatory cytokines which play roles in maintenance of 
cartilage and bone homeostasis [66-69]. The details of IPFP inflammatory characteristics have 
been investigated during the past decades. Ushiyama et al. reported that IPFP homogenates 
from knee OA patients contained detectable levels of IL-6 and TNF-, suggesting that IPFP 
may be another source of these cytokines which may contribute to knee OA [104]. Another 
group described that IPFP tissues obtained from obese OA patients had a 2-fold increase in the 
expression of gene for IL-6 and in the release of IL-6, and a 3.6-fold increase in the release of 
soluble IL-6 receptor (sIL-6R) compared with subcutaneous adipose tissue (ScAT) [67]. Klein-
Wieringa et al. also reported that IPFP samples from knee OA patients secreted higher levels 
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of IL-6, and larger amounts of TNF- and adipokines were found in IPFP-conditioned media, 
compared with ScAT [66]. A recent study reported that autologous fibroblast-like synoviocytes 
from knee OA patients cultured in IPFP-conditioned medium had significant higher expression 
and release of pro-inflammatory cytokines than ScAT-conditioned medium, suggesting that 
IPFP may induce synovial inflammation in patients with severe knee OA [69]. The 
inflammatory process in IPFP may have a positive feedback. Clockaerts et al. found that the 
expression and release of inflammatory cytokines could be stimulated by IL-1 and inhibited 
by an agonist of peroxisome proliferator activated receptor  (PPAR) [68]. Witonski et al. 
investigated the association between IL-6 and TNF- expression in IPFP and anterior knee 
pain and reported that patients with this knee pain had a significant higher expression of IL-6 
and TNF- in IPFP as compared to those who had no symptoms [105]. These suggest that IPFP 
may be involved in the pathogenesis of OA though inflammatory pathways. 
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Figure 1.5   Histomicrographs of IPFP under normal conditions where OA is not present (top) 
vs. OA induced by obesity (bottom) [106] 
 
1.2.2.3   Adipokines 
Besides the cytokines such as IL-1, IL-6 and TNF- secreted by IPFP, another group of 
proteins secreted mainly by white adipose tissues (also include IPFP) are adipokines, that can 
be also involved in the pathogenesis of knee OA. The adipokines act in an autocrine or 
paracrine manner and have potential roles in cartilage degradation, osteophyte formation and 
synovitis [107]. Leptin, well-researched adipokine, was thought to be beneficial for OA, as it 
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could upregulate proteoglycan synthesis and production of growth factors, and stimulate its 
own synthesis [36]. Recent evidence suggests that it has a different role. It can stimulate IL-1 
production [108], increase the effect of pro-inflammatory cytokines [109], induce the 
expression of matrix metalloproteinases (MMPs) in OA cartilage [108, 110], activate nitric 
oxide synthase synergistically with interferon- or enhance activation of nitric oxide synthase 
2 by IL-1 [109, 111], facilitate the activation of macrophages, neutrophils, natural killer cells 
and T helper 1 cells [112]. Another well-researched adipokine is adiponectin, which may have 
dual effects: it may have roles of resisting obesity and vascular diseases, and act as pro-
inflammatory agent [113]. It can also induce production of IL-6, nitric oxide and MMPs in 
different sites in knee joint [114, 115]. Resistin has been described as an inflammatory factor 
being associated with multiple inflammatory diseases [116, 117]. This adipokine can act as an 
endogenous ligand of Toll-like receptor (TLR)-4 that triggers major inflammatory pathways 
and has a significant role in mediating inflammatory responses [118]. Recent studies described 
that resistin could induce the secretion of pro-inflammatory cytokines such as IL-1β, IL-6 and 
TNF-α [39, 40] which had been implicated in the initiation and progression of OA [119]. 
 
The concentration of adipokines in the synovial fluid differs from serum levels, and joint 
structure may also release adipokines [120]. Synovium and osteophytes were believed to be 
the major sources of these adipokines [120]. Structurally similar as white adipose tissue, IPFP 
may also contribute to the release of adipokines. Previous studies have identified this secretory 
ability of IPFP [66, 68, 120, 121]. A recent study described that IPFP and synovium could 
express similar levels of adipokines, including leptin, chemerin and visfatin, in which leptin 
was the majority [121]. Interestingly, IPFP and synovium obtained from OA patients expressed 
significantly higher leptin and chemerin than those obtained from healthy donors. A similar 
result was found in another study, that IPFP from end-stage OA had higher expression of 
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adiponectin and leptin than those from early-stage of OA patients [122]. Although IPFP is not 
the only joint tissue secreting adipokines, the evidence shows that IPFP from OA patients 
releases higher amounts of adipokines, suggesting that it may be one pathway which IPFP 
involves in knee OA process. 
 
1.2.2.4   Lipid mediators 
Adipose tissue has the main biological function that stores and releases energy. Thus, it can 
secrete lipids that may also be involved in the process of knee OA. The main lipids and fatty 
acids are released in the process of lipolysis. These main lipids are considered to display 
immune modulatory properties: saturated fatty acids which have the pro-inflammatory effects 
[123], and unsaturated fatty acids which have the anti-inflammatory effects [124]. Besides fatty 
acids, their oxygenated derivatives, oxylipids, also have dual immune modulatory properties: 
anti- or pro- inflammatory effects, depending on their fatty acid precursor and the oxidizing 
enzymes involved in their synthesis [125, 126]. Prostaglandin E2 (PGE2), a mostly researched 
oxylipid, is produced by oxidation of -6 fatty acids by the cyclooxygenase, and has been 
shown to have a link with the pathogenesis of OA [127, 128]. Leukotriene B4 (LTB4), which 
has the same fatty acid precursor but is produced by the different oxidizing enzyme, the 
lipoxygenase, has the similar properties as PGE2: regulating pro-inflammatory cytokines and 
interstitial collagenase synthesis. Interestingly, OA osteoblasts which produce high levels of 
PGE2, have a low production of LTB4 and vice versa [129], suggesting that there could exist a 
selective metabolism of fatty acid via different oxidizing enzymes in the process of OA.  
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IPFP may also release free fatty acids and oxylipids. A study cultured IPFP-derived adipocytes 
to obtain adipocytes-conditioned medium and reported that free fatty acids were present 
including oleic, linoleic, palmitic and palmitoleic acids, as well as monohydroxylated 
derivatives of arachidonic acid, 5-, 12- and 15- hydroxyeicosatetraenoic acid, and PGE2 which 
were significantly detectable [130]. Another study compared different secretive profiles of fatty 
acids and oxylipids by IPFP obtained from OA and healthy donors [131]. It reported that a total 
of 29 oxylipids and fatty acids could be detected in IPFP-conditioned medium, and OA group 
contained reduced levels of the anti-inflammatory lipid mediator lipoxin A4 and elevated levels 
of thromboxane B2 and arachidonic acid compared with the healthy group. These interesting 
findings indicate that IPFP in OA patients may release more pro-inflammatory and less anti-
inflammatory lipid mediators, which may be a pathway that IPFP contributes to OA 
pathogenesis. 
 
In summary, IPFP may have dual roles in the homeostasis of the knee joint. With the normal 
structure and uninflamed status, IPFP may have the capacity of lubrication, pressure-relieving 
and shock absorbance, and joint stability maintenance, and could release anti-inflammatory 
cytokines, adipokines and lipid mediators. In contrast, inflamed IPFP may release pro-
inflammatory cytokines, adipokines and lipid mediators. IPFP may play an important role in 
the initiation and progression of knee OA through biomechanical and inflammatory pathways. 
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1.3   MRI structural biomarkers 
Radiographic OA including measures of JSN and osteophytes is an indirect measurement of 
cartilage loss [2]. It is weakly associated with clinical symptoms and a poor predictor of 
cartilage loss and total knee arthroplasty [132-134]. An estimate of over 10% of knee cartilage 
has been lost and over 40% patients have had cartilage defects at the time of knee structural 
changes presenting on a radiograph [135], suggesting it is not sensitive to detect structural 
changes in the knee. Plain radiography is not specific to one tissue. A recent study described 
that radiographic changes had no correlation with cartilage volume loss, but had a moderate 
correlation with changes in meniscal tears, over 10 years [136]. Thus, cartilage volume loss 
and meniscal pathologies cannot be distinguished on knee radiograph[137].  
As knee OA has been considered as a whole joint disease, new methods which can assess most 
knee joint structural changes and are more sensitive to these changes are needed in research 
areas and clinical practice. Imaging biomarkers, especially acquired from MRI, have been used 
in OA research for a decade [133]. Because of its advantage in quantitative assessments of 
morphology and integrity of the whole joint, MRI has been considered a sensitive technique to 
assess cartilage and subchondral bone abnormalities, synovitis, ligament and menisci failures, 
and several semi-quantitative scoring systems have been developed for evaluating these 
structural changes in OA [138-140]. 
 
1.3.1   Cartilage volume 
Traditionally cartilage loss was considered as the primary feature of knee OA progression. 
Although cartilage volume may increase due to swelling at an early stage of OA, cartilage 
volume is lost at a rate of up to 5% per year and 60% is lost by end stage knee OA [132]. 
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Cartilage of the whole joint can be directly visualized on MRI in one examination. Thus, 
cartilage volume, regardless of its location, can be directly measured on MRI, and semi-
automatically measures of the whole cartilage volume have been developed [141, 142]. Studies 
show that MRI-based cartilage volume measures have high accuracy and reproducibility [141, 
143, 144]. These quantitative data could be beneficial in both the assessment of risk factors 
and longitudinal monitoring of OA. 
 
The association between cartilage volume and knee symptoms is still inconsistent. A study 
including 132 subjects with symptomatic knee OA found a weak association between tibial 
cartilage volume and symptoms at baseline. In a longitudinal analysis, an increase in cartilage 
loss was weakly associated with worsening of symptoms [145]. Another study also reported 
that knee pain change was associated with a greater cartilage volume loss in the central tibial 
plateau [146]. In contrast, a study with a small sample size reported that changes in knee pain 
was not associated with cartilage loss over 2.4 years [147]. 
 
Cartilage volume is correlated with radiographic assessment. A cross-sectional study reported 
that radiographic joint space narrowing was inversely associated with tibial cartilage volume 
[148]. The same result was found in another study, that joint space narrowing but not 
osteophytes was associated with tibial cartilage volume [149]. A longitudinal study reported 
that joint space narrowing was strongly associated with cartilage loss in the central areas of 
both plateaus and condyles [146]. On the other hand, there are studies reporting no longitudinal 
associations between cartilage volume loss and radiographic changes in the knee [150, 151]. 
 
Cartilage volume loss is an independent predictor of total knee arthroplasty (TKA). One study 
reported that for every 1% increase in the rate of tibial cartilage loss there was a 20% increased 
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risk of undergoing a TKA after 4 years [132]. Another study reported that medial compartment 
of cartilage volume loss was one of strong predictors (OR: 18.70; 95%CI: 2.40 to 145.67) of 
TKA [152]. 
 
1.3.2   Cartilage defects 
Cartilage defects, semi-quantitatively assessed by MRI, are the abnormal intrachondral signal 
or irregularities on the surface or bottom of articular cartilage [135]. This assessment can be 
used to evaluate the morphological characteristics of regional articular cartilage, while cartilage 
volume mainly represents global cartilage morphology. Although knee cartilage defects are 
very common in healthy individuals and have a relatively variable natural history [153, 154], 
improvement is highly unlikely and predicted by young age, lower BMI, decrease in BMI and 
no radiographic changes [135]. The etiology of cartilage defects remains unclear and they are 
not synonymous with cartilage loss. They can identify individuals at risk of faster cartilage loss, 
and can be regarded as important MRI biomarkers of early cartilage damage [133]. 
 
The associations between cartilage defects and knee symptoms have been investigated in the 
past decade. Most studies reported that the severity of cartilage defects was associated with 
knee pain in both young and older adults [135, 155-157]. One study investigated the 
associations between cartilage defects and incident knee pain, and found that medial tibial 
cartilage defects at baseline were positively correlated with the incidence of knee pain, as well 
as there was a positive association between progressive cartilage defects and the incidence of 
knee pain [158]. Another study also reported that cartilage defects could predict the increase 
of knee pain over 3.3 and 7.5 years[159]. Moderate to severe cartilage defects, especially full-
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thickness cartilage defects accompanied by subchondral bone exposure, were more likely 
associated with knee pain [160]. 
 
Cartilage defects have been shown to have a significant association with radiographic changes 
in knee joint [161-163]. A cross-sectional study including 372 participants indicated that 
cartilage defects had an independent correlation with osteophytes, but not with joint space 
narrowing [153]. A longitudinal study with a 2.9-years follow-up showed that radiographic OA 
score was positively associated with cartilage defects cross-sectionally and could predict an 
increase in cartilage defects over years [154]. The same results were also found in another 
study [164]. 
 
Although cartilage defects are not synonymous with cartilage volume loss, there is a dose-
response relationship between cartilage defect score and cartilage volume loss [165]. One study 
reported that patellar cartilage defects were positively associated with annual patellar cartilage 
loss, and this association was not found in tibiofemoral compartment [166]. Another study 
illustrated that baseline cartilage defects could predict cartilage volume loss at both tibial and 
patellar sites over 2.9 years [154]. Conversely, baseline cartilage volume had a site-specifically 
association with changes in cartilage defects over 2 years [167].  
 
Cartilage defects are predictive of TKA. Subjects with higher score of cartilage defects were 
associated with a 6.0-fold increased risk of TKA over 4 years compared with those with lower 
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score of cartilage defects [166]. Recent studies also described that baseline cartilage defects 
were associated with an increased risk of TKA over 5 years [154, 168].  
 
1.3.3   Bone marrow lesions 
BMLs, also known as bone marrow oedema, are characterized as non-cystic ill-defined 
subchondral areas of high signal intensity on T2-weighted or proton density-weighted fat-
suppressed (FS) fast spin echo (FSE) or short tau inversion recovery (STIR) images [169]. 
These regional bone marrow signal intensity alterations on MRI were initially described by 
Wilson et al. for the MRI finding in patients with severe knee and hip pain without any specific 
radiographic changes [170]. Histological studies have shown that various pathological entities, 
but not only oedema, could exhibit the same pattern on MRI [171-173]. One histological study 
using samples taken from end-stage knee OA patients undergoing TKA identified that these 
abnormalities consisted of bone marrow necrosis, abnormal trabeculae, bone marrow fibrosis, 
bone marrow oedema, and bone marrow bleeding [174]. Thus, the term of BMLs, but not bone 
marrow oedema, has been more commonly accepted in the OA research community [139]. 
 
BMLs has been associated with knee symptoms. A cross-sectional study reported that BMLs 
were independently correlated with the presence of knee pain and large lesions appeared 
exclusively in patients with knee pain [175]. The cross-sectional association between BMLs 
and knee pain was confirmed both in patients with knee OA and in older adults [156, 160]. A 
study using Boston Leeds Osteoarthritis Score (BLOKS) to assess BMLs reported that maximal 
area of BMLs had a positive association with VAS pain [139]. A nested case-control study 
examined the correlation of the development of knee pain with enlarging BMLs, and illustrated 
that cases without knee pain at baseline but with knee pain at follow-up had significantly larger 
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increases in BMLs compared to controls [176]. Zhang et al. reported that changes in BMLs 
were significantly associated with fluctuations in knee pain in patients with knee OA [177]. A 
population-based cohort study showed that changes in BMLs size was associated with changes 
in knee pain in participants without established ROA [178]. Two systematic reviews provided 
evidence that BMLs had a moderate to strong correlation with knee pain [179, 180]. 
 
BMLs could be considered as a predictor of radiographic progression of knee OA. One study 
with 15-month and 30-month follow-up investigated the association between BMLs and 
radiographic progression of knee OA, and found that BMLs were associated with site-specific 
progression of knee OA [181]. Another study defined the radiographic progression of knee OA 
as an increase of K/L score from 1 to 2, and reported that BMLs was positively associated 
with the progression of knee OA (OR: 2.0, 95%CI: 1.2 to 3.4) [182]. The similar results were 
obtained from other two studies [183, 184]. 
 
BMLs are associated with other MRI biomarkers. Carnes et al. demonstrated a cross-sectional 
association between cartilage defects and BMLs [154]. This cross-sectional association was 
also found in younger adults [185]. In addition, longitudinal associations between BMLs and 
cartilage loss were illustrated [139]. A longitudinal study reported that patellar BMLs were 
associated with patellar cartilage volume and defects at baseline, and could predict changes in 
both cartilage volume and defects in patellar compartment [186]; furthermore, patellofemoral 
cartilage volume was negatively associated with patellofemoral BMLs and baseline 
patellofemoral cartilage defects were positively associated with an increase in patellofemoral 
BMLs [187]. Besides the patellofemoral compartment, BMLs could predict site-specific 
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cartilage defect progression and cartilage volume loss in a dose-response manner in the 
tibiofemoral compartment [188]. 
 
The predictive values of BMLs for TKA have been investigated in recent years. One study with 
a 3-year follow-up reported that subjects with BMLs had a higher risk of TKA than those 
without BMLs [189]. BMLs, especially in the medial compartment, were the strongest 
independent long-term predictor of TKA [152]. In subjects from the general population, but 
not knee OA patients, baseline BMLs were predictive of TKA [178]. Another study also 
reported that increases in BML score was correlated with the risk of TKA [190]. 
 
1.3.4   Effusion-synovitis 
Effusion-synovitis refers MRI-detected joint effusion, which equals both inflamed synovium 
and synovial fluid, but not the definite synovitis, and it is present in 96.3% knees with effusion 
[191]. Non-enhanced MRI cannot differentiate synovitis and effusion [140]. However, due to 
the higher cost and chance of side effects of enhanced MRI, effusion-synovitis measured by 
non-enhanced MRI has been widely used in OA research community. Furthermore, effusion-
synovitis detected on un-enhanced MRI had higher correlations and sensitivity with synovitis 
measured by enhanced MRI [192].  Effusion-synovitis could be visualised in different regions 
within the knee, including peri-patellar areas, intercondylar region and around the anterior and 
posterior cruciate ligament [191]. 
 
Our group assessed effusion-synovitis using semi-quantitative and quantitative methods [193, 
194]. Effusion-synovitis assessed by semi-quantitative method was independently associated 
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with knee pain both cross-sectionally and longitudinally [195]. Quantitative and semi-
quantitative assessments of baseline effusion-synovitis were associated with baseline MRI-
detected structural changes including cartilage defects, cartilage volume and BMLs, and 
predicted the changes in MRI-detected structures, in population-based study [193, 194]. In 
patients with knee OA, baseline cartilage defects and JSN were associated with change in 
effusion-synovitis, and baseline effusion-synovitis predicted changes in cartilage volume [196]. 
In this study, effusion-synovitis had a positive association with cartilage defects and BMLs, 
and a negative association with cartilage volume in analyses using mix-effects models. Another 
longitudinal study reported that baseline effusion-synovitis was associated with an increased 
risk of cartilage loss [197]. 
 
There is strong evidence to show that effusion-synovitis is correlated with symptomatic and 
radiographic progression of knee OA [198-201]. A nested case-control study using K/L score 
to define the incidence of knee OA, and reported that participants with the presence of effusion-
synovitis had a higher risk for the occurrence of incident ROA [201]. A similar result was 
found by another nested case-control study, which showed that the presence of effusion-
synovitis could predict the radiographic OA incidence [200]. Other two nested case-control 
study described that more cases with knee OA progression experienced worsening in effusion-
synovitis [198, 199]. 
 
There are a few studies demonstrating effusion-synovitis predicts TKA [202, 203]. A study 
reported that participants who underwent TKA were more likely to have effusion-synovitis at 
baseline, and have worsening effusion-synovitis over 12 months, compared to those did not 
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undergo TKA [202]. A more recent study reported that knees exhibited effusion-synovitis at 
two or more subregions had increased risks of TKA in the subsequent 12 months compared 
with knees that did not [203]. 
 
1.3.5   Infrapatellar fat pad signal intensity alteration 
Signal intensity alterations of IPFP measured by MRI can be regarded as an imaging biomarker 
for knee OA. These signal intensity alterations include higher or lower signal changes. IPFP 
high signal intensity alteration assessed on unenhanced T2-weighted or proton density-
weighted fat-suppressed MRI, has been widely used in the clinical research community of knee 
OA as a surrogate for peripatellar synovitis [204, 205]. The contrast-enhanced T1-weighted 
MRI, which is the ideal way to quantify knee synovitis, cannot become the routine method to 
assess knee synovitis, as the contrast injection is costly and may have side effects. 
 
 High signal intensity alteration of IPFP are named as Hoffa-synovitis. However, a pathological 
study illustrated that there were vascular neoformations, fibrosis, and chronic inflammation in 
IPFP obtained from end-stage OA patients [206]. Signal intensity alterations within the IPFP 
may not be only a surrogate for synovitis, but also other pathological changes which may be 
involved in the pathogenesis of knee OA. Although a recent study suggested that effusion-
synovitis should be preferred over Hoffa-synovitis as a surrogate marker for synovial 
thickening [192], IPFP signal intensity alteration may not only represent synovitis, should be 
given an important consideration in knee OA research. 
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IPFP high signal intensity alteration are associated with knee pain in knee OA patients [207]. 
A most recent study reported that Hoffa-synovitis was significantly associated with WOMAC 
knee pain [208]. Consistently, changes in Hoffa-synovitis were strongly related to changes in 
knee pain in longitudinal study [205]. 
 
IPFP high signal intensity alterations are associated with knee OA progression. A nested case-
control study described that the presence of Hoffa-synovitis strongly predicted the 
development of radiographic knee OA [201]. Another nested case-control study showed that 
the presence of Hoffa-synovitis had strong associations with the increased risks of ROA in the 
subsequent 12 or 24 months [200]. Besides radiographic progression, two other nested case-
control studies including symptomatic progression reported that cases experienced more 
worsening in Hoffa-synovitis than controls [198, 199]. 
 
IPFP high signal intensity alteration is related to MRI- and serum- biomarkers. A cross-
sectional study described that high signal intensity alteration in superolateral IPFP was 
positively associated with cartilage damage and BMLs in patellofemoral joint  [209]. In 
contrast, a study demonstrated that baseline Hoffa-synovitis was not associated with an 
increased risk of cartilage loss over 30 months [197]. There were also significant associations 
between Hoffa-synovitis and serum biomarkers including hyaluronic acid, MMP-3, and 
nitrated epitope of the α-helical region of type II collagen (sColl2-1NO2) [210]. Another study 
demonstrated that IPFP high signal intensity alteration was associated with serum IL-17 and 
adipokines such as adiponectin and resistin [211]. 
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Similar as effusion-synovitis, Hoffa-synovitis can predict TKA [203]. Knees with Hoffa-
synovitis in two or more subregions had the higher risk (OR: 2.17, 95%CI: 1.33 to 3.56) for 
TKA compared with knees that did not exhibit these features. Baseline Hoffa-synovitis had no 
associations with the risk of TKA, but the worsening of Hoffa-synovitis over 12 months was 
associated with an increased risk of TKA [202].  
 
There are few studies reporting the associations between hypointense signals within IPFP and 
knee OA. Hypointense signals within IPFP on T2-weighted MRI may represent fibrosis or 
postoperative scarring [70, 73], chronic inflammation progressing from acute inflammation of 
the synovium due to micro-trauma of this tissue [212], or synovial thickening or fibrosis [213, 
214]. A study compared low signal intensity changes in the plantar fat pad on MRI with 
histological changes and reported that these signal changes corresponded to fibrosis [215]. This 
fibrosis can be induced by chronic inflammation in the synovium [212], or periarticular 
surgeries or trauma around knees [70]. Although links between synovitis, surgical history and 
trauma in knee OA have been identified [216, 217], there has been no evidence showing that 
low signal intensity within the IPFP assessed by MRI is associated with symptoms and knee 
structure changes in the knee. 
 
In summary, MRI biomarkers have been widely used in the clinical research of knee OA. New 
MRI biomarkers, or new methods to assess structural changes of the knee using MRI, is 
important in knee OA research. The thesis mainly focuses on the semi-quantitative and 
quantitative measurement of IPFP signal intensity alterations. 
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1.4   Summary 
 
OA is the most common and prevalent chronic joint disorder in older adults, and the knee is 
the most common joint affected. To date, it has been considered as a disease of the whole joint, 
affecting not only articular cartilage but also subchondral bone, menisci, ligaments, muscles, 
capsule, synovium and IPFP. Although the aetiology and progression of this disease are not 
well understood, it is a multifactorial condition with risk factors including genetics, aging, 
female sex, injury and obesity. 
 
IPFP may have dual roles in the homeostasis of knee joint. With the normal structure and 
uninflamed status, IPFP may have the capacity of lubrication, pressure-relieving and shock 
absorbance, and joint stability maintenance, which contributes to the normal function of the 
knee joint. In addition, unaffected IPFP may release anti-inflammatory cytokines, adipokines, 
and lipid mediators, which help keep the knee joint free of inflammation. After a trigger (e.e. 
obesity, trauma, or ageing) is pulled, IPFP becomes inflamed and releases more pro-
inflammatory cytokines, adipokines, and lipid mediators, which cross-talks with other joint 
structures such as the synovium, cartilage, meniscus, and subchondral bone, and results in low-
grade inflammation in the knee joint. This low-grade inflammation could induce the 
degradation of cartilage and other knee joint structures. Furthermore, high release of pro-
inflammatory mediators may lead to knee pain and other symptoms. The degradation of the 
IPFP causes abnormal changes in knee structures and function. Abnormal IPFP may play an 
important role in the initiation and progression of knee OA through biomechanical and 
inflammatory pathways. 
 
MRI is becoming a popular research tool for the visualization of all structural abnormalities 
within the knee joint. Besides the commonly used MRI biomarkers such as cartilage volume, 
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cartilage defects, BMLs and effusion-synovitis, MRI can also assess IPFP abnormalities semi-
quantitatively and quantitatively, which may be correlated with disease symptoms and 
progression of knee OA. 
 
The following chapters investigate the associations between semi-quantitative and quantitative 
IPFP high or low signal intensity alterations and joint symptoms, structural changes, and serum 
biomarkers in knee OA, as well as the natural history and factors affecting their changes. The 
research questions which directed this work are described in the following chapter. 
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Chapter 1 reviews the background and rationale of this thesis. The research questions of this 
thesis are summarized as follows: 
1. Is there any cross-sectional and/or longitudinal association between semi-quantitative 
measures of infrapatellar fat pad high signal intensity alteration and knee symptoms 
and structural changes in older adults? 
2. Is there any cross-sectional and/or longitudinal association between semi-quantitative 
measures of hypointense signals in the infrapatellar fat pad and knee structural change 
and symptoms in older adults? 
3. Are quantitative measures of infrapatellar fat pad high signal intensity alteration 
associated with knee structural abnormalities in patients with symptomatic knee OA? 
4. Is serum levels of resistin associated with knee synovitis measures and structural 
changes in patients with knee OA? 
5. What is the natural history of infrapatellar fat pad high signal intensity alteration 
(quantitative measures) and which factors could affect its changes? 
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Chapter 4 and 5 arose from analyses using the data from the TASOAC study. Chapter 6, 7 and 
8 arose from analyses using data from the VIDEO study, which is a randomized, double-blind, 
placebo-controlled clinical trial. This chapter describes the study population and design for the 
TASOAC and VIDEO study, as well as the protocols for measurements of factors which are 
common to multiple chapters in the thesis. Additional factors which are unique to each chapter 
are described in more detail in the methodology section of each of the subsequent chapters. 
 
It should be noted that the following chapters are presented in the form in which they were 
submitted to, or accepted by, peer-reviewed journals for publication. Thus, throughout these 
chapters, there are some differences in the description of methods, analyses, results, and 
interpretation, due chiefly to requests from journal reviewers. 
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3.1    Study Design of Tasmanian Older Adult Cohort (TASOAC) study 
The TASOAC study is an ongoing prospective, population-based study, aimed at identifying 
the environmental, genetic, and biochemical factors associated with the development and 
progression of OA (assessed by both X-ray and MRI) at multiple sites including hand, knee, 
hip and spine. 
 
3.1.1   Study population and design 
The cohort consisted of participants aged between 50 and 80 years (mean: 62 years; SD: 7 
years), selected from the roll of electors in southern Tasmania (population 229,000), a 
comprehensive population listing with an equal number of men and women, using stratified 
simple random sampling without replacement. Due to the compulsion of voting in federal and 
state election in Australia, electoral rolls represent the complete population information. The 
sample was stratified by sex to provide equal numbers of men and women, and equal 
distribution was drawn from urban and rural areas in Southern Tasmania. Institutionalized 
older adults were excluded in this study as it was designed to examine community-dwelling 
older adults. Participants, who reported contraindication for MRI such as metal sutures, the 
presence of shrapnel, iron filings in the eye and claustrophobia, were excluded as this test was 
required in this study. 
 
The overview of participant recruitment and withdrawal during the study period was shown in 
Figure 3.1. The first phase of this study was performed between March 2002 and September 
2004. A total of 2,135 eligible participants were identified from which 1,904 were able to be 
contacted. Of them, 1,100 enrolled in the study, and 1099 attended a baseline clinic (response 
rate 51%). The phase 2 follow-up was conducted 2.6 years later (rang: 1.4 – 4.9 years), with a 
set of measures completed also at a phase 3 follow-up after 5.1 years (range: 3.6 – 6.9 years), 
Chapter 3. Methodology 
 
52 
and a phase 4 follow-up after 10.7 years (range: 9.2 – 12.5 years).  
 
3.1.2   Sample size 
This study was in progress when the commencement of the PhD candidature, thus, formal 
sample size calculations were not performed during the design of the thesis. Participants in the 
analyses reported in the thesis were limited to those recruited at baseline and follow-up, and to 
those had completed data for relevant outcome and study factors. Therefore, sample sizes vary 
between chapters, and the reasons for exclusion are described in each chapter. Otherwise, it 
subsequently proved that sample sizes were more than adequate to answer the thesis research 
questions. 
 
3.1.3   Ethical issues 
The TASOAC study were approved by the Southern Tasmanian Health and Medical Human 
Research Ethics Committee (Ethics Approval Number: H6488). Written informed consent was 
obtained from all participants prior to enrolment in the study. 
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Figure 3.1   Flowchart of TASOAC study participants. 
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3.2   Study design of Vitamin D Effect on Osteoarthritis (VIDEO) study 
VIDEO study is a multicentre, randomized, placebo-controlled double-blind clinical trial. 
The aim of this study is to compare the effects of vitamin D supplementation versus placebo 
on knee structural and symptomatic changes in patients with symptomatic knee OA over a 2-
year period. 
 
3.2.1   Study population and design 
The VIDEO study recruited patients with symptomatic knee OA in Southern Tasmania and 
Melbourne, by using a combined strategy, including collaboration with general practitioners, 
specialist rheumatologists, and orthopaedic surgeons, as well as advertising through local 
media. The inclusion and exclusion criteria of participants for this study are listed below: 
Inclusion criteria:  
I. Age 50-79 years old;   
II. Men and women with symptomatic knee OA for at least 6 months with a pain visual 
analogue scale (VAS) of at least 20 mm;   
III. Meet the ACR criteria [21] for symptomatic knee OA assessed by a rheumatologist;   
IV. Have an ACR functional class rating of I, II and III [218];   
V. Have relatively good health (0-2 according to the investigators global assessment of 
disease status on a 5-point Likert scale, range 0 [very well] to 4 [very poor]); and   
VI. Have serum vitamin D level of >12.5 nmol/L and <60 nmol/L.   
VII. Is able to read, speak and understand English, capable of understanding the study 
requirements and willing to co-operate with the study instructions.  
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Exclusion criteria:  
I. Patients with severe radiographic knee OA (grade 3 according to Altman’s atlas [219]);  
II. Patients with severe knee pain (on standing more than 80 mm on a 100-mm VAS);   
III. Any contra-indication to having an MRI.   
IV. Patients with rheumatoid arthritis, psoriatic arthritis, lupus, or cancer;   
V. Patients with severe cardiac or renal function impairment   
VI. Patients with hypersensitivity to vitamin D;   
VII. Patients with any condition possibly affecting oral drug absorption (e.g. gastrectomy or 
clinically significant diabetic gastro-enteropathy);   
VIII. Having significant trauma to the knees including arthroscopy or significant injury to 
ligaments or menisci of the knee within 1 year preceding the study;   
IX. Having anticipated need for knee or hip surgery in the next 2 years;   
X. Having taken Vitamin D supplements in last 30 days.  
An overview of participant recruitment and withdrawal during this study is shown in Figure 
3.2. A total of 599 participants were screened for eligibility from Jun 2010 to Dec 2011. Of 
which, 186 participants were excluded according to the exclusion criteria, and 413 participants 
were randomized to treatment and control groups. 
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Figure 3.2   Flowchart of VIDEO study participants. 
 
3.2.2   Randomization and masking 
Participants were allocated to either vitamin D or placebo group at a ratio of 1:1 based on 
computer-generated random numbers. Allocation concealment was ensured by a central 
automated allocation procedure that was independent of investigators. Participants, research 
coordinators and investigators were all blinded to the treatment assignment. Blinding was 
Chapter 3. Methodology 
 
57 
maintained until all the data were collected, confirmed for accuracy and cleaned, and statistical 
analyses were performed. 
 
3.2.3   Interventions 
Participants in the treatment group were given a monthly capsule of 50,000IU (1.25 mg) 
vitamin D3 (cholecalciferol) for 24 months. The vitamin D3 compound was purchased from 
Nationwide Compounding Pharmacy, Melbourne, Australia. In the control group, participants 
were given an identical inert placebo provided by the same company. 
 
3.2.4   25OHD assays 
Serum 25OHD was assayed at screening, month 3 and 24, utilizing a direct competitive 
chemiluminescent immunoassay (DiaSorin Inc., Stillwater, Minnesota, USA). The intra- assay 
and interassay coefficients of variation were 3.2% and 6.0%.  
 
3.2.5   Outcomes 
 
Primary outcome measures were changes in knee pain assessed using the WOMAC score from 
baseline to month 24. Secondary outcomes included VAS knee pain, lower limb muscle 
strength and structural changes on MRI.  
 
3.2.6   Sample size 
Sample size calculation assumed α = 0.05 and β = 0.20, and was performed based on the Cohen 
formula [220]. For change in WOMAC pain, the previous study reported a standard deviation 
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of 70.5 on a score from 0 to 500 [221]. The minimal clinically important difference (MCID) 
for WOMAC pain was previously reported to be 16% reduction of the score from baseline [222, 
223]. With 400 participants, a difference between groups of 20 units on the score is detectable 
with 80% power.  
 
3.2.7   Ethical issues 
Ethics approval was received from the Tasmania Health and Human Medical Research Ethics 
Committee (reference number H1040) and Monash University Human Research Ethics 
Committee (reference number CF10/1182-2010000616). Informed written consent was 
obtained from all participants.  
 
3.3   Anthropometrics 
Height was measured to the nearest 0.1 cm (with shoes, socks, and headgear removed) using a 
stadiometer. Weight was measured to the nearest 0.1 kg (with shoes, socks, and bulky clothing 
removed) by using a single pair of electronic scales (Delta Model 707, Seca, Hamburg, 
Germany) that were calibrated using a known weight at the beginning of each clinic. Body 
mass index (BMI, weight (kg)/height (m2)) was calculated. 
 
3.4   X-ray 
A standing anteroposterior semi-flexed view of the right knee with 15 degrees of fixed knee 
flexion was performed, and radiographs were individually assessed for JSN and osteophytes 
on a scale of 0-3 (0 = normal and 3 = most severe) using the OARSI atlas developed by Altman 
et al [224]. JSN was assessed in medial and lateral compartments, while osteophytes in medial 
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femoral, medial tibial, lateral femoral, and lateral tibial compartments. Each score was 
determined by consensus of two readers who simultaneously assessed the radiograph with 
immediate reference to the atlas. Intra-observer repeatability was assessed in 40 subjects with 
an interval of at least one week between the two measurements. Intraclass correlation 
coefficients (ICCs) ranged from 0.65– 0.85. The presence of ROA was defined as any score ≥ 
1 for JSN or osteophytes, as previously described [149]. 
 
3.5   Magnetic resonance imaging 
3.5.1   MRI protocol 
In the TASOAC study, MRI scans of the right knees were performed at baseline and follow-
up. Knees were imaged in the sagittal plane on a 1.5-T whole body magnetic resonance unit 
(Picker, Cleveland, OH, USA) with use of a commercial transmit-receive extremity coil. Image 
sequences included the following: (1) a T1-weighted fat saturation three-dimensional (3D) 
gradient-recalled acquisition in the steady state, flip angle 30◦, repetition time 31 ms, echo time 
6.71 ms, field of view 16 cm, 60 partitions, 512 × 512 pixel matrix, acquisition time 5 min 58 
s, one acquisition; sagittal images were obtained at a slice thickness of 1.5 mm without an inter-
slice gap; and (2) a T2-weighted fat saturation two- dimensional (2D) fast spin echo, flip angle 
90◦, repetition time 3067 ms, echo time 112 ms, field of view 16 cm, 15 partitions, 228 × 256 
pixel matrix; sagittal images were obtained at a slice thickness of 4 mm with an inter-slice gap 
of 0.5–1.0 mm.  
 
In the VIDEO study, MRI scans of the study knee were obtained according to a standardized 
protocol using a 1.5 T whole-body MRI unit with a commercial transmit-receive extremity coil. 
The following sequences were used: a) sagittal fat saturated (FS) T1-weighted spoiled gradient 
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echo (GRE) with flip angle 30◦, repetition time 31 ms, echo time 6.71 ms, field of view (FOV) 
160 mm, acquisition time 5 min 58 s, 60 slices, 512 × 512 pixel matrix slice thickness of 1.5 
mm without between-slice gap. b) T2-weighted/proton density-weighted fast spin echo (FSE) 
sequences: sagittal FS T2-weighted 3D FSE sequence, flip angle 90◦, repetition time 3,067 ms, 
echo time 112 ms, FOV 16 cm, 15 slices, 228 × 256 pixel matrix slice thickness of 2 mm with 
a between-slices gap of 0.5–1.0 mm; coronal FS proton density- weighted FSE sequence, 
repetition time 3,400 ms, echo time 64 ms, flip angle 90◦, slice thickness 3 mm, FOV 16 cm, 
pixel matrix 256 × 256, acquisition time 5 min 26 s.  
 
3.5.2   Cartilage volume assessment 
Cartilage volume was assessed using the previously described image processing techniques 
[225]. The volumes of individual cartilage plates (medial tibial, lateral tibial and patellar) were 
isolated by manually drawing disarticulation contours around the cartilage boundaries on a 
section-by-section basis then resampled by means of bilinear and cubic interpolation for final 
3D rendering using OsiriX Lite imaging software (32-bit version 5·9, Pixmeo SARL, Geneva, 
Switzerland). The coefficient of variation (CV) was 2·1% for medial tibia and 2·2% for lateral 
tibia [226].  
 
3.5.3   Cartilage defects assessment 
Cartilage defects were evaluated using a modified Outerbridge classification [227] at medial 
tibial, lateral tibial, medial femoral, lateral femoral, femoral trochlear, and patellar  sites: grade 
0, normal cartilage; grade 1, focal blistering and intracrtilaginous hyperintensity with an normal 
contour; grade 2, irregularities on the surface and loss of thickness of less than 50%; grade 3, 
deep ulceration with loss of thickness of more than 50% without exposure of subchondral bone; 
grade 4, full thickness chondral wear with exposure of subchondral bone. Intra-observer 
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reliabilities (expressed as ICCs) ranged from 0.89 to 0.94 for different compartments. Inter-
observer reliabilities were assessed in 50 MR images and yielded correlation coefficients of 
0.85 to 0.93 for different compartments [153].  
 
3.5.4   Subchondral bone marrow lesions assessment 
Subchondral bone marrow lesions (BMLs) were defined as discrete areas of increased signal 
adjacent to the subchondral bone. They were measured semi-quantitatively using the modified 
Whole-Organ Magnetic Resonance Imaging Score (WORMS) method [138]. BMLs were 
scored from 0 to 3 based on the extent of subregional involvement (0 = none; 1 = < 25% of the 
subregion; 2 = 25-50%; 3 = >50%). The ICCs were 0.93-0.98 for this scoring system [228]. 
 
3.5.5   Effusion-synovitis assessment 
Quantitative measurement: 
Effusion-synovitis was distinguished in the following subregions according to the anatomy of 
the knee joint synovial cavity [229]: 1) the suprapatellar pouch, extending superiorly from the 
upper surface of the patellar, between the posterior suprapatellar fat pad (quadriceps femoris 
tendon) and the anterior surface of the femur; 2) the central portion, that includes the area 
between the central femoral and tibial condyles, around the ligaments and menisci, and the area 
behind the posterior portion of each femoral condyle, inside of the joint capsule. The volumes 
of individual joint subregions were isolated from the total volume by selecting each region of 
interest (ROI) according to the intra-articular fluid-equivalent signal on a section-by-section 
basis. The final 3-D volume rendering was generated using commercial in-house OsiriX Lite 
imaging software cursors (32-bit version 5.9, Pixmeo SARL, Geneva, Switzerland) [230]. The 
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readers were blinded to treatment allocation and patients’ information. The ICCs were 0.96-
0.97 and inter-reader correlation coefficients were 0.93-0.99 in different subregions. 
 
Semi-quantitative measurement: 
Effusion-synovitis in each subregion was scored individually according to WORMS, grading 
collectively from 0 to 3 based on the estimated maximal distention of the synovial cavity as 
following: 0 = normal; 1 = ≤ 33% of maximum potential distention; 2 = 33%-66% of maximum 
potential distention; 3 = ≥ 66% of maximum potential distention [138]. The inter-reader 
reliability was 0.63-0.75 and intra-reader reliability was 0.60-0.75 (weighted κ) in different 
subregions as described previously [231]. 
 
3.5.6   IPFP signal intensity alteration assessment 
Semi-quantitative measurement: 
IPFP signal intensity alteration at baseline and follow-up was assessed by an experienced 
orthopaedist trained by an experienced radiologist, using T2-weighted MR images (Figure 3.3). 
Signal intensity alteration, defined as discrete areas of increased signal within IPFP, was graded 
as follows: grade 0 = none; grade 1＝ < 10% of the region; grade 2 = 10% to 20% of the region; 
grade 3 = >20% of the region. Intraobserver and interobsever reliabilities were assessed in 100 
subjects with an ICCs of 0.90 and an interclass correlation coefficient of 0.89, respectively. 
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Figure 3.3   Semi-quantitative measurements of IPFP high signal intensity alteration. 
A: normal IPFP; B: arrow indicates signal intensity alteration of IPFP (grade 1); C: arrow points to signal 
intensity alteration of IPFP (grade 2); D: arrow indicates signal intensity alteration of IPFP (grade 3). 
 
Hypointense signals within IPFP was scored by counting imaging slices with this abnormality: 
grade 0 = none; grade 1 = 1- 2 slices, grade 2 = 3-5 slices, grade 3 = ≥ 6 slices. This 
measurement was conducted by two experienced orthopaedists trained by an experienced 
radiologist, and determined using T2-weighted MR images (Figure 3.4).  Intraobserver and 
interobsever reliabilities were assessed in 100 subjects with an ICC of 0.94 and an interobserver 
correlation coefficient of 0.88. 
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Figure 3.4   Hypointense signals on sagittal T2-weighted images with fat saturation. 
A: normal IPFP; B: grade 1 hypointense signals of IPFP (arrow); C: grade 2 hypointense signals of IPFP (arrow); D: 
grade 3 hypointense signals of IPFP (arrow). 
 
 
 
Quantitative measurement: 
High signal intensity in IPFP was assessed (by WH) on sagittal planes of FSS T2-weighted 
images using MATLAB as described previously (Figure 3.5) [232]. The segmentation of IPFP 
was performed at ten intermediate slices in whole IPFP in order to avoiding the interference 
from other tissues (i.e. synovium, ligaments and subcutaneous fat) and effusion which were 
hard to distinguish in the beginning and ending slices. This measurement is a semi-automated 
procedure. An initial lasso was automatically created by a set of points selected manually near 
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the outer contour of IPFP and then contracted inward to approximate the real boundary of IPFP 
automatically. High signal intensity alterations were obtained by newly developed algorithm. 
Data were output automatically. We previously reported [232]: among these measurements, 
Clustering factor (H) and sDev (IPFP) were consistently and significantly associated with all 
joint structural measurements; Percentage (H) and Volume (H) were consistently and 
significantly associated with knee cartilage defects and ROA but not with BMLs, while Median 
(H) and UQ (H) were only significantly associated with tibiofemoral cartilage defects; Mean 
(IPFP) was not significantly associated with any knee structural measurements. 
 
All these measures can be classified as four categories: signal intensity of whole IPFP, high 
signal intensity of IPFP, volume of high signal intensity and clustering effect of high signal 
intensity. Based on the concurrent validity and the clinical construct validity we reported, we 
selected one measure from each category into the current study: sDev (IPFP), UQ (H), 
Percentage (H) and Clustering factor (H).  Of them, sDev (IPFP), being introduced to represent 
signal intensity variation of IPFP, is the standard deviation of whole IPFP signal intensity; UQ 
(H), representing the value of high signal intensity, is the upper quartile value of high signal 
intensity; Percentage (H), being calculated as the ratio of volume of high signal intensity region 
to whole IPFP volume, represents the adjusted quantity of high signal intensity; and Clustering 
factor (H) is calculated as: 
Clustering factor (H) =
∑ 𝑉𝑜𝑙𝑖/ ∑ 𝑉𝑜𝑙𝑗
n
j=1
m
i=1
m/n
 
 where, 
m = {
n ∗ 10%    n > 10
1                 n ≤ 10
 
n is the number of high intensity regions. Volj is the volume of seed group  Pj. ∑ Volj
n
j=1  is the 
total volume of high intensity regions.  ∑ Voli
m
i=1  is the volume of the top m largest high 
intensity regions. Clustering factor (H) reflects the actual clustering effects, the bigger 
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Factor(H) , the greater clustering effects. Intraobserver and interobsever reliabilities of these 
quantitative measurements ranged from 0.92 to 0.96 (ICC) and from 0.90 to 0.94, respectively. 
 
 
Figure 3.5   Quantitative measurements of signal intensity alteration in IPFP using 
MATLAB. 
Semi-automatic segmentations of IPFP were performed first. Then, high signal intensity regions, 
showing as the red areas, were obtained by newly developed algorithm 
Figure 1A has the lowest Percentage (H) and Clustering factor (H), and Figure 1B has the highest sDev 
(IPFP) and UQ (H). Although Figure 1B and Figure 1C have similar Percentage (H) and Clustering 
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factor (H), they have different sDev (IPFP) and UQ (H). Figure 1D has the biggest Percentage (H), 
but its sDev (IPFP) and UQ (H) are lower than Figure 1B. 
 
3.6   Knee pain assessment 
The assessment of knee pain was self-administered, using the WOMAC Index [233]. There are 
five categories of pain in the questionnaire (walking on flat surface, going up/down stairs, 
standing upright, in bed when at night, and sitting/lying). In the TASOAC study, each category 
of WOMAC knee pain was rated on a 10-point numeric scale from 0 (no pain) to 9 (most severe 
pain). In the VIDEO study, it was measured on a 100-mm visual analogue scale (score range 
0–100).  
 
3.7   Statistical analysis 
T-tests and chi-squared tests were used to compare differences in means and proportions as 
appropriate. Standard diagnostic checks of model fit and residuals were routinely performed, 
and data points with large residuals and/or high influence were investigated for data errors. A 
p value less than 0.05 (two-tailed) is considered statistically significant. A more detailed 
description of statistical analyses performed is presented in their relevant chapters. All 
statistical analyses were performed on SPSS version 20.0 for Windows (SPSS Inc., Chicago, 
IL) or Stata for Windows (version 13.0, Stata Corporation, TX, USA).  
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4.1   Introduction 
OA is one of the most common diseases and is a leading cause of chronic disability in older 
adults [234]. It not only affects the articular cartilage and subchondral bone but also involves 
other structures of the joint, including menisci, synovial membrane, joint capsule, ligaments, 
muscles and infrapatellar fat pad [1, 64].  
 
Obesity has been considered as the primary preventable risk factor for OA [235, 236], despite 
that the underlying mechanisms are not very clear. Obesity-related factors can induce pro-
inflammatory cytokines and degradative enzymes which lead to cartilage matrix impairment 
and subchondral bone remodelling [237], suggesting that adipose tissue may act through its 
metabolic properties. IPFP, a local adipose tissue, has been considered as an active joint tissue 
in knee OA [65]. A recent review paper suggested that it would play an important role in knee 
OA [14]. Although the mechanisms of IPFP in pathological processes of knee OA are largely 
unknown, biomechanical and biochemical pathways may be involved [93, 238]. 
Biomechanically, IPFP may reduce the impact loading and absorb forces generated through 
the knee joint, and thus may play a beneficial role in knee OA. Biochemically, abnormal IPFP 
can produce various pro-inflammatory cytokines such as IL-1β, TNF-α, IL-6 and IL-8, , as 
well as various adipokines such as leptin and resistin [66-69], and thus may play a detrimental 
role in knee OA. 
 
IPFP signal intensity alteration can be observed in knee OA patients using T2-or proton-
density-weighted MRI [239]. Although IPFP signal intensity alteration was considered as a 
nonspecific feature, several clinical and epidemiological studies have utilised it as a surrogate 
for peripatellar synovitis [204, 205]. This type of synovitis within IPFP predicted the 
development of incident of radiographic OA [240]. A pathological study showed there were 
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vascular neoformations, fibrosis and inflammatory infiltrates in IPFP specimens obtained from 
patients with end-stage OA [206]; therefore, IPFP signal intensity alteration observed in MRI 
may be related to not only synovitis, but also other pathological changes. So far there are few 
studies focusing on the association between IPFP signal intensity alteration and knee symptom 
and structural changes so it is unclear whether IPFP signal intensity alteration is an important 
surrogate marker in knee OA. The aim of this study was, therefore, to determine the 
associations between IPFP signal intensity alteration at baseline and knee symptoms or joint 
structural changes in older adults with or without knee OA. 
 
4.2   Method 
4.2.1   Study design, setting and participants 
This study consisted of a consecutive sample of 874 participants who had knee MRI scans at 
baseline from the TASOAC study, which is described in Section 3.1.  
 
4.2.2   Assessment of knee pain 
Knee pain was assessed at baseline and follow-up using the WOMAC Index, which is 
described in Section 3.6. 
 
4.2.3   Knee radiographic assessment 
The radiographic changes of the knee was assessed using the OARSI atlas developed by 
Altman et al [224], which is described in Section 3.4. The osteophytes and JSN scores were 
summed as the knee total ROA score, which of 1 or greater was used to define the presence of 
knee ROA [241].  
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4.2.4   MRI assessment of knee structural changes     
MRI scans of the study knee were obtained according to a standardized protocol as described 
on Section 3.5.1. 
 
IPFP signal intensity alteration at baseline and follow-up was assessed semi-quantitatively, 
which is described in Section 3.5.6.  
 
Knee cartilage volume at baseline and follow-up was assessed on T1-weighted MR images 
with image processing on an independent workstation, which is described in Section 3.5.2. 
Changes in cartilage volume were calculated as: percentage change per annum = [(follow-up 
volume – baseline volume)/baseline cartilage volume]/time between 2 scans in years ×100. 
 
Knee Cartilage defects (0-4 scale) at baseline and follow-up were determined at the medial 
tibial, medial femoral, lateral tibial, lateral femoral, and patellar sites as described in Section 
3.5.3. An increase in cartilage defects was defined as a change in cartilage defects of ≥ 1. 
 
Subchondral BMLs at baseline and follow-up were assessed on T2-weighted MR images using 
a semi-quantitative (0-3) scoring system as described in Section 3.5.4. An increase in BMLs 
was defined as a change in BMLs of ≥ 1. 
 
Tibial plateau bone area at baseline was determined by manually measuring on axial T1-
weighted MR images, as previously described [241].  
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4.2.5   Statistical methods 
Student t or χ2 tests were used to compare means or proportions, respectively. Multivariable 
linear regression analyses were used to examine the associations between IPFP signal intensity 
alteration (independent variable) and knee cartilage volume or change in cartilage volume 
(dependent variables) after adjustment for age, sex, BMI, ROA and tibial bone area. 
Multivariable binary logistic regression analyses were used to examine the associations 
between IPFP signal intensity alteration (independent variable) and knee joint space narrowing, 
osteophytes, as well as baseline or increases in knee cartilage defects, BMLs and knee pain 
(dependent variables), after adjustment for age, sex, BMI and/or ROA. Interactions between 
ROA status and IPFP signal intensity alteration on the outcome measures were investigated by 
regressing individual change in an outcome on a binary (0/1) term for ROA within IPFP signal 
intensity alteration, and assessed by testing the statistical significance of the coefficient of a 
(sex × IPFP signal intensity alteration). 
 
4.3   Results 
4.3.1   Participants 
A total of 874 subjects between 50 and 80 years of age (mean, 62.1 years) took part in the 
present study. There were no significant differences in demographic factors (age, sex, and BMI) 
between these participants and those excluded (n = 226) (data not shown). Over 2.6 years, 104 
subjects were lost to follow-up study due to: 25 deceased, 18 moved to other states or overseas, 
12 had joint replacement, 24 physically unable, and others refused or no reason. The remaining 
770 subjects completed the follow-up study; however, MRI scans were only performed on 357 
of these due to decommissioning of the MRI scanner during the study. There were no 
significant differences in terms of age (62.5 vs 61.9 years, p=0.779), female sex (50.7% vs 
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49.7%, p=0.783), BMI (27.6 vs 27.8, p=0.105), and ROA (57.2% vs 60.1%, p=0.426) between 
these subjects and those without follow-up MRI. 
 
Characteristics of the study population (n=874) are presented in Table 4.1. The subjects with 
IPFP signal intensity alteration were older, had a higher prevalence of BMLs, lateral 
tibiofemoral and patellar cartilage defects, and greater tibial cartilage volume and tibial bone 
area than those without IPFP signal intensity alteration. A greater proportion were men in those 
with IPFP signal intensity alteration. Additionally, subjects with IPFP signal intensity 
alteration had a greater proportion of radiographic OA but it was of borderline significance. 
There was no significant difference in BMI, patellar cartilage volume, JSN, osteophytes, 
WOMAC knee pain and medial tibiofemoral cartilage defects between two groups. 
Characteristics of the participants with complete MRI data at follow-up (n=357) are also 
presented in Table A.1. 
 
4.3.2   IPFP high signal intensity alteration and cartilage defects 
Cross-sectionally, IPFP signal intensity alteration was significantly and positively associated 
with cartilage defects in univariable analyses and these associations remained significant after 
adjustment for age, sex, BMI, and ROA (Table 4.2). Longitudinally, baseline IPFP signal 
intensity was significantly and positively associated with increases in cartilage defects at 
medial and lateral tibiofemoral compartments in unadjusted (Figure A.1) and multivariable 
analyses (Table 4.2). It was not significantly associated with an increase in patellar cartilage 
defects (Table 4.2). 
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Table 4.1   Baseline characteristics of participants based on IPFP signal intensity 
alteration 
 IPFP signal 
intensity alteration 
No 
N = 443 
IPFP signal 
intensity alteration 
Yes 
N = 431 
 
 
 
P-value 
Age (year) 
Female sex (%) 
Body mass index (kg/m²) 
Medial tibial cartilage volume (ml) 
Lateral tibial cartilage volume (ml) 
Patella cartilage volume (ml) 
Medial tibial bone area (cm²) 
Lateral tibial bone area (cm²) 
Medial joint space narrowing (%) 
Lateral joint space narrowing (%) 
MTF osteophytes (%) 
LTF osteophytes (%) 
BML present (%) 
MTF cartilage defects (%) 
LTF cartilage defects (%) 
Patellar cartilage defects (%) 
Knee pain (%) 
Radiographic osteoarthritis (%) 
61.3 (7.3) 
57.3 
27.5 (4.9) 
2.2 (0.6) 
2.7 (0.7) 
3.2 (0.9) 
20.4 (3.0) 
11.8 (2.0) 
50.4 
24.7 
5.7 
2.7 
28.2 
21.1 
16.4 
32.4 
47.1 
55.6 
63.0 (7.2) 
42.7 
28.0 (4.4) 
2.4 (0.6) 
2.8 (0.7) 
3.3 (1.0) 
21.4 (3.0) 
12.5 (2.2) 
55.3 
22.8 
8.7 
5.0 
44.5 
26.2 
26.5 
45.9 
52.2 
62.3 
0.001 
<0.001 
0.119 
0.004 
0.025 
0.372 
<0.001 
<0.001 
0.158 
0.534 
0.098 
0.096 
<0.001 
0.075 
<0.001 
<0.001 
0.128 
0.052 
Two-tailed t tests were used for differences between means, and χ2 tests were used for proportions 
(percentages). Significant differences are shown in bold. Mean (SD) except for percentages. IPFP: infrapatellar 
fat pat; BMI: body mass index; BML: bone marrow lesions; MTF: medial tibiofemoral; LTF: lateral 
tibiofemoral  
 
 
4.3.3   IPFP high signal intensity alteration and BMLs 
 
Cross-sectionally, IPFP signal intensity alteration was significantly and positively associated 
with BMLs in univariable and multivariable analyses (Table 4.3). Longitudinally, baseline 
IPFP signal intensity alteration was significantly and positively associated with increases in 
BMLs at all sites before (Figure A.2) and after adjustment for age, sex, BMI and ROA (Table 
4.3).  
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Table 4.2   Associations of baseline IPFP signal intensity alteration with baseline and 
changes in knee cartilage defects 
 Univariable  
OR (95% CI) 
Multivariable* 
OR (95% CI)  
Baseline cartilage defects  
Medial tibiofemoral 
Lateral tibiofemoral  
Patellar 
Increase in knee cartilage defects  
Medial tibiofemoral 
Lateral tibiofemoral  
Patellar 
 
1.42 (1.18, 1.71) 
1.67 (1.38, 2.01) 
1.49 (1.25, 1.76) 
 
1.49 (1.16, 1.93) 
1.61 (1.24, 2.10) 
1.14 (0.86, 1.51) 
 
1.40 (1.13, 1.72) 
1.58 (1.28, 1.95) 
1.56 (1.29, 1.88) 
 
1.48 (1.12, 1.95) 
1.50 (1.14, 1.97) 
1.18 (0.87, 1.59) 
N=874 at baseline and n=357 at follow-up. Dependent variables: baseline cartilage defects or 
increases in knee cartilage defects (yes v no); independent variables: IPFP signal intensity alteration 
(per grade). *Adjusted for age, sex, body mass index, and radiographic osteoarthritis. IPFP: 
infrapatellar fat pat 
Table 4.3   Associations of baseline IPFP signal intensity alteration with baseline and 
changes in bone marrow lesions  
 Univariable  
OR (95% CI) 
Multivariable* 
OR (95% CI)  
Baseline bone marrow lesions 
Any bone marrow lesions  
Medial tibiofemoral 
Lateral tibiofemoral  
Patellar 
Increases in bone marrow lesions  
Any bone marrow lesions  
Medial tibiofemoral 
Lateral tibiofemoral  
Patellar 
 
1.72 (1.44, 2.04) 
1.42 (1.18, 1.71) 
1.82 (1.50, 2.22) 
1.24 (1.00, 1.52) 
 
1.76 (1.34, 2.32) 
1.66 (1.21, 2.29) 
1.80 (1.33, 2.44) 
1.45 (1.06, 2.00) 
 
1.70 (1.41, 2.05) 
1.40 (1.14, 1.71) 
1.81 (1.46, 2.24) 
1.30 (1.04, 1.63) 
 
1.74 (1.30, 2.34) 
1.56 (1.11, 2.19) 
1.75 (1.26, 2.42) 
1.52 (1.09, 2.13) 
N=874 at baseline and n=374 at follow-up. Dependent variables: baseline bone marrow lesions or increases 
in bone marrow lesions (yes v no); independent variables: IPFP signal intensity alteration (per grade). 
*Adjusted for age, sex, BMI, and radiographic osteoarthritis. IPFP: infrapatellar fat pat 
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4.3.4   IPFP high signal intensity alteration and cartilage volume 
In cross-sectional analyses, IPFP signal intensity alteration was significantly and positively 
associated with medial and lateral tibial cartilage volume, but not significantly associated with 
patellar cartilage volume. After adjustment for age, sex, BMI, radiographic OA and tibial bone 
area, IPFP signal intensity alteration was not significantly associated with medial and lateral 
cartilage volume, but was significantly and negatively associated with patellar cartilage volume 
(Table 4.4). The large reductions in the coefficients were largely due to adjustment for tibial 
bone area (data not shown). Longitudinally, baseline IPFP signal intensity alteration was not 
significantly associated with changes in cartilage volume at all sites in univariable analyses. 
After adjustment for covariates, it was negatively and significantly associated with change in 
lateral tibial cartilage volume, but not with changes in medial tibial and patellar cartilage 
volume (Table 4.4).  
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Table 4.4   Associations of baseline IPFP signal intensity alteration with baseline and 
changes in knee cartilage volume  
 Univariable 
β (95% CI) 
Multivariable*  
β (95% CI) 
Baseline cartilage volume    
    Medial tibial 87.3 (37.0, 137.6) 1.6 (-38.6, 42.0) 
    Lateral tibial 65.6 (6.8, 124.4) -25.5 (-73.9, 22.9) 
    Patellar 13.9 (-63.9, 91.7) -117.1 (-186.1, -48.2) 
Change in cartilage volume   
    Medial tibial -0.3 (-1.0, 0.3) -0.1 (-0.8, 0.6) 
    Lateral tibial -0.5 (-1.0, 0.5) -0.5 (-1.3, -0.2) 
    Patellar -0.1 (-0.8, 0.5) -0.1 (-0.9, 0.7) 
N=874 at baseline and n=357 at follow-up. Dependent variables: knee cartilage volume (mm3) or change 
in knee cartilage volume per annum (%); independent variables: IPFP signal intensity alteration (per 
grade). *Adjusted for age, sex, BMI, radiographic osteoarthritis, tibial bone area. IPFP: infrapatellar fat 
pat 
 
4.3.5   IPFP high signal intensity alteration and knee pain 
In cross-sectional analyses, IPFP signal intensity alteration was significantly and positively 
associated with prevalence of total knee pain, pain when going up/down stairs, and pain at 
night while in bed in univariable analyses. These associations remained, and the association 
with pain when sitting/lying became significant after adjustment for age, sex, BMI, and 
radiographic OA (Table 4.5). These associations were similar when using knee pain scores as 
continuous variables (date not shown). Longitudinally, baseline IPFP signal intensity alteration 
was only significantly associated with an increase in pain when going up/down stairs in 
univariable and multivariable analyses (Figure A.3 and Table 4.5). 
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Table 4.5   Association of baseline IPFP signal intensity alteration with baseline and 
increases in WOMAC knee pain 
 Univariable 
OR (95% CI) 
Multivariable* 
OR (95% CI) 
Baseline WOMAC pain 
Total knee pain 
    Pain on flat surface 
    Pain on stairs 
    Pain in bed 
    Pain when sitting 
    Pain when standing 
Increases in WOMAC pain  
Total knee pain 
    Pain on flat surface 
    Pain on stairs 
    Pain in bed 
    Pain when sitting 
    Pain when standing 
 
1.17 (1.00, 1.38) 
1.13 (0.94, 1.36) 
1.19 (1.01, 1.40) 
1.26 (1.05, 1.50) 
1.19 (0.99, 1.44) 
1.16 (0.96, 1.39) 
 
1.10 (0.89, 1.35) 
1.09 (0.83, 1.43) 
1.28 (1.03, 1.59) 
0.93 (0.71, 1.22) 
0.86 (0.64, 1.17) 
1.03 (0.77, 1.37) 
 
1.20 (1.01, 1.44) 
1.12 (0.91, 1.37) 
1.21 (1.01, 1.45) 
1.34 (1.10, 1.63) 
1.23 (1.01, 1.51) 
1.19 (0.97, 1.48) 
 
1.05 (0.84, 1.31) 
1.01 (0.82, 1.49) 
1.29 (1.02, 1.64) 
0.93 (0.70, 1.24) 
0.90 (0.65, 1.24) 
0.96 (0.70, 1.30) 
N=874 at baseline and n=770 at follow-up. Dependent variables: baseline WOMAC measures or increases 
in WOMAC measures (yes vs. no); independent variables: IPFP signal intensity alteration (per grade). 
*Adjusted for age, sex, BMI, and radiographic osteoarthritis. WOMAC: Western Ontario and McMasters 
osteoarthritis index; IPFP: infrapatellar fat pat 
 
4.3.6   IPFP high signal intensity alteration and radiographic OA 
In cross-sectional analyses, IPFP signal intensity alteration was significantly and positively 
associated with ROA (OR: 1.23, P<0.05), tibiofemoral osteophytes (OR: 1.64 and 1.74, 
respectively, for medial and lateral compartments; both P<0.05), but not with JSN, after 
adjustment for age, sex and BMI. 
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Change in IPFP signal intensity score was positively and significantly associated only with 
change in cartilage defects in lateral tibiofemoral compartment (OR: 1.41, 95%CI: 1.06, 1.87), 
but not with changes on other structural measures (data not shown). No significant interactions 
between ROA status and IPFP signal intensity alteration on the outcome measures were found 
(data not shown), so we combined subjects with and without ROA for all analyses.  
 
4.4   Discussion 
Although there were several studies using IPFP signal intensity alteration as a surrogate for 
peripatellar synovitis in knee OA patients [204, 205, 240], this is a comprehensive cohort study 
to investigate the association of baseline IPFP signal intensity alteration with knee structure 
changes assessed by MRI and symptoms in older adults. We found that, cross-sectionally, IPFP 
signal intensity alteration was associated with increased knee symptoms, cartilage defects, 
BMLs, and radiographic OA, and with reduced patellar cartilage volume. Longitudinally, 
higher IPFP signal intensity alteration score at baseline predicted more increases in 
tibiofemoral cartilage defects and BMLs, greater loss of lateral tibial cartilage volume and more 
increases in knee symptoms. Our findings suggest that IPFP signal intensity alteration may 
play an important role in knee osteoarthritic changes in older adults. 
 
Although the exact function of IPFP in knee joint is unknown, it has been considered as an 
active OA joint tissue [65] and may play an important role in knee OA [14]. As a component 
of the enthesis organ in anterior knee region [242], IPFP may help to reduce stress at attachment 
sites and assist in decreasing shearing forces between adjacent structures [243], and indeed, 
our recent study [244] reported that larger IPFP size was associated with reduced knee pain, 
MRI-assessed structural pathology and radiographic OA, suggesting a potentially protective 
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effect of IPFP size. Previous studies focusing on its biochemical components have indicated 
different roles of IPFP in OA processes. Bastiaansen-Jenniskens et al reported that fat-
conditioned medium derived from IPFP of end-stage OA inhibited catabolic processes in 
cartilage [238]. Ushiyama et al reported that IPFP obtained from patients during knee surgery 
contained protein levels of basic fibroblast growth factor, vascular endothelial growth factor, 
TNFα, and IL-6 in homogenised tissues [104]. Klein-Wieringa et al reported that IPFP from 
patients with primary OA secreted higher levels of IL-6, adipsin, adiponectin and visfatin than 
subcutaneous adipose tissue from same patients [66]. Based on the above evidence, we 
conjecture that IPFP would have biphasic effects in knee OA: it may play a beneficial role 
physiologically (through increased size) largely due to its biomechanical or anti- catabolic 
properties but could also be detrimental pathologically (observed as signal intensity alteration 
on MRI) due to its pro-inflammatory or metabolic properties.    
 
IPFP signal intensity alterations can be detected using T2-weighted fast spin echo MRI. 
Although this signal intensity alteration has been recognised as a non-specific feature in MR 
imaging, it was used as a surrogate for peripatellar synovitis in some clinical and 
epidemiological studies [204, 205], and Hoffa-synovitis has been associated with incident 
radiographic OA [240]. This assessment was sensitive but not specific for synovitis [245]. 
Pathological evidence has indicated that IPFP signal intensity alteration may represent a 
multitude of conditions such as chronic inflammation, vascular neoformations and edema 
rather than only synovitis [206]. So far, there are no direct comparisons between IPFP signal 
intensity alteration within whole IPFP and pathological changes in knee OA. 
 
Knee cartilage loss is the hallmark of OA. Inflammatory and metabolic factors, such as IL-6, 
TNFα, basic fibroblast growth factor and leptin, have been involved in cartilage breakdown 
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and eventually cartilage loss [246, 247]. IPFP is the main resource of these factors, and thus 
could have a role to play in the degradation of articular cartilage. Our current study reported 
that IPFP signal intensity alteration was independently associated with focal cartilage loss 
observed as knee cartilage defects but inconsistently with loss of entire cartilage plates 
(assessed using cartilage volume). These findings suggest that IPFP signal intensity alteration 
may precede focal cartilage defects. 
 
BMLs and osteophytes are the commonest subchondral bone abnormalities in knee OA. Both 
are associated with knee pain, cartilage defects and cartilage loss, and predict total knee 
replacement [178, 188, 248]. In this study, we found that IPFP signal intensity alteration was 
positively and consistently associated with BMLs and knee osteophytes at baseline, and also 
predicted increases in BMLs in all compartments over 2.6 years, suggesting that pathological 
changes in IPFP may affect subchondral bone abnormalities. Some biochemical and 
biomechanical factors would underlie this association. Leptin and VEGF have been shown to 
promote osteophytes formation [36, 249].  
 
Knee pain is an important clinical outcome in knee OA. Some preliminary studies reported that 
signs of inflammation in IPFP (assessed using dynamic contrast-enhanced MRI) were cross-
sectionally associated with knee pain in obese patients with knee OA [207], and inflammation 
and oedema of IPFP contributed to knee pain [207, 212]. Oedema within IPFP could increase 
pressure and lead to irritation of nearby tissues such as knee capsule and nociceptive nerve 
fibers that contain substance-P [250, 251], resulting in increased knee pain. Our current study 
reported that, cross-sectionally, IPFP signal intensity alteration was positively associated with 
knee pain (especially when going up/down stairs, at night while in bed, and when sitting or 
lying). Over 2.6 years, IPFP signal intensity alteration was only associated with an increase in 
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knee pain when going up/down stairs. Our results suggest that IPFP signal intensity alteration 
may play an important role in knee pain. 
 
The main strength of this cohort study is that we selected participants randomly from the 
community with a large sample size and both structural and symptomatic measurements. This 
study has several potential limitations. First, the response rate at baseline was 57%, possibly 
due to the extensive protocol, which did leave the possibility open for selection bias. However, 
there were no significant differences in age, gender and BMI between those responded and 
those did not. We also had high rates of retention (with the follow-up visit completed, 88%) to 
offset this. Second, although the retention rate at follow-up was high, these participants only 
completed WOMAC questionnaires and there were 59% subjects who did not have follow-up 
MRIs. However, there were no significant differences in baseline characteristics between those 
with and without follow-up MRI. Third, radiographs were not performed at the 2.7 years 
follow-up, so we were unable to determine the association between IPFP quality and change 
in radiographic OA. Fourth, histological examinations were not able to perform in our study. 
Fifth, we used a change in knee pain score of ≥1 to define an increase in knee pain which may 
not be sensitive for our tested hypothesis; however, multiple sensitivity analyses suggested that 
this definition is the most appropriate. We also used pain sore ≥1 to define presence of knee 
pain which may not be the most clinically relevant, but the associations remained similar while 
using knee pain scores as continuous variables or defining prevalent knee pain using different 
cutpoints. Sixth, subjects with ROA (>50%) were included in the study and IPFP signal 
intensity could be a consequence of ROA; however, all the associations were adjusted for ROA 
and there were no significant interactions between ROA and IPFP signal intensity on the 
outcome measures, suggesting our findings were not influenced by ROA status. Last, 
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measurement error may influence results. However, all measures were highly reproducible 
suggesting this is unlikely. 
 
In conclusion, baseline IPFP signal intensity alteration was associated with knee structural 
abnormalities and clinical symptoms cross-sectionally and longitudinally in older adults, 
suggesting that it may be an important imaging biomarker in knee OA.  
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5.1   Introduction 
OA is the most prevalent chronic joint disorder, characterized by pain and progressive 
deterioration of joint structures, and is strongly associated with risk factors such as age, female 
sex and obesity [252]. The most commonly affected joint is the knee, and the whole knee joint 
structures including articular cartilage, subchondral bone, synovium, ligaments, meniscus and 
periarticular fat pad can be affected in the course of knee OA [64]. Imaging biomarkers, 
especially from MRI, have been used in OA research for over a decade [133]. Because of its 
advantage in direct visualization of morphology and integrity of the whole joint, MRI has been 
considered as a sensitive and accurate tool to assess cartilage loss, subchondral bone 
abnormalities, synovitis, and ligament and meniscal lesions [138-140]. Quantitative or semi-
quantitative scoring systems have been developed for evaluating these structural changes in 
OA [138-140].  
 
The IPFP, the local fat around knee joint, may play an important role in the initiation and 
progression of knee OA [14, 65]. Biomechanically, it can promote efficient lubrication, reduce 
impact loading and absorb forces generated through the knee joint, which may be protective 
against OA [72]. Biochemically, it can produce various pro-inflammatory cytokines and 
adipokines, which may be deleterious to the knee joint [66-69]. Pathological examination of 
IPFP obtained from patients with end-stage OA found that vascular neoformations, fibrosis, 
and chronic inflammation were present in these specimens [206]. Dragoo et al have suggested 
that sagittal MRI can be used to assess abnormal IPFP quality, including fibrosis, inflammation, 
oedema and mass-like lesions [239].  
 
So far, there are few clinical and epidemiological studies reporting the association between 
abnormal changes within IPFP and knee osteoarthritic changes. Higher signal intensity change 
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around IPFP assessed by T2-weighted MRI has been considered as a surrogate for peripatellar 
synovitis [204, 205]. Our previous study reported that high signal intensity alteration within 
the IPFP was associated with knee symptoms and structural changes in older adults [253]. 
While hyperintense signals within IPFP on T2-weighted MRI can indicate inflammation, acute 
haemorrhage and/or oedema, hypointense signals within IPFP on T2-weighted MRI may 
indicate fibrosis [239]. So far, there are no studies reporting whether hypointense signals within 
IPFP are associated with symptoms and structures in knee OA. The aim of this study was to 
describe whether hypointense signals within IPFP measured by T2-weighted MRI are 
associated with symptoms or joint structural abnormalities cross-sectionally and longitudinally 
in older adults. 
 
5.2   Method 
5.2.1   Study design, setting and participants 
This study consisted of a consecutive sample of 874 participants who had knee MRI scans at 
baseline from the TASOAC study, which is described in Section 3.1.  
 
5.2.2   Assessment of knee pain 
Knee pain was assessed at baseline and follow-up using the WOMAC Index, which is 
described in Section 3.6. 
 
5.2.3   Knee radiographic assessment 
The radiographic changes of the knee was assessed using the OARSI atlas developed by 
Altman et al [224], which is described in Section 3.4. The osteophytes and JSN scores were 
summed as the knee total ROA score, which of 1 or greater was used to define the presence of 
knee ROA [241].  
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5.2.4   MRI assessment of knee structural changes     
MRI scans of the study knee were obtained according to a standardized protocol as described 
on Section 3.5.1. 
 
IPFP hypointense signals at baseline and follow-up was assessed semi-quantitatively, which is 
described in Section 3.5.6.  
 
Knee cartilage volume at baseline and follow-up was assessed on T1-weighted MR images 
with image processing on an independent workstation, which is described in Section 3.5.2. 
Changes in cartilage volume were calculated as: change per annum = (follow-up volume – 
baseline volume)/time between 2 scans in years. 
 
Knee Cartilage defects (0-4 scale) at baseline and follow-up were determined at the medial 
tibial, medial femoral, lateral tibial, lateral femoral, and patellar sites as described in Section 
3.5.3. An increase in cartilage defects was defined as a change in cartilage defects of ≥ 1. 
 
Subchondral BMLs at baseline and follow-up were assessed on T2-weighted MR images using 
a semi-quantitative (0-3) scoring system as described in Section 3.5.4. An increase in BMLs 
was defined as a change in BMLs of ≥ 1. 
 
Tibial plateau bone area at baseline was determined by manually measuring on axial T1-
weighted MR images, as previously described [241].  
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5.2.5   Statistical methods 
Student t or χ2 tests were used to compare means or proportions, respectively. Multivariable 
linear regression analyses were used to examine the associations between IPFP hypointense 
signals (independent variable) and knee cartilage volume or change in cartilage volume 
(dependent variables) after adjustment for age, sex, BMI, ROA, tibial bone area, and/or 
baseline cartilage volume (for change in cartilage volume) with further adjustment for cartilage 
defects or BMLs. Multivariable binary logistic regression analyses were used to examine the 
associations between IPFP hypointense signals (independent variable) and presences of knee 
joint space narrowing, osteophytes, as well as baseline or increases in knee cartilage defects, 
BMLs and WOMAC measures (dependent variables), after adjustment for covariates.  
 
5.3   Results 
5.3.1   Participants 
A total of 874 subjects between 50 and 80 years of age (mean, 62.1 years) took part in the 
present study. There were no significant differences in demographic factors (age, sex, and BMI) 
between these participants and those excluded (n = 226) (data not shown). Over 2.6 years, 104 
subjects were lost to follow-up study due to: 25 deceased, 18 moved to other states or overseas, 
12 had joint replacement, 24 physically unable, and 25 no reason specified. The remaining 770 
subjects completed the follow-up study and the first 357 had the second MRI scans but not the 
others as the MRI machine in the hospital was decommissioned. There were no significant 
differences between these subjects and those without follow-up MRI, as previously described 
[254]. 
 
Table 5.1 describes characteristics of the study population. There was no significant difference 
in age, patellar cartilage volume and knee pain between subjects with and without IPFP 
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hypointense signals; but the group with IPFP hypointense signals had a greater proportion of 
men, and higher prevalence of JSN, osteophytes, BMLs, cartilage defects, as well as higher 
BMI. Additionally, these subjects had greater tibial cartilage volume and tibial bone area. 
 
5.3.2   IPFP hypointense signals and cartilage defects 
 
IPFP hypointense signals were significantly and positively associated with baseline (data not 
shown) and increases in (Figure 5.1) cartilage defects at all compartments in unadjusted 
analyses. They were significantly and positively associated with all cartilage defects after 
adjustment for age, sex, BMI, and radiographic OA cross-sectionally and longitudinally (Table 
5.2). These associations remained significant after further adjustment for BMLs, except that 
the longitudinal association at patellar site decreased in magnitude and became of borderline 
significance (Table 5.2).  
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Table 5.1   Baseline characteristics of participants split by presence of IPFP hypointense 
signal 
 IPFP hypointense 
signal 
No (N = 305) 
IPFP hypointense 
signal 
YES (N = 569) 
 
P-value 
Age (year) 
Female sex (%) 
Body mass index (kg/m²) 
Medial tibial cartilage volume (ml) 
Lateral tibial cartilage volume (ml) 
Patella cartilage volume (ml) 
Medial tibial bone area (cm²) 
Lateral tibial bone area (cm²) 
Medial joint space narrowing (%) 
Lateral joint space narrowing (%) 
MTF osteophytes (%) 
LTF osteophytes (%) 
BML present (%) 
MTF cartilage defects (%) 
LTF cartilage defects (%) 
Patellar cartilage defects (%) 
Knee pain (%) 
61.6 (6.9) 
65.9 
27.0 (4.5) 
2.2 (0.6) 
2.6 (0.7) 
3.2 (0.9) 
19.9 (2.9) 
11.4 (1.9) 
32.9 
15.2 
1.8 
0.7 
29.2 
10.2 
11.3 
29.4 
46.2 
62.4 (7.5) 
41.7 
28.1 (4.7) 
2.4 (0.6) 
2.8 (0.7) 
3.2 (1.0) 
21.4 (3.0) 
12.5 (2.2) 
63.3 
28.2 
10.0 
5.5 
40.1 
30.8 
26.7 
44.3 
51.4 
0.090 
<0.001 
<0.001 
<0.001 
<0.001 
0.235 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
0.001 
0.001 
<0.001 
<0.001 
<0.001 
0.144 
Two-tailed t tests were used for differences between means, and χ2 tests were used for proportions 
(percentages). Significant differences are shown in bold. 
Mean (SD) except for percentages. IPFP: infrapatellar fat pat; BMI: body mass index; BML: bone marrow 
lesions; MTF: medial tibiofemoral; LTF: lateral tibiofemoral  
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Table 5.2   Associations of IPFP hypointense signals with baseline knee cartilage defects 
and increases in knee cartilage defects over 2.6 years 
 Multivariable*  
OR (95% CI) 
Multivariable**  
OR (95% CI)  
Baseline cartilage defects  
Any cartilage defects 
Medial tibiofemoral 
Lateral tibiofemoral  
Patellar 
Increase in knee cartilage defects  
Any cartilage defects 
Medial tibiofemoral 
Lateral tibiofemoral  
Patellar 
 
2.38 (1.87, 3.03) 
2.93 (2.24, 3.83) 
2.62 (2.02, 3.42) 
1.84 (1.47, 2.31) 
 
2.27 (1.61, 3.21) 
1.62 (1.21, 2.19) 
1.46 (1.09, 1.96) 
1.38 (1.00, 1.90) 
 
2.24 (1.74, 2.87) 
2.70 (2.05, 3.54) 
2.57 (1.95, 3.38) 
1.93 (1.50, 2.47) 
 
2.08 (1.46, 2.97) 
1.55 (1.15, 2.09) 
1.39 (1.03, 1.88) 
1.36 (0.99, 1.88) 
Dependent variables: baseline cartilage defects or increases in knee cartilage defects (yes v no); 
independent variables: IPFP hypointense signals (per grade). *Adjusted for age, sex, BMI, and 
radiographic osteoarthritis.  **Further adjustment for bone marrow lesions. IPFP: infrapatellar fat pat 
 
Figure 5.1   Association of IPFP hypointense signals with increase in knee cartilage defects 
and bone marrow lesions. 
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5.3.3   IPFP hypointense signals and cartilage volume 
Cross-sectionally, IPFP hypointense signals were not significantly associated with medial and 
lateral tibial cartilage volume, but significantly and negatively associated with patellar cartilage 
volume after adjustment for age, sex, BMI, radiographic OA and tibial bone area (Table B.1). 
This significant association disappeared after further adjustment for patellar cartilage defects 
but remained unchanged after further adjustment for patellar BMLs (Table B.1). 
Longitudinally, IPFP hypointense signals were negatively and significantly associated with 
change in lateral tibial cartilage volume, but not with changes in medial tibial and patellar 
cartilage volume, after adjustment for age, sex, BMI, radiographic OA, tibial bone area and 
baseline cartilage volume, and this association were remained after further adjustment for 
cartilage defects or BMLs (Table B.1).  
 
5.3.4   IPFP hypointense signals and BMLs 
In cross-sectional analyses, IPFP hypointense signals were significantly and positively 
associated with any BMLs and tibiofemoral BMLs after adjustment for age, sex, BMI and 
radiographic OA. The associations decreased in magnitude and became non-significant after 
further adjustment for cartilage defects (Table 5.3). Longitudinally, IPFP hypointense signals 
were significantly and positively associated with increases in BMLs at all sites before (Figure 
5.1) and after adjustment for age, sex, BMI and radiographic OA (Table 5.3). After further 
adjustment for cartilage defects, the associations decreased in magnitude and became non-
significant at lateral tibiofemoral and patellar sites (Table 5.3).  
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Table 5.3   Associations between IPFP hypointense signals and baseline bone marrow 
lesions and increases in bone marrow lesions over 2.6 years 
 Multivariable*  
OR (95% CI) 
Multivariable**  
OR (95% CI)  
Baseline bone marrow lesions 
Any bone marrow lesions  
Medial tibiofemoral 
Lateral tibiofemoral  
Patellar 
Increases in bone marrow lesions  
Any bone marrow lesions  
Medial tibiofemoral 
Lateral tibiofemoral  
Patellar 
 
   1.64 (1.32, 2.03) 
1.77 (1.39, 2.25) 
1.40 (1.08, 1.80) 
1.21 (0.93, 1.57) 
 
   1.91 (1.39, 2.62) 
2.11 (1.46, 3.07) 
1.66 (1.17, 2.35) 
1.50 (1.04, 2.15) 
 
1.11 (0.87, 1.42) 
1.24 (0.95, 1.63) 
1.03 (0.78, 1.36) 
0.83 (0.61, 1.13) 
 
1.45 (1.02, 2.04) 
1.59 (1.06, 2.39) 
1.36 (0.93, 1.97) 
1.34 (0.92, 1.95) 
Dependent variables: baseline bone marrow lesions or increases in bone marrow lesions (yes v no); 
independent variables: IPFP hypointense signals (per grade). *Adjusted for age, sex, BMI, and radiographic 
osteoarthritis.  **Further adjustment for cartilage defects. IPFP: infrapatellar fat pat 
 
5.3.5   IPFP hypointense signals and knee pain 
IPFP hypointense signals were significantly and positively associated with total knee pain, pain 
when going up/down stairs, at night while in bed, and when sitting/lying after adjustment for 
age, sex, BMI, and radiographic OA in cross-sectional analyses, but these significant 
associations disappeared after further adjustment for cartilage defects or BMLs except for pain 
when at night while in bed (Table 5.4). Longitudinally, IPFP hypointense signals were 
significantly associated with an increase in total knee pain, pain when walking on flat surface, 
pain when going up/down stairs and when standing (Table 5.4), but these became non-
significant after further adjusting for cartilage defects. The associations between IPFP 
hypointense signals and an increase in knee pain decreased in magnitude but became non-
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significant for all knee pain subscales (except pain when going up/down stairs) after further 
adjustment for BMLs (Table 5.4).  
 
Table 5.4   Association of IPFP hypointense signals with WOMAC measures and 
increases in WOMAC measures over 2.6 years 
 Multivariable* Multivariable** Multivariable*** 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Baseline WOMAC measures    
Total knee pain 1.27 (1.03, 1.56) 1.07 (0.85, 1.35) 1.15 (0.93, 1.43) 
   Pain on flat surface 1.22 (0.97, 1.55) 1.02 (0.79, 1.33) 1.13 (0.88, 1.44) 
   Pain on stairs 1.26 (1.02, 1.55) 1.05 (0.84, 1.32) 1.14 (0.92, 1.42) 
   Pain in bed 1.47 (1.16, 1.85) 1.42 (1.10, 1.82) 1.42 (1.12, 1.79) 
   Pain when sitting 1.29 (1.02, 1.64) 1.25 (0.96, 1.62) 1.24 (0.97, 1.58) 
   Pain when standing 1.22 (0.96, 1.55) 1.10 (0.85, 1.43) 1.12 (0.87, 1.43) 
Increases in WOMAC 
measures 
   
Total knee pain 1.36 (1.05, 1.76) 1.32 (0.99, 1.74) 1.30 (1.00, 1.69) 
   Pain on flat surface 1.52 (1.08, 2.14) 1.22 (0.83, 1.79) 1.33 (0.94, 1.89) 
   Pain on stairs 1.51 (1.14, 2.01) 1.34 (0.98, 1.82) 1.42 (1.06, 1.89) 
   Pain in bed 1.18 (0.85, 1.63) 1.04 (0.73, 1.49) 1.14 (0.82, 1.58) 
   Pain when sitting 1.25 (0.88, 1.78) 1.14 (0.77, 1.67) 1.20 (0.84, 1.71) 
   Pain when standing 1.44 (1.02, 2.03) 1.22 (0.84, 1.78) 1.38 (0.98, 1.97) 
Dependent variables: baseline WOMAC measures or increases in WOMAC measures (yes vs. no); 
independent variables: IPFP hypointense signals (per grade). *Adjusted for age, sex, BMI, and radiographic 
osteoarthritis. **Further adjustment for cartilage defects. *** Further adjustment for bone marrow lesions 
but not for cartilage defects. WOMAC: Western Ontario and McMasters osteoarthritis index; IPFP: 
infrapatellar fat pat 
 
5.3.5   IPFP hypointense signals and radiographic OA 
In cross-sectional analyses, IPFP hypointense signals were significantly and positively 
associated with ROA (OR: 2.91, P < 0.001), tibiofemoral joint space narrowing (OR: 2.72 and 
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1.59, respectively, for medial and lateral compartments; both P < 0.01), and tibiofemoral 
osteophytes (OR: 4.25 and 3.34, respectively, for medial and lateral compartments; both P < 
0.001), after adjustment for age, sex and BMI. 
 
Higher grade of IPFP hypointense signals was significantly associated with smaller IPFP 
maximal area after adjustment for age, gender, BMI, and total tibial bone area (Figure B.1). 
The associations of IPFP hypointense signals with the above outcome measures remained 
unchanged after further adjustment for IPFP maximal area (data not shown).  
 
5.4   Discussion 
This study is the first study to investigate the association of IPFP hypointense signals with knee 
structural and symptoms changes in older adults. We found that IPFP hypointense signals were 
cross-sectionally associated with increased knee symptoms, cartilage defects, BMLs, and 
radiographic OA, and with reduced patellar cartilage volume and IPFP maximal area. 
Longitudinally, these signal intensity changes predicted increases in cartilage defects at all sites 
and BMLs, loss of lateral tibial cartilage volume and increases in knee symptoms. The 
associations with knee cartilage defects remained significant after adjustment for BMLs, but 
the associations with BMLs and knee pain were weakened after adjustment for cartilage defects. 
This suggests that IPFP hypointense signals are associated with increased knee cartilage defects 
primarily and with knee BMLs and pain secondarily in older adults. 
 
IPFP, an intracapsular but extrasynovial structure [70], is situated in the knee under the patella, 
between the patellar tendon, femoral condyle and tibial plateau [65], and is structurally similar 
to subcutaneous adipose tissue [79]. As a deformable soft tissue within anterior compartment 
of knee joint, it can adapt to change contours of the articular surface and is able to distribute 
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synovial fluid within joint cavity to reduce articular surface cushion, besides supporting the 
feasibility of intra-articular ligaments [72].  Composed of a fibrous scaffold with adipose tissue 
and synovial recesses within it, IPFP can secrete cytokines, adipokines, and lipid mediators 
[66-69],[131]. Therefore, IPFP may play a biphasic role in the pathologic progression of knee 
abnormalities.  
 
MRI has been used to assess signal alterations within or around IPFP, and the high signal 
intensity alteration was mainly considered as synovial inflammation or Hoffa synovitis [204, 
240]. In addition, hypointense signals closing to the synovium within or around IPFP was 
regarding as chronic synovitis [213, 255]. Hoffa synovitis is recognised as a key imaging 
biomarker for knee OA [140], and can predict the progression of knee OA [240]. Our previous 
study also suggested that high signal intensity alteration within IPFP was associated with knee 
structural and symptomatic changes in older adults [253]. As IPFP signal intensity alteration 
may reflect different pathological changes, more studies are required to assess the roles of IPFP 
signal intensity changes in knee OA. 
 
So far, there have been no studies reporting the clinical significance of IPFP hypointense 
signals observed on T2-weighted fat saturation MRI images. Low signal intensity changes 
within IPFP may represent fibrosis or postoperative scarring [70, 73], chronic inflammation 
progressing from acute inflammation of the synovium due to microtrauma of this tissue [212], 
or synovial thickening or fibrosis [213, 214]. A study compared low signal intensity changes 
in plantar fat pad on MRI with histological changes and reported that these signal changes 
corresponded to fibrosis [215]. This fibrosis can be induced by chronic inflammation in the 
synovium [212], or periarticular surgeries or trauma around knees [70]. Although the roles of 
synovitis, surgical history and trauma in knee OA have been identified [216, 217], there has 
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been no evidence showing that low signal intensity within IPFP assessed by MRI is associated 
with symptoms and knee structure changes in the knee. 
 
In this study, we found that in older adults, IPFP hypointense signals were consistently 
associated with knee cartilage defects cross-sectionally and longitudinally, independent of 
factors such as BMLs. They were also associated with BMLs and reduced cartilage volume 
cross-sectionally and longitudinally, but these associations were largely dependent of cartilage 
defects. Further, there were significant association between IPFP hypointense signals and knee 
pain, but again, these associations were largely dependent of cartilage defects rather than BMLs. 
These suggest that IPFP hypointense signals may induce knee structural changes and symptoms 
starting from cartilage defects.  
 
The mechanisms underlying the associations between IPFP low signal intensity and knee OA 
measures are largely unknown. These hypointense signals within synovial membrane have 
been considered as synovial fibrosis and were corresponding to chronic synovitis [213, 255]. 
This chronic synovitis can contribute to cartilage degradations and knee pain [256]. Other 
pathological changes such as adipocyte necrosis or adipose fibrosis may be observed as 
hypointense signals within IPFP in MR imagines. Fibrosis is an abnormal tissue healing 
process that occurs sequentially from an inflammatory response to surgery or injury of the knee 
and severe fibrosis was found in 33% of IPFP biopsy specimens resected from patients with 
end-stage knee OA [206]. Fibrosis was also found in monoiodoacetate-induced OA models 
and was associated with knee pain [212]. In addition, a study focusing on the effect of strenuous 
running on IPFP histological changes in a rat OA model reported that fibrosis within IPFP was 
associated with excess physical activities and related to knee pain [257]. Fibrosis within IPFP 
may increase cartilage contact pressures and decrease the ability of absorbing the shocking 
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through the knee, and thus induce the degradation of neighbouring knee structures including 
cartilage and subchondral bone. Furthermore, our current study found that this abnormal signal 
was negatively associated with IPFP maximum area, suggesting it may decrease this absorbing 
ability through reducing the IPFP size. 
 
The main strength of this cohort study lies in a large sample size with the comprehensive MRI 
structural measurements. There are several potential limitations. First, the response rate at 
baseline was 57%, possibly due to the extensive protocol, which did leave the possibility open 
for selection bias. However, there were no significant differences in age, gender and BMI 
between those responded and those did not. We also had high rates of retention (82%) to offset 
this. Second, we did not have radiographic OA measurements at the follow-up because X-ray 
is insensitive for change over this short period, so we are unable to determine the association 
between IPFP quality and change in radiographic OA. Third, measurement error may influence 
results. However, all measures were highly reproducible suggesting this is unlikely. Lastly, 
histological examination was not able to perform in this community-based study, so the 
pathological changes associated with IPFP low signal intensity are unknown. 
 
In conclusion, hypointense signals in the IPFP were associated primarily with increased knee 
cartilage defects and also with BMLs and knee symptoms in cross-sectional and longitudinal 
analyses, suggesting the abnormality represented by this signal has a potentially important role 
in osteoarthritis progression. 
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6.1   Introduction 
OA is a common cause of chronic disability in older adults and has been considered as a 
multifactorial condition with risk factors including genetics, aging, female sex, injury and 
obesity [258, 259]. Obesity is a primary preventable risk factor which has effects partly through 
increasing loading in the knee joint [260]. Obese adipose tissue also has endocrine function 
that can produce pro-inflammatory cytokines and adipokines affecting the process of joint 
degradation [120, 261]. Similar to systemic adipose tissue, local adipose tissue such as IPFP 
has the ability of secreting pro- and anti-inflammatory cytokines and various adipokines, all of 
which may play roles in maintenance of cartilage and bone homeostasis in the knee joint [66-
69]. 
 
IPFP is structurally similar to subcutaneous adipose tissue [79] with an abundance of 
adipocytes, immune cells, vessels and nerve fibres [65]. Our previous studies reported that 
larger IPFP size had a potentially protective effect on knee symptoms and structural changes 
[93, 94]. Despite its capabilities of reducing the impact loading and absorbing forces generated 
through the knee joint, recent evidence suggests that abnormal IPFP appears to play an 
important role in the initiation and progression of knee OA [14] [65]. IPFP can be an important 
local source of age-related inflammation and a central contributor to the degradation of 
neighbouring tissues within the knee [27].  
 
Inflammation within IPFP can be assessed using non-contrast enhanced MRI [262]. High 
signal intensity alteration of IPFP has been regarded as a surrogate of peripatellar synovitis in 
epidemiological studies [204, 205]. We used semi-quantitative measurements to assess signal 
intensity alterations in IPFP and reported that they were significantly associated with knee 
symptoms and structural abnormalities in older adults [263]. There are currently few studies 
Chapter 6. Quantitative measures of IPFP high signal intensity alteration and knee OA 
 
101 
that have used quantitative measurements to evaluate IPFP signal intensity alterations and to 
describe their relationship with knee osteoarthritic abnormalities [264]. We recently 
established a method to quantitatively assess IPFP signal intensity alterations and reported that 
this method was reproducible, and associated with knee structural changes [232]. Therefore, 
our current study aims to describe the cross-sectional and longitudinal associations between 
quantitative measures of IPFP signal intensity alterations and knee structural abnormalities in 
patients with symptomatic knee OA. 
 
6.2   Method 
6.2.1   Study design, setting and participants 
This study consisted of a sample of 261 participants who had sagittal T2-weighted MRI scans 
in Tasmania from VIDEO study, which is described in Section 3.2. The sample of 152 
participants who had coronal T2-weighted MRI scans in Melbourne was not included in this 
study. Treatment and placebo groups were combined as a cohort. 
 
6.2.2   Knee radiographic assessment 
The radiographic changes of the knee was assessed using the OARSI atlas developed by 
Altman et al [224], which is described in Section 3.4. We summed the osteophyte and JSN 
scores as total knee ROA score, as previously described [149].  
 
6.2.3   MRI assessment of knee structural changes     
MRI scans of the study knee were obtained according to a standardized protocol as described 
on Section 3.5.1. 
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High signal intensity in IPFP was quantitatively assessed on sagittal planes of FSS T2-weighted 
images using MATLAB as described in Section 3.5.6.  
 
Knee cartilage volume at baseline and follow-up was assessed on T1-weighted MR images 
with image processing on an independent workstation, which is described in Section 3.5.2. 
Total tibial cartilage volume was summed, and change in cartilage volume per annum was 
defined as (follow-up – baseline)/interval. 
 
Knee Cartilage defects (0-4 scale) at baseline and follow-up were determined at the medial 
tibial, medial femoral, lateral tibial, lateral femoral, and patellar sites as described in Section 
3.5.3. A total score was calculated as the total of subregional scores with a maximum score of 
24. Presence of tibiofemoral cartilage defects was defined as any tibial or femoral cartilage 
defects of >= grade 2, and an increase in cartilage defects was defined as the value from 
(follow-up cartilage defects – baseline cartilage defects) of >= 1. 
 
Subchondral BMLs at baseline and follow-up were assessed on T2-weighted MR images using 
a semi-quantitative (0-3) scoring system as described in Section 3.5.4. Any presence of 
tibiofemoral BMLs was defined as a BML score of >= grade 1, and an increase in BMLs was 
defined as the value from (follow-up BMLs – baseline BMLs) of >= 1. 
 
6.2.4   Statistical methods 
Baseline characteristics were summarised using descriptive statistics. Univariable and 
multivariable linear regression analyses were used to examine the associations between 
baseline IPFP signal intensity alteration measures (independent variables) and baseline ROA 
score, and baseline and change in tibial cartilage volume (dependent variables). The 
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associations between baseline IPFP signal intensity alteration measures (independent variables) 
and the presence of or increase in tibiofemoral cartilage defects and BMLs (dependent 
variables) over 2 years were assessed using logistic regression analyses. The associations were 
adjusted for age, sex and BMI in cross-sectional analyses, and adjusted for age, sex, BMI and 
vitamin D treatment allocation in longitudinal analyses. Interactions between the 
measurements of IPFP high signal intensity alterations and sex or BMI on knee structural 
abnormalities were assessed by testing the statistical significance of the coefficient of a (sex or 
BMI × measures of IPFP high signal intensity alteration).  
 
Multivariable linear/logistic regression was used to analyse the difference in change in tibial 
cartilage volume or an increase in tibiofemoral cartilage defects/BMLs over 2 years among 
tertiles of Clustering factor (H), in Figure 2, which visualised the association between knee 
structural changes and Clustering factor (H). 
 
A p-value < 0.05 (2-tailed) or a 95% CI not including the null (for linear regression) or 1 (for 
logistic regression) point was considered as statistical significance. All statistical analyses were 
performed on SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL). 
 
6.3   Results 
6.3.1   Participants 
Characteristics of the study population are presented in Table 6.1. A total of 261 participants 
(49.4% females) between 50 and 79 years of age (mean, 63.0 years) took part in the present 
study. There were no significant differences in demographic factors (age, sex, and BMI) 
between these participants and those who were excluded from this study due to no sagittal knee 
MRI scans available (n = 152) (data not shown). The mean baseline total score of radiographic 
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OA was 6.9, and the mean tibial cartilage volume was 3.7 ml. Tibiofemoral cartilage defects 
and any tibiofemoral BMLs were present in 53.3% and 65.3% of participants, respectively. 
Using quantitative measurements, the values of sDev (IPFP), UQ (H), Percentage (H) and 
Clustering factor (H) were presented in Table 6.1. 
Table 6.1   Baseline characteristics of participants 
Characteristic Values*(n = 261) 
Age (years) 63.0 (7.2) 
Female sex (%) 49.4 
BMI (kg/m2) 29.7 (4.9) 
ROA (grade, 0 - 30) 6.9 (5.0) 
Tibial cartilage volume (ml)  3.7 (1.1) 
Tibiofemoral cartilage defects present (%) 53.3 
Any tibiofemoral BMLs present (%) 65.3 
sDev (IPFP)  7.8 (2.2) 
UQ (H)  3.8 (1.0) 
Percentage (H)  6.9 (1.3) 
Clustering factor (H)  6.1 (0.7) 
*Mean (SD) or percentage of patients. BMI: body mass index; IPFP: infrapatellar fat pad; ROA: radiographic 
osteoarthritis; BMLs: bone marrow lesions; sDev (IPFP): standard deviation of IPFP signal intensity values; 
UQ(H): upper quartile value of high signal intensity region; Percentage (H): ratio of volume of high signal 
intensity region/whole IPFP volume; Clustering factor(H): clustering factor of high signal intensity. Presence 
of tibiofemoral cartilage defects was defined as any tibial or femoral cartilage defects of >= grade 2. Any 
presence of tibiofemoral BMLs was defined as a BML score of >= grade 1. 
6.3.2   Cross-sectional associations  
All baseline IPFP signal intensity alteration measures were significantly and positively 
associated with total radiographic OA score and presence of tibiofemoral cartilage defects and 
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BMLs, but not significantly with presence of patellar cartilage defects and BMLs, in both 
univariable and multivariable analyses (Table C.1-C.3). Baseline Percentage (H) and 
Clustering factor (H) were significantly and negatively associated with tibial cartilage volume, 
while sDev (IPFP) and UQ (H) were significantly and negatively associated with patellar 
cartilage volume, in multivariable analyses (Table C.4). 
 
6.3.2   Longitudinal associations 
Cartilage volume loss 
Higher baseline sDev (IPFP), UQ (H) and Clustering factor (H) were significantly associated 
with greater tibial cartilage loss, but not associated with patellar cartilage loss, over 2 years 
before and after adjustment for covariates (Table 6.2). Patients with low tertile of Clustering 
factor (H) had 3.3% loss of cartilage volume per annum (p.a.), while those with medium tertile 
had 4.6% loss of cartilage volume p.a., and with high tertile had 4.9% loss of cartilage volume 
p.a. (Figure 6.1a). The results were similar when medial and lateral tibial cartilage volumes 
were analysed individually (data not shown). 
 
Increase in cartilage defects 
Higher baseline sDev (IPFP), UQ (H) and Clustering factor (H) were significantly associated 
with higher risks of an increase in tibiofemoral cartilage defects over 2 years in both univariable 
and multivariable analyses, while all baseline IPFP signal intensity alteration measures were 
not associated with increase in patellar cartilage defects (Table 6.3). There was a significant 
and positive association between tertiles of Clustering factor (H) and an increase in 
tibiofemoral cartilage defects (Figure 6.1b). 
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Table 6.2   Longitudinal associations between baseline IPFP signal intensity alteration 
and changes in cartilage volume  
 Univariable Multivariable* 
 β (95% CI) β (95% CI) 
Change in tibial cartilage volume   
sDev (IPFP) -0.34 (-0.61, -0.08) -0.37 (-0.65, -0.09) 
UQ (H) -0.90 (-1.51, -0.29) -0.93 (-1.56, -0.31) 
Percentage (H) -0.13 (-0.54, 0.28) -0.15 (-0.56, 0.26) 
Clustering factor (H) -1.01 (-1.66, -0.35) -1.41 (-2.25, -0.57) 
Change in patellar cartilage 
volume 
  
sDev (IPFP) -0.10 (-0.45, 0.25) -0.05 (-0.41, 0.32) 
UQ (H) -0.21 (-0.92, 0.51) -0.11 (-0.85, 0.62) 
Percentage (H) -0.02 (-0.58, 0.54) -0.04 (-0.61, 0.53) 
Clustering factor (H) -0.59 (-1.73, 0.56) -0.47 (-1.63, 0.70) 
Dependent variable: cartilage volume; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, gender, BMI, tibial bone area and treatment allocation. 
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Figure 6.1   Longitudinal associations between Clustering factors of the high signal 
intensity alterations in IPFP and knee structural changes over 2 years. 
(A) Change of tibial cartilage volume per annum (%); (B) Increase in tibiofemoral cartilage defects (%); (C) 
Increase in tibiofemoral BMLs (%). *p values were those after adjustment for baseline age, gender, BMI, and 
treatment allocation.   
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Table 6.3   Longitudinal associations between baseline IPFP signal intensity alteration 
and increase in cartilage defects 
 Univariable Multivariable* 
 RR (95% CI) RR (95% CI) 
Increase in tibiofemoral cartilage defects   
sDev (IPFP) 1.33 (1.16, 1.53) 1.37 (1.18, 1.58) 
UQ (H) 2.00 (1.46, 2.74) 2.10 (1.51, 2.92) 
Percentage (H) 0.90 (0.76, 1.08) 0.89 (0.74, 1.07) 
Clustering factor (H) 2.15 (1.44, 3.22) 2.19 (1.46, 3.30) 
Increase in patellar cartilage defects   
sDev (IPFP) 0.01 (-0.01, 0.03) 0.01 (-0.01, 0.03) 
UQ (H) 0.03 (-0.01, 0.06) 0.03 (-0.01, 0.06) 
Percentage (H) -0.02 (-0.04, 0.01) -0.03 (-0.05, 0.01) 
Clustering factor (H) 0.03 (-0.02, 0.09) 0.03 (-0.02, 0.08) 
Dependent variable: cartilage defects; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, gender, BMI and treatment allocation. 
An increase in cartilage defects was defined as the value from (follow-up cartilage defects – baseline cartilage 
defects) of >= 1. 
 
Increase in BMLs 
Higher baseline Percentage (H) and Clustering factor (H) were significantly associated with 
higher risks of an increase in tibiofemoral BMLs over 2 years in both univariable and 
multivariable analyses. In contrast, there were no significant associations between all baseline 
IPFP signal intensity alteration measures and an increase in patellar BMLs in both analyses 
(Table 6.4). Tertiles of baseline Clustering factor (H) were positively associated with an 
increase in tibiofemoral BMLs over 2 years (Figure 6.1c). 
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Table 6.4   Longitudinal associations between baseline IPFP signal intensity alteration 
and increase in BMLs 
 Univariable Multivariable* 
 RR (95% CI) RR (95% CI) 
Increase in tibiofemoral BMLs   
sDev (IPFP) 1.09 (0.96, 1.23) 1.09 (0.96, 1.24) 
UQ (H) 1.10 (0.83, 1.45) 1.08 (0.81, 1.44) 
Percentage (H) 1.28 (1.06, 1.55) 1.28 (1.05, 1.55) 
Clustering factor (H) 1.47 (1.00, 2.17) 1.52 (1.02, 2.26) 
Increase in patellar BMLs   
sDev (IPFP) 0.00 (-0.02, 0.02) 0.00 (-0.02, 0.02) 
UQ (H) -0.01 (-0.04, 0.02) -0.01 (-0.05, 0.03) 
Percentage (H) 0.02 (-0.01, 0.04) 0.02 (-0.01, 0.05) 
Clustering factor (H) 0.00 (-0.06, 0.06) 0.00 (-0.06, 0.06) 
Dependent variable: BMLs; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, gender BMI and treatment allocation. 
An increase in BMLs was defined as the value from (follow-up BMLs – baseline BMLs) of >= 1. 
 
Baseline IPFP signal intensity alteration was positively associated with baseline effusion-
synovitis but not with changes in effusion-synovitis (data not shown). There were no significant 
interactions between the measurements of IPFP signal intensity alterations and sex or BMI on 
knee structural abnormalities (data not shown); therefore, men and women, and those who were 
normal weight, overweight or obese were combined for analyses. 
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6.4   Discussion 
This is the first study to describe the longitudinal associations between quantitative measures 
of IPFP signal intensity alteration and knee structural abnormalities in patients with 
symptomatic knee OA. We found that, quantitative measurements of IPFP high signal intensity 
alteration were significantly associated with increased ROA, tibiofemoral cartilage defects and 
BMLs, and reduced cartilage volume at baseline. Furthermore, most of higher baseline IPFP 
high signal intensity alteration measures were significantly associated with greater tibial 
cartilage volume loss and increases in tibiofemoral cartilage defects and BMLs over 2 years. 
In contrast, these quantitative measurements were not significantly associated with knee 
structural abnormalities at patellar site. 
 
IPFP is the biggest adipose tissue structure within the knee. Abundant with adipocytes, immune 
cells and vessels [65], IPFP is an important source of inflammatory cytokines and adipokines 
[67-69, 120], which can be a key contributor to knee OA. A pathological study illustrated that 
there were vascular neoformations, fibrosis, and chronic inflammation in IPFP obtained from 
end-stage OA patients [206]. T2-weighted FSE MRI can be used to assess IPFP signal intensity 
alterations [262], and these high signal intensity alterations may represent inflammation and 
vascular neoformations in IPFP. Several clinical and epidemiological studies used high signal 
intensity alteration of IPFP as a surrogate for peripatellar synovitis [204, 205]; however, the 
measurement was semi-quantitative. Our study uses a quantitative assessment of IPFP signal 
intensity alteration, which is more objective and includes more details of IPFP signal intensity 
changes. In addition to the rare report of associations between IPFP signal intensity alterations 
and knee structural changes in patients with knee OA, the results of the current study suggested 
that IPFP signal intensity quantitative measurements could be considered as outcome measures 
in future knee OA research. 
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Routine radiography is considered as the gold diagnostic standard of OA in clinical practice 
due to the ability of revealing joint space loss and osteophytes at the joint margin, and this 
method provides an indirect measurement of cartilage loss [2]. The OARSI atlas developed by 
Altman et al [219] is frequently used to assess features of radiographic OA [265]. Our current 
study found that all measures of signal intensity alteration were positively associated with 
radiographic knee OA in patients with symptomatic knee OA. Our findings are consistent with 
two recent publications using semi-quantitative assessments of IPFP signal intensity alteration. 
Atukorala et al reported that Hoffa-synovitis (assessed as high signal intensity alterations in 
IPFP) strongly predicted the incidence of radiographic knee OA [201]. We recently reported 
signal intensity alteration score was significantly associated with radiographic knee OA in 
population-based older adults [263]. We were unable to evaluate the temporal relationship 
between IPFP signal intensity alteration and ROA, as  X-ray assessment was only performed 
at baseline as an exclusion criteria in the original clinical trial. 
 
Cartilage loss is generally considered as a major feature of OA progression. Inflammatory and 
metabolic factors, such as IL-6, TNFα and leptin, have been involved in cartilage breakdown 
and eventually cartilage loss[246, 247]. Klein-Wieringa et al reported that IPFP in patients 
with knee OA could secrete higher levels of inflammatory mediators (IL-6, adipsin, 
adiponectin, and visfatin) that contributed to the pathogenesis of cartilage loss [66]. Other 
studies also showed that IPFP in knee OA could release pro-inflammatory factors and 
adipokines that could induce cartilage degradation [67, 266]. Our previous observational study 
illustrated that semi-quantitative measure of IPFP signal intensity alteration was significantly 
and positively associated with tibiofemoral cartilage loss in older adults [263]. Consistent with 
these reports, we found that baseline sDev (IPFP), UQ (H) and Clustering factor (H) were 
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associated with tibiofemoral cartilage volume loss and cartilage defects (focal cartilage loss) 
in patients with symptomatic knee OA over 2 years in the current study. Both studies did not 
find significant associations between IPFP signal intensity alterations and patellar cartilage 
volume loss. In this study, nearly half of the participants were with grade 4 patellar cartilage 
defects, and only 15% of participants had an increase in patellar cartilage defects. Moreover, 
the change in patellar cartilage volume was only one third of change in tibiofemoral cartilage 
volume. The patellofemoral compartment had more severe disease and less changes than the 
tibiofemoral compartment, and this may be the reason that we did not find significant 
associations with changes in patellar compartment. This may also explain why we only found 
significantly cross-sectional associations with cartilage defects and BMLs in tibiofemoral 
compartment. Moreover, we found that, cross-sectionally, some measures (Percentage (H), 
Clustering factor (H)) were related tibial cartilage volume, while others (sDev (IPFP), UQ (H)) 
were significantly related to patellar cartilage volume. The reasons underlying these 
discrepancies are unclear but the cross-sectional findings were not the focus of our current 
study. 
 
Subchondral BMLs have been considered as a hallmark of OA and been related with cartilage 
damage and pain in the initiation and progression of OA [188, 267]. These subchondral 
pathological lesions may be influenced by inflammatory mediators [268] and may have a cross-
talk with IPFP pathological changes through inflammatory pathways. Our previous study 
reported that high signal intensity alteration score in IPFP was significantly and positively 
associated with BMLs in older adults, suggesting there may be a link between IPFP and 
subchondral bone changes in the process of knee OA [263]. Consistently, our current study 
reported that baseline Percentage (H) and Clustering factor (H) were associated with 
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tibiofemoral BMLs in patients with symptomatic knee OA, while there were no significant 
associations between these quantitative measures and patellar BMLs. 
Our current study used a novel and a semi-automatic method to assess signal intensity 
alterations in IPFP with the output of quantitative measures. Using this new method, our results 
were consistent with previous semi-quantitative methodology, suggesting the pathology of 
IPFP signal intensity alteration may play an important role in the progression of knee OA. 
Furthermore, these quantitative measures are more objective and the results showed that 
Clustering factor (H), sDev (IPFP) and UQ (H), but not Percentage (H), had stronger 
associations with knee structure changes. These measures may reflect different magnitudes of 
pathological changes of IPFP, and this is why they were associated with different MRI-assessed 
knee structural changes of knee OA. Further pathological studies are needed to identify these 
differences. Overall, Clustering factor (H) was more consistently associated with all MRI-
assessed knee structural changes, suggesting it may be a more useful biomarker for future 
research. Although this quantitative methodology focused on high rather than low signal 
intensity alterations in IPFP, it included more details of IPFP signal intensity alteration than 
previous semi-quantitative methodology and had more advantages over this semi-quantitative 
one.  It will enrich the MRI-based whole joint assessment of knee OA, and could be included 
in selection of participants for future clinical trials in knee OA as by excluding those in the low 
tertile of increased signal intensity in the IPFP thus enriching for those with faster progression 
of knee OA. This measure appears to provide an additional selection method, independent of 
age, gender, radiological grade and other structural changes.  
The main strength of this study is that we used a novel quantitative measurement to assess the 
signal intensity alterations in IPFP. Additionally, this study included blind readings and the 
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standardized methods used for data acquisition with high intra- and inter- reader reliabilities. 
This study has several potential limitations. First, as this study is conducted as a post-hoc 
analysis within a subsample of a RCT it may not generalizable to general population of knee 
OA and needs further confirmations in the further studies. Second, MRI coronal planes were 
used at Melbourne so the quantitative measures in these participants were unable to be 
performed; however, there were no significant differences in demographic factors between 
participants included and excluded from this study. Third, histological examinations were not 
able to perform in our study so the pathological changes of IPFP signal intensity alterations are 
unknown. Fourth, more severe structural abnormalities in patellofemoral compartment at 
baseline would result in “ceiling effects” for the changes, which could be the reason why we 
did not detect significantly longitudinal associations in patellofemoral compartment. Future 
studies are required to examine these in patients without advanced disease in this compartment. 
Last, measurement error may influence results. However, all measures were highly 
reproducible suggesting this is unlikely. 
 
In conclusion, the quantitative measures of IPFP signal intensity alteration were significantly 
and positively associated with knee structural abnormalities in tibiofemoral compartment over 
2 years in patients with symptomatic knee OA, suggesting that the pathology of IPFP may play 
an important role in knee OA progression. Additionally, these quantitative measurements of 
IPFP signal intensity alterations could be used as an additional entry criteria in order to enrich 
for ‘faster progressors’ in studies of in knee OA. 
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7.1   Introduction 
Obesity is a prominent risk factor for OA [269]. In addition to its contribution through 
increased mechanical loading of the joint, obesity may also have a metabolic link with OA as 
positive associations between obesity and OA have not only been observed for the knee joint 
but also for non-weight-bearing joints such as the hand [237, 270]. This link may involve 
factors originating from adipose tissue including adipokines (e.g., leptin, adiponectin and 
resistin) and cytokines which have been shown to play roles in cartilage degradation, synovial 
inflammation and bone erosions, and have a potential to predict total knee replacement [43, 
107, 271]. 
 
Resistin, one of the adipokines, is a polypeptide of 105 amino acids mainly produced by white 
adipose tissue, with the ability to promote insulin resistance in mice [113] [272]. It has been 
described as an inflammatory factor associated with multiple inflammatory diseases [116, 117]. 
Resistin can act as an endogenous ligand of TLR-4 that triggers major inflammatory pathways 
and has a significant role in mediating inflammatory responses [118]. Resistin induces the 
secretion of pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α [39, 40] which have 
been implicated in the initiation and progression of OA [119]. Therefore, resistin may make an 
important contribution to the pathogenesis of knee OA.  
 
MRI biomarkers such as cartilage defects, BMLs, Hoffa-synovitis and effusion-synovitis have 
been widely used in the research of OA initiation and progression [240, 273]. Semi-quantitative 
measurements of cartilage defects are associated with radiographic OA and decreased cartilage 
volume [153, 227]. BMLs predict cartilage defect progression and cartilage volume loss [188]. 
We previously reported that IPFP signal intensity alteration, a surrogate for Hoffa-synovitis, 
was significantly associated with knee structural and pain worsening [274]. Effusion-synovitis, 
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a measure of synovial inflammation, has also been associated with knee structural 
abnormalities [194]. These MRI biomarkers such as BMLs, Hoffa-synovitis and effusion-
synovitis play important roles in the initiation and progression of knee OA. 
 
To date, few studies have explored the association between resistin and OA measures, and their 
findings are inconsistent. Serum resistin levels were not associated with cartilage turnover and 
volume loss in knee OA patients [275] but were significantly and positively associated with 
synovial inflammation [41]. Some cross-sectional studies reported that serum levels of resistin 
were significantly associated with cartilage defects, BMLs and IPFP signal intensity alteration 
[211, 276], but not with cartilage volume[277]. The longitudinal associations between serum 
resistin and knee OA measures are uncertain so far. Therefore, our current study aims to 
describe the longitudinal associations of serum levels of resistin with knee synovitis measures 
and structural abnormalities in patients with knee OA. 
 
7.2   Method 
7.2.1   Study design, setting and participants 
This study randomly selected 200 participants from one site of the VIDEO study, which is 
described in Section 3.2. Treatment and placebo groups were combined as a cohort. 
 
7.2.2   Serum levels of resistin and knee pain assessment 
Fasting blood samples were taken in the morning. The samples were first allowed to coagulate 
and were then centrifuged (2200rpm/1000g, 10 minutes). Samples were stored at -80C until 
analysed. 
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Serum levels of resistin were measured at baseline and after 24 months as paired samples using 
multiplex assay kit (Luminex technology; MILLIPORE, USA) according to manufacturer’s 
protocol. Each sample was analyzed in duplicate and resistin concentrations were determined 
based on assay standard curve. The limits of detection are 2.2 pg/ml. The CV in our hands was 
3%.  
 
Knee pain was assessed at baseline and at month 24 using a 100-mm visual analog scale. 
 
7.2.3   MRI assessment of knee structural changes     
MRI scans of the study knee were obtained according to a standardized protocol as described 
on Section 3.5.1. 
 
High signal intensity in IPFP was quantitatively assessed on sagittal planes of FSS T2-weighted 
images using MATLAB as described in Section 3.5.6.  
 
Knee cartilage volume at baseline and follow-up was assessed on T1-weighted MR images 
with image processing on an independent workstation, which is described in Section 3.5.2. 
Total tibial cartilage volume was summed, and change in cartilage volume per annum was 
defined as (follow-up – baseline)/interval. 
 
Knee Cartilage defects (0-4 scale) at baseline and follow-up were determined at the medial 
tibial, medial femoral, lateral tibial, lateral femoral, and patellar sites as described in Section 
3.5.3. A total score was calculated as the total of subregional scores with a maximum score of 
24. Presence of tibiofemoral cartilage defects was defined as any tibial or femoral cartilage 
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defects of >= grade 2, and an increase in cartilage defects was defined as the value from 
(follow-up cartilage defects – baseline cartilage defects) of >= 1. 
 
Subchondral BMLs at baseline and follow-up were assessed on T2-weighted MR images using 
a semi-quantitative (0-3) scoring system as described in Section 3.5.4. Any presence of 
tibiofemoral BMLs was defined as a BML score of >= grade 1, and an increase in BMLs was 
defined as the value from (follow-up BMLs – baseline BMLs) of >= 1. 
 
Effusion-synovitis was assessed quantitatively and semi-quantitatively as described in Section 
3.5.5. Total effusion-synovitis score of the whole joint was defined as the maximum score of 
either subregion, ranging from 0-3. Presence of effusion-synovitis was defined as an effusion-
synovitis score of ≥ 2. 
 
7.2.4   Statistical methods 
A linear mixed-effects model allows to fully analyze longitudinal data of repeated measures, 
including both baseline and follow-up data, as well as account for correlation between repeated 
measures [278]. In this study, a linear mixed-effects regression was used to analyse the 
longitudinal associations between serum levels of resistin (independent variable) and IPFP 
signal intensity alteration, effusion-synovitis volume, cartilage volume, cartilage defects and 
BMLs (dependent variables) before and after including intercepts of age, sex, BMI and vitamin 
D treatment allocation in the models. Logistic mixed-effects regressions were used to analyse 
the associations between serum levels of resistin (independent variable) and the presence of 
effusion-synovitis (dependent variables) before and after including intercepts of age, sex, BMI 
and vitamin D treatment allocation in the models. The correlation within the repeated measures 
was addressed by using individual participant ID as a random effect. Interactions between 
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serum levels of resistin, time interval, sex or BMI were assessed by testing the statistical 
significance of coefficients of (time interval × serum levels of resistin, sex × serum levels of 
resistin or BMI × serum levels of resistin). Student’s t-test or χ2 tests were used to compare 
between-group differences in baseline knee structure abnormalities among tertiles of baseline 
serum resistin levels. Cross-sectional associations between tertiles of serum resistin levels and 
knee structure abnormalities were assessed by using multivariable linear or logistic regressions 
(adjustment for age, sex and BMI) 
 
A p-value of < 0.05 (2-tailed) or a 95% CI not including the null point (for linear regression) 
or 1 (for logistic regression) was considered as statistically significant. All statistical analyses 
were performed on STATA version 12.0 for Mac (StataCorp, College Station, TX, USA). 
 
7.3   Results 
7.3.1   Participants 
Characteristics of the study sample are presented in Table 7.1. A total of 200 participants (46.5% 
females) between 50 and 79 years of age (mean, 63.1 years) took part in the present study. 
There were no significant differences in demographic factors (age, sex, and BMI) between 
these participants and those who were excluded (n = 213) (data not shown). The median serum 
level of resistin was 36.24 ng/ml (the interquartile range: 29.27 - 47.12 ng/ml) and all 
participants were with detectable levels of resistin. Participants were divided into three groups 
based on tertiles of resistin levels. There were no statistically significant differences between 
three groups in terms of age, sex and BMI as well as IPFP high signal intensity alterations, 
total effusion-synovitis volume, tibial cartilage volume and tibiofemoral cartilage defects, but 
the presence of effusion-synovitis and tibiofemoral BMLs were greater in the groups with 
higher resistin levels (Table 7.1). 
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7.3.2   Resistin and IPFP high signal intensity alteration 
Cross-sectionally, higher tertiles of baseline serum resistin levels were associated with greater 
Percentage (H) after adjustment for age, sex and BMI (Figure 7.1a). Longitudinally, in linear 
mixed-effects regression analyses, higher serum levels of resistin were associated with higher 
Percentage (H) and Clustering factor (H) before and after including intercepts of age, sex, BMI 
and intervention in the models (Table 7.2).  There were no statistically significant associations 
between serum resistin and sDve (IPFP) and UQ (H) before and after adjustment for age, sex, 
BMI and intervention (Table 7.2). 
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Table 7.1   Baseline characteristics of participants based on resistin levels (n = 200) 
Characteristic Low tertile Medium tertile High tertile P values* 
Age (years) 62.3 (7.6) 63.1 (7.2) 63.8 (7.3) 0.494 
Female sex (%) 49.3 48.5 41.8 0.636 
BMI (kg/m2) 28.9 (4.5) 29.9 (5.8) 29.7 (4.0) 0.498 
sDev (IPFP) 8.1 (2.8) 8.8 (3.4) 8.9 (2.8) 0.243 
UQ (H) 4.0 (1.4) 4.3 (1.5) 4.4 (1.4) 0.296 
Percentage (H)  6.6 (1.7) 6.9 (1.9) 7.1 (1.8) 0.360 
Clustering factor (H) 6.2 (1.0) 6.4 (0.9) 6.5 (0.8) 0.069 
Total effusion-synovitis volume (ml) 10.1 (10.1) 10.1 (10.3) 10.2 (8.1) 0.945 
Effusion-synovitis presence (%) 40.3 63.1 63.6 0.008 
Tibial cartilage volume (ml) 3.6 (1.1) 3.7 (0.9) 3.8 (1.1) 0.523 
Tibiofemoral cartilage defects (grade) 8.6 (2.9) 8.8 (3.5) 9.7 (2.7) 0.097 
Tibiofemoral BMLs (grade) 1.8 (2.2) 2.8 (3.4) 3.2 (3.1) 0.019 
*Mean (SD) or percentage of patients. BMI: body mass index; IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of 
IPFP signal intensity; UQ (H): upper quartile value of high signal intensity region; Percentage (H): ratio of volume of high signal 
intensity region/whole IPFP volume; Clustering factor (H): clustering factor of high signal intensity. 
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7.3.2   Resistin and effusion-synovitis 
Figure 7.1b showed that higher tertiles of baseline serum resistin levels were associated with a 
greater presence of effusion-synovitis at baseline in an adjusted analysis. Longitudinally, 
higher serum resistin levels were associated with greater total effusion-synovitis volume before 
and after adjustment for age, sex, BMI and intervention (Table 7.2). Serum levels of resistin 
were also positively associated with the presence of knee effusion-synovitis before and after 
the adjustment (Table 7.2).  
 
Table 7.2   Associations between serum resistin and IPFP high signal intensity and joint 
effusion-synovitis 
 Univariable 
β (95% CI) 
Multivariable* 
β (95% CI) 
IPFP high signal intensity alterations    
sDev (IPFP) (unit per 100ng/ml) 0.95 (-1.19, 3.10) 1.04 (-0.97, 3.05) 
UQ (H) (unit per 100ng/ml) 0.39 (-0.62, 1.40) 0.49 (-0.47, 1.45) 
Percentage (H) (% per 100ng/ml) 1.52 (0.52, 2.52) 1.34 (0.38, 2.30) 
Clustering Factor(H) (unit per 100ng/ml) 0.72 (0.06, 1.38) 0.69 (0.07, 1.31) 
   
Effusion-synovitis   
Volume (ml per 100ng/ml) 0.81 (0.04, 1.58) 0.77 (0.01, 1.54) 
 RR (95% CI) RR (95% CI) 
Presence 1.06 (1.02, 1.10) 1.06 (1.02, 1.10) 
Independent variable: serum resistin levels  
Dependent variable: IPFP high signal alterations or effusion-synovitis  
*Adjustment for age, sex, BMI and treatment allocation. 
Values in bold indicate statistically significant.  
β: coefficient of regression; for example: β=1.34 means that an increase in 100 ng/ml of serum resistin was 
associated with an increase in 1.34% of Percentage (H) in multivariable analysis. 
IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of IPFP signal intensity; UQ (H): upper quartile 
value of high signal intensity region; Percentage (H): ratio of volume of high signal intensity region/whole IPFP 
volume; Clustering Factor (H): clustering factor of high signal intensity. 
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7.3.2   Resistin and knee structural changes 
Longitudinally, there was no association between serum levels of resistin and tibial cartilage 
volume (Table 7.3). However, higher serum levels of resistin were associated with greater 
tibiofemoral cartilage defect and BML scores before and after adjustment for age, sex, BMI 
and intervention (Table 7.3). There were positively associations between tertiles of baseline 
serum resistin levels and baseline presence of tibiofemoral cartilage defects and BMLs (Figure 
7.1c and d). 
 
 
Figure 7.1   Associations between tertiles of baseline serum resistin levels and baseline 
knee structural abnormalities. 
(A) The percentage of IPFP high signal intensity alteration volume to whole IPFP volume [Percentage (H)]; (B) 
Presence of effusion-synovitis (%); (C): Presence of tibiofemoral cartilage defects (%); (D) Presence of 
tibiofemoral BMLs (%). *p values were those after adjustment for baseline age, sex, and BMI. Presence of 
effusion-synovitis was defined as an effusion-synovitis score of >= 2. Presence of tibiofemoral cartilage defects 
was defined as cartilage defect score at any compartment >= 2. Presence of tibiofemoral BMLs was defined as 
BMLs score at any compartment were of >= 1. 
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Table 7.3   Association between resistin and knee structural factors 
 Univariable Multivariable* 
 β (95% CI) β (95% CI) 
Tibial cartilage volume (mm3 per ng/ml) -2.57 (-8.02, 2.88) -0.92 (-6.00, 4.17) 
Tibiofemoral cartilage defects (grade per 100ng/ml) 2.22 (0.60, 3.84) 1.92 (0.31, 3.52) 
Tibiofemoral BMLs (grade per 100ng/ml) 3.15 (0.99, 5.31) 2.97 (0.79, 5.15) 
Independent variable: serum resistin levels  
Dependent variable: knee structural factors 
*Adjustment for age, sex, BMI and treatment allocation. 
Values in bold indicates statistically significant. 
BMLs: bone marrow lesions 
 
The relationships between serum resistin, and IPFP signal intensity alteration, effusion-
synovitis and knee structures were not modified by time interval, sex or BMI (data not shown). 
Serum resistin levels were not associated with cartilage volume, cartilage defects and BMLs at 
the patellar site (data not shown). There was no significant longitudinal association between 
serum resistin and knee pain (data not shown). 
 
7.4   Discussion 
 
In this study, Serum levels of resistin were positively associated with quantitative measures of 
IPFP high signal intensity alteration, effusion-synovitis volume, presence of effusion-synovitis, 
and scores of tibiofemoral cartilage defects and BMLs. These associations were independent 
of age, sex, BMI and treatment. Our results suggest that serum resistin may be linked to 
synovial inflammation and structural abnormalities in knee OA. 
 
Resistin was initially investigated as an adipokine to promote insulin resistance [272]. A meta-
analysis suggested that patients with OA had higher expression of resistin than healthy controls 
[38], but its contribution to OA pathogenesis is largely unknown. As resistin has pro-
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inflammatory properties and the ability to trigger the release of pro-inflammatory cytokine 
such as IL-1β, IL-6 and TNF-α [39, 40], it may play an important role in OA progression. 
Serum levels of resistin have been shown to be correlated with increased synovial inflammation 
assessed histologically and positively associated with sPIIINP and the prevalence and 
incidence of radiographic knee OA [41, 42]. Synovial fluid levels of resistin have also been 
shown to be positively associated with local IL-6 levels in OA patients suggesting both 
systemic and local resistin may contribute to the progression of OA  [43].  
 
Although resistin has been proven to have pro-inflammatory effects that may contribute to OA 
pathogenesis, there are a few studies providing clinical evidence for its associations with knee 
OA. Several studies reported that there were cross-sectional associations between resistin and 
MRI assessed structural changes in knee OA [276, 277], but there are no studies describing the 
longitudinal associations so far. This study was the first to describe the longitudinal 
associations; however, it did not provide evidence for the temporal relationships between 
resistin and knee structural changes, which needs to be examined by further cohort studies.   
 
Although contrast-enhanced T1-weighted MRI is the most sensitive method for quantifying 
knee synovitis, the need for intra-venous gadolinium adds significantly to costs and increases 
the risk of adverse events so it cannot be routinely used in epidemiological studies to assess 
knee synovitis. Instead, IPFP high signal intensity alteration assessed on unenhanced T2- or 
proton density-weighted fat-suppressed MRI is generally considered as a surrogate for 
peripatellar synovitis [204]. A pathological study showed that there were vascular 
neoformations, fibrosis and inflammatory infiltrates in IPFP specimens obtained from patients 
with end-stage OA [206]; therefore, IPFP signal intensity alteration observed in MRI may be 
related to not only synovitis, but also other pathological changes. Thus, we used IPFP high 
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signal intensity alteration in our current study. This signal alteration is related to knee pain and 
cartilage loss [204, 205], and predicts the incidence of radiographic knee OA [240]. We 
previously showed that semi-quantitative measurements of high signal intensity alterations 
predicted knee pain, cartilage defects, cartilage volume loss and BMLs [274]. We developed a 
valid and reproducible quantitative method to measure IPFP high signal intensity alteration 
semi-automatically [232]. In our current study, we utilised this method and found that higher 
serum levels of resistin were associated with higher quantitative measurements of IPFP high 
signal intensity alteration in patients with knee OA. These were significant for the quantity 
[Percentage (H)] and clustering effect [Clustering factor (H)] of IPFP high signal intensity 
alteration, but not for a high value [UQ (H)] and variation [sDve (IPFP)] measure of the high 
signal, although these associations were in a similar direction.  
 
Effusion-synovitis is a measure of knee joint inflammation and has been shown to predict 
progression of OA including radiographic changes and total knee replacement [240, 273]. 
Effusion-synovitis is also significantly associated with knee pain and knee structural changes 
assessed using MRI [194, 195, 231]. In our current study, we used semi-quantitative and 
quantitative measurement to assess effusion-synovitis, both of which are reproducible and have 
clinical predictivities [194, 231]. We found significant and positive associations between serum 
levels of resistin and effusion-synovitis scores and volume, which is consistent with our 
findings for IPFP signal intensity alteration. A case-control study reported that serum levels of 
resistin were positively associated with histological synovial inflammation but not with 
cartilage degeneration in patients with knee OA [41]. Overall, these findings suggest that 
resistin may act as a pro-inflammatory factor in the progression of knee OA. 
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The hallmarks of knee OA include knee cartilage degradation and subchondral bone 
abnormalities. Cartilage loss, cartilage defects and BMLs assessed by MRI are generally used 
as imaging biomarkers in knee OA research [138, 153]. Previous studies reported that serum 
levels of resistin were not significantly associated with cartilage loss in patients with knee OA 
[275, 277]. Consistent with these studies, our current study did not find a statistically 
significant association between serum levels of resistin and cartilage volume. This non-
significantly negative association may due to power issue or the short follow-up length. 
Although there have been studies to describe the associations between resistin and cartilage 
turnover and subchondral bone biomarkers[42, 275, 279], there are fewer studies investigating 
the associations between resistin and MRI-assessed cartilage defects and BMLs. Berry et al. 
found that serum levels of resistin had no significant associations with changes in cartilage 
volume and defects over 2 years [275], while another study found that serum levels of resistin 
was positively and significantly associated with cartilage defect and BMLs cross-sectionally 
[276]. Our current study found that serum levels of resistin was positively associated with 
cartilage defect and BML scores in patients with knee OA cross-sectionally and longitudinally.  
 
The mechanisms underlying the associations between serum resistin and knee structures in 
knee OA are unknown. Previous studies have suggested that higher level of resistin were 
related to the expression of genes such as MMPs and aggrecanases, as well as other factors 
such as PGE2, PIIINP, and C-terminal propeptide of type II collagen (CTX-II) [42, 280]. An 
in vitro study also suggested that resistin induced a dose-dependent loss of proteoglycan in 
mice, and inhibited proteoglycan synthesis in human [279]. Resistin may affect knee structural 
changes through the above pathways. However, we did not find temporal relationships between 
resistin and knee structural changes over 2 years, as there were no significant interactions 
between serum resistin and time interval on knee structures and synovial inflammation. This 
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makes it difficult to determine the direction of effect. Resistin may induce synovial 
inflammation and then structural damage in knee OA.  It is also possible that osteoarthritic 
joint tissues such IPFP and synovium could promote resistin production, or that increased 
resistin, knee structural damage, and inflammation may co-occur as part of the disease process. 
 
The main strength of this study is that we had multiple measures of synovitis surrogates 
(including IPFP signal intensity alteration and effusion-synovitis) and knee osteoarthritic 
changes (cartilage loss, cartilage defects and BMLs) over 2 years. This study has several 
potential limitations. First, the original study was a RCT; therefore, results could be affected 
by the intervention. However, our analyses were adjusted for treatment allocation. Second, 
synovial fluid levels of resistin could not be measured in our current study and the association 
between local resistin levels and knee structural abnormalities remains unknown. Third, as 
inclusion and exclusion criteria were applied in the original RCT design, the generalizability 
to the general knee OA population needs to be confirmed.  
 
In conclusion, higher serum levels of resistin were significantly associated with knee synovitis 
surrogate measures and structural abnormalities, suggesting a potential role of resistin in the 
pathogenesis of knee OA. 
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8.1  Introduction 
Obesity is considered one of the most consistent risk factors for onset of knee OA, together 
with previous knee injury, female sex and aging [31]. The underlying mechanisms may include 
abnormal joint loading and inflamed adipose tissue producing adipokines and inflammatory 
mediators, resulting in cartilage degradation, synovial inflammation and bone erosions [32, 33]. 
Intra-articular adipose tissue has greater fibrosis, vascularisation, leucocyte and mast cell 
infiltration, and releases higher levels of IL-6, IL-8 and PGE2 than autologous subcutaneous 
adipose tissue in end-stage OA patients [281], suggesting that local inflamed adipose tissue 
may play crucial roles in the progression of knee OA. 
 
IPFP, the biggest intra-articular adipose tissue in the knee, is a source of cytokines, adipokines 
and growth factors [66, 104, 282], and has similar compositions of immune cells as synovium 
[283]. A recent study illustrated that locally produced leptin from IPFP had the ability to 
upregulate proteolytic enzymes inducing catabolic process on cartilage metabolism in vitro 
[266].  Another in vitro study showed that IPFP might be the trigger of cartilage degradation 
as well as synovial inflammation, and could have specific inflammatory phenotypes 
independent from systemic inflammation in obesity [284]. The interactions of IPFP with other 
neighbouring tissue (i.e. synovium, cartilage and bone) in the pathophysiology of knee OA 
indicate that this local adipose tissue may play an important role in knee OA [14]. 
 
Contrast-enhanced T1-weighted MRI is considered as the ideal way to measure peripatellar 
synovitis but it is costly and may have side effects with the contrast injection [204]. As a result, 
IPFP high signal intensity alteration assessed on unenhanced T2-weighted or proton density-
weighted fat-suppressed MRI is generally accepted as a surrogate for peripatellar synovitis. 
IPFP high signal intensity alteration is associated with knee symptoms, cartilage loss and 
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subchondral bone damages [205, 263], predicts the development of ROA [201] and total knee 
arthroplasty [273]  and is independently associated with OA progression [198]. IPFP high 
signal intensity alteration is also associated with serum levels of cytokines and adipokines 
[211].  
 
So far, no study has examined how IPFP high signal intensity alteration changes over time, and 
whether it is related to OA risk factors and other structural measures of disease. Our current 
study, therefore, aims to describe the natural history of IPFP high signal intensity alteration 
and factors associated with its change over 2 years in patients with knee OA. 
 
8.2  Methods 
8.2.1  Study design, setting and participants 
This study consisted of a sample of 261 participants who had sagittal T2-weighted MRI scans 
in Tasmania from VIDEO study, which is described in Section 3.2. The sample of 152 
participants who had coronal T2-weighted MRI scans in Melbourne was not included in this 
study. Treatment and placebo groups were combined as a cohort. 
 
8.2.2   Knee radiographic assessment 
The radiographic changes of the knee was assessed using the OARSI atlas developed by 
Altman et al [224], which is described in Section 3.4. We summed the osteophyte and JSN 
scores as total knee ROA score, as previously described [149].  
 
8.2.3   MRI assessment of knee structural changes     
MRI scans of the study knee were obtained according to a standardized protocol as described 
on Section 3.5.1. 
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High signal intensity in IPFP was quantitatively assessed on sagittal planes of FSS T2-weighted 
images using MATLAB as described in Section 3.5.6. In order to describe the natural history 
of IPFP high signal intensity alteration (i.e. an increase, stable or a decrease) (Figure 8.1) was 
defined based on the least significant criterion (LSC) [285] which took measurement error and 
the correlation between the baseline and follow-up measurements into account. A decrease in 
IPFP high signal intensity alteration was defined as a decrease of more than the LSC, stable 
was defined as change less than the LSC and an increase was defined as an increase more than 
the LSC. 
 
Knee cartilage volume at baseline and follow-up was assessed on T1-weighted MR images 
with image processing on an independent workstation, which is described in Section 3.5.2. 
Total tibial cartilage volume was summed, and change in cartilage volume per annum was 
defined as (follow-up – baseline)/interval. 
 
Knee Cartilage defects (0-4 scale) at baseline and follow-up were determined at the medial 
tibial, medial femoral, lateral tibial, lateral femoral, and patellar sites as described in Section 
3.5.3. A total score was calculated as the total of subregional scores with a maximum score of 
24. Presence of tibiofemoral cartilage defects was defined as any tibial or femoral cartilage 
defects of >= grade 2, and an increase in cartilage defects was defined as the value from 
(follow-up cartilage defects – baseline cartilage defects) of >= 1. 
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Figure 8.1. Decreases or increases of IPFP signal intensity alteration. 
A1 and A2 shows the IPFP high signal intensity alteration of patient A at baseline and 2-years’ follow-
up, respectively. There were significant decreases in all four measures: sDev (IPFP), UQ (H), 
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Percentage (H) and Clustering factor(H). In contrast, patient B (B1: baseline MRI, B2: follow-up MRI) 
had significant increases in these four measures. Patient C, whose baseline MRI was C1 and 2-years’ 
follow-up MRI was C2, had stable Percentage (H) and Clustering factor(H), but significant increases 
in sDev (IPFP) and UQ (H). 
 
Subchondral BMLs at baseline and follow-up were assessed on T2-weighted MR images using 
a semi-quantitative (0-3) scoring system as described in Section 3.5.4. Any presence of 
tibiofemoral BMLs was defined as a BML score of >= grade 1, and an increase in BMLs was 
defined as the value from (follow-up BMLs – baseline BMLs) of >= 1. 
 
Effusion-synovitis was assessed quantitatively and semi-quantitatively as described in Section 
3.5.5. Total effusion-synovitis score of the whole joint was defined as the maximum score of 
either subregion, ranging from 0-3. Presence of effusion-synovitis was defined as an effusion-
synovitis score of ≥ 2. 
 
8.2.4   Statistical methods 
Student t or χ2 tests were used to compare means or proportions between two groups basing on 
any or no increase in sDev (IPFP), respectively. Multivariable linear regression analyses were 
used to examine the associations of demographic factors, ROA, baseline knee structures and 
changes in knee structures (independent variables) with changes in IPFP high signal intensity 
alteration (dependent variables). All analyses were adjusted for age, sex, BMI, vitamin D 
treatment allocation and baseline high signal intensity alteration.  
 
A p-value < 0.05 (2-tailed) or a 95% CI not including the null (for linear regression) or 1 (for 
logistic regression) point was considered as statistically significant. All statistical analyses 
were performed on SPSS version 20.0 for Windows (SPSS Inc., Chicago, IL). 
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8.3  Results 
8.3.1  Characteristics of the study participants. 
A total of 233 patients (mean 63 years, range 49-79, 42% female) were included in this study. 
There were no significant differences in baseline characteristics, ROA, cartilage volume or 
defects, BMLs and effusion-synovitis between these participants and those who were excluded 
from the Victoria site (data not shown). Baseline characteristics of the study sample are shown 
in Table 8.1. Participants were divided into two groups based on whether they had an increase 
in sDev (IPFP) (LSC >0.39) or not. There were no significant differences in age, female sex, 
BMI, total ROA scores, total cartilage volume and defects scores, BMLs and effusion-synovitis 
between these two groups. 
 
Table 8.1. Baseline characteristics of participants  
 No change or decrease Any increase*  
Characteristic N = 119 N = 104 P value 
Age (years) 62.2 (6.6) 63.9 (7.9) 0.078 
Female sex (%) 55.8 49.2 0.433 
BMI (kg/m2) 29.6 (4.8) 29.7 (5.0) 0.899 
ROA (grade, 0 - 23) 6.5 (4.9) 7.5 (5.3) 0.173 
Cartilage volume (ml)  6.1 (1.8) 5.7 (1.6) 0.068 
Cartilage defects (grade, 5 – 24) 14.3 (4.2) 14.6 (4.2) 0.641 
BMLs (grade, 0 – 17) 3.2 (3.0) 3.7 (3.6) 0.241 
Effusion-synovitis (ml) 9.0 (8.7) 10.5 (9.8) 0.214 
*Any increase was based on an increase in standard deviation of IPFP signal intensity values [sDev 
(IPFP)] 
Two-tailed student’s t tests were used for differences between means, χ2 tests were used for proportions 
(percentages).  
Mean (SD) or percentage of patients. BMI: body mass index; IPFP: infrapatellar fat pad; ROA: 
radiographic osteoarthritis; BMLs: bone marrow lesions. 
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8.3.2  Natural history of IPFP high signal intensity alteration. 
At baseline, the mean  SD of sDev (IPFP), UQ (H), Percentage (H) and Clustering Factor (H) 
were 8.4  3.0 (range 3.7 – 21.5), 4.2  1.4 (range 2.1 – 8.9), 6.8  1.4 (range 3.6 – 9.7) and 
6.3  0.9 (range 4.4 – 8.9), respectively. The LSC for sDev (IPFP), UQ (H), Percentage (H) 
and Clustering Factor (H) were 0.39, 0.21, 0.22 and 0.12, respectively. Over 2 years, 40.4% 
decreased, 13% remained stable, and 46.6% increased in sDev (IPFP); 41.7% decreased, 17% 
remained stable, and 41.3% increased in UQ (H); 35.5% decreased, 11.3% remained stable, 
and 53.4% increased in Percentage (H); and 40.4% decreased, 11.2% remained stable, and 48.4% 
increased in Clustering Factor (H) (Figure 8.2). 
 
 
Figure 8.2. Natural history of IPFP signal intensity alteration over 2 years. 
IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of IPFP signal intensity values; UQ (H): 
upper quartile value of high signal intensity region; Percentage (H): ratio of volume of high signal 
intensity region/whole IPFP volume; Clustering factor(H): clustering factor of high signal intensity. 
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Table 8.2. Associations of baseline demographic factors and ROA with changes in IPFP 
signal intensity alteration 
 Multivariable* 
 β (95% CI) 
Changes in 
sDev 
(IPFP) 
 
Age (unit 
per year) 
0.06 (0.02, 0.11) 
Female sex 
(vs males) 
-0.86 (-1.53, -0.19) 
BMI (unit 
per kg/m2) 
0.01 (-0.07, 0.08) 
ROA (unit 
per grade) 
0.15 (0.07, 0.22) 
Cartilage 
volume 
(unit per 
ml) 
-0.40 (-0.68, -0.13) 
Effusion-
synovitis 
(unit per 
ml) 
0.20 (-0.01, 0.40) 
  
Changes in 
UQ (H) 
 
Age (unit 
per year) 
0.02 (0.01, 0.05) 
Female sex 
(vs males) 
-0.39 (-0.73, -0.05) 
BMI (unit 
per kg/m2) 
0.01 (-0.04, 0.05) 
ROA (unit 
per grade) 
0.07 (0.03, 0.11) 
Cartilage 
volume 
(unit per 
ml) 
-0.17 (-0.31, -0.03) 
Effusion-
synovitis 
(unit per 
ml) 
0.15 (0.04, 0.25) 
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Changes in 
Percentage 
(H) 
 
Age (unit 
per year) 
0.03 (0.01, 0.05) 
Female sex 
(vs males) 
-0.30 (-0.61, 0.02) 
BMI (unit 
per kg/m2) 
0.01 (-0.03, 0.04) 
ROA (unit 
per grade) 
0.02 (-0.02, 0.05) 
Cartilage 
volume 
(unit per 
ml) 
-0.06 (-0.19, 0.07) 
Effusion-
synovitis 
(unit per 
ml) 
0.01 (-0.09, 0.10) 
  
Changes in 
Clustering 
factor (H) 
 
Age (unit 
per year) 
0.02 (0.01, 0.04) 
Female sex 
(vs males) 
-0.09 (-0.31, 0.12) 
BMI (unit 
per kg/m2) 
0.01 (-0.04, 0.05) 
ROA (unit 
per grade) 
0.03 (0.01, 0.05) 
Cartilage 
volume 
(unit per 
ml) 
-0.02 (-0.11, 0.07) 
Effusion-
synovitis 
(unit per 
ml) 
0.09 (0.03, 0.16) 
Dependent variable: changes in IPFP signal intensity alteration; Independent variable: baseline 
demographic factors or ROA.  
*Adjusted for each other (for demographic factors) or age, sex and BMI (for ROA), treatment 
allocation and baseline IPFP signal intensity alteration.  
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IPFP: infrapatellar fat pad; ROA: radiographic osteoarthritis; sDev (IPFP): standard deviation of 
IPFP signal intensity values; UQ(H): upper quartile value of high signal intensity region; Percentage 
(H): ratio of volume of high signal intensity region/whole IPFP volume; Clustering factor(H): 
clustering factor of high signal intensity. 
Table 8.3. Associations of changes in cartilage defects, BMLs and effusion-synovitis with 
changes in IPFP signal intensity alteration 
 Multivariable* 
 β (95% CI) 
Changes 
in 
cartilage 
volume 
 
Changes 
in sDev 
(IPFP) 
(unit per 
ml) 
-0.49 (-1.11, 0.12) 
Changes 
in UQ (H) 
(unit per 
ml) 
-0.23 (-0.54, 0.09) 
Changes 
in 
Percentage 
(H) (unit 
per ml) 
-0.08 (-0.37, 0.21) 
Changes 
in 
Clustering 
factor (H) 
(unit per 
ml) 
-0.06 (-0.26, 0.14) 
  
Changes 
in 
cartilage 
defects 
 
Changes 
in sDev 
(IPFP) 
(unit per 
grade) 
0.08 (-0.17, 0.28) 
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Changes 
in UQ (H) 
(unit per 
grade) 
0.05 (-0.06, 0.15) 
Changes 
in 
Percentage 
(H) (unit 
per grade) 
0.10 (0.01, 0.16) 
Changes 
in 
Clustering 
factor (H) 
(unit per 
grade) 
0.01 (-0.06, 0.07) 
  
Changes 
in BMLs 
 
Changes 
in sDev 
(IPFP) 
(unit per 
grade) 
0.09 (-0.04, 0.22) 
Changes 
in UQ (H) 
(unit per 
grade) 
0.10 (-0.03, 0.24) 
Changes 
in 
Percentage 
(H) (unit 
per grade) 
0.05 (0.01, 0.11) 
Changes 
in 
Clustering 
factor (H) 
(unit per 
grade) 
0.10 (0.04, 0.15) 
  
Changes 
in 
effusion-
synovitis 
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Changes 
in sDev 
(IPFP) 
(unit per 
ml) 
0.04 (0.01, 0.08) 
Changes 
in UQ (H) 
(unit per 
ml) 
0.02 (-0.01, 0.04) 
Changes 
in 
Percentage 
(H) (unit 
per ml) 
0.02 (0.01, 0.04) 
Changes 
in 
Clustering 
factor (H) 
(unit per 
ml) 
0.02 (0.01, 0.03) 
Dependent variable: changes in IPFP signal intensity alteration; Independent variable: changes in 
total cartilage defects, BMLs and effusion-synovitis.  
*Adjusted for age, sex, BMI, treatment allocation and baseline IPFP signal intensity alteration.  
IPFP: infrapatellar fat pad; BMLs: bone marrow lesions; sDev (IPFP): standard deviation of IPFP 
signal intensity values; UQ(H): upper quartile value of high signal intensity region; Percentage (H): 
ratio of volume of high signal intensity region/whole IPFP volume; Clustering factor(H): clustering 
factor of high signal intensity. 
 
8.3.3  Associations of baseline demographic factors and knee structural abnormalities 
with changes in IPFP high signal intensity alteration. 
Table 8.2 shows the baseline factors associated with changes in IPFP high signal intensity 
alteration. Age was positively associated with changes in sDev (IPFP), UQ (H), Percentage (H) 
and Clustering Factor (H), while female sex was negatively associated with changes in sDev 
(IPFP) and UQ (H), after adjustment for age or sex, BMI, treatment allocation and baseline 
IPFP high signal intensity alteration. There were no significant associations between BMI and 
changes in IPFP high signal intensity alteration in multivariable analyses.  
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Baseline total ROA score was positively associated with changes in sDev (IPFP), UQ (H) and 
Clustering Factor (H) after adjustment for covariates. Baseline total cartilage volume was 
negatively associated with changes in sDev (IPFP) and UQ (H) after adjustment for age, sex, 
BMI, treatment allocation and baseline IPFP high signal intensity alteration. There were 
positive associations of baseline total effusion synovitis volume with changes in UQ (H) and 
Clustering Factor (H) in multivariable analyses (Table 8.2).  
 
There were no significant associations between baseline cartilage defects, BMLs and changes 
in IPFP signal intensity alteration in multivariable analyses (data not shown). 
 
8.3.4  Associations between changes in joint structures and changes in IPFP high signal 
intensity alteration. 
There was a positive association between change in cartilage defects and change in Percentage 
(H) after adjustment for age, sex, BMI, treatment allocation and baseline IPFP high signal 
intensity alteration, and change in total BMLs score was positively associated with changes in 
Percentage (H) and Clustering Factor (H) after adjustment for covariates (Table 8.3). Change 
in total effusion synovitis volume were positively associated with changes in sDev (IPFP), 
Percentage (H) and Clustering Factor (H) after adjustment for covariates (Table 8.3). Change 
in cartilage volume was not associated with changes in IPFP signal intensity alteration (Table 
8.3). 
 
8.4  Discussion 
To the best of our knowledge, this study is the first to explore the natural history of IPFP high 
signal intensity alteration and factors associated with its change over 2 years. IPFP high signal 
intensity alteration was not static, with nearly 90% of signal intensity alteration measures either 
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worsening or improving over the study period. Changes in IPFP high signal intensity alteration 
were age-related and independent of BMI. Baseline higher ROA scores, less cartilage volume 
and more severe effusion-synovitis were associated with an increase in signal intensity 
alteration over 2 years. Changes in signal intensity alteration were also associated with changes 
in neighbouring structural factors (i.e., cartilage, subchondral bone and synovium) over time.  
 
Our previous studies show that both semi-quantitative and quantitative measures of IPFP high 
signal intensity alteration were significantly and positively associated with ROA in cross-
sectional analyses [232, 263]. In our present study, we found that higher grades of ROA at 
baseline predicted increases in IPFP high signal intensity alteration. This is consistent with 
another observation that patients with knee OA have greater baseline IPFP high signal intensity 
alteration and larger increases in these values than controls over 2 years [286]. A nested case-
control studies also showed that participants with OA were more likely to experience 
worsening in high signal intensity alteration within IPFP over 2 years [198]. Altogether this 
suggest that signal intensity alteration within the IPFP is ROA-related and further studies 
examining the pathology of MRI-detected signal intensity alteration are needed. 
 
Ageing is a prominent risk factor for the development and progression of OA [24]. Although 
the precise underlying mechanisms have not been identified, chronic low-grade inflammation 
may be one link between ageing and OA, as age-related low-grade systemic and local 
inflammation could promote OA progression [28, 287]. We found that increases in IPFP high 
signal intensity alteration were age-related and independent of BMI in present study. 
Consistently, an animal study reported that ageing was associated with significantly higher 
secretion of TNF- and IL-13 from IPFP in murine [288], suggesting that age-related local 
adipose tissue inflammation may have an independent contribution to knee OA [27]. 
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Interestingly, BMI was not associated with changes in IPFP high signal intensity alteration in 
our current study. This indicates that abnormalities in knee local adipose tissue may contribute 
to the process of knee OA independently of obesity. Although ageing is an unmodifiable risk 
factor for OA, targeting the underlying mechanism (i.e. local adipose tissue inflammation) may 
not be difficult to achieve.  
 
Knee OA has been considered as a whole joint disease [64]. The cross-talk between cartilage 
and neighbouring tissues is important in the pathogenesis of knee OA. We found in the current 
study that baseline knee cartilage volume was negatively associated with increases in IPFP 
high signal intensity alteration, while baseline effusion-synovitis was positively associated 
with changes in these measures. This indicates that cartilage volume loss and effusion-synovitis 
could precede IPFP high signal intensity alteration in the process of knee OA. In the study, we 
did not find significant associations between baseline cartilage defects and BMLs with changes 
in signal intensity alteration. While we reported that baseline IPFP signal intensity alteration 
was associated with changes in cartilage defects and BMLs over 2 years in older adults [263], 
these suggest that IPFP high signal intensity alteration may precede cartilage defects and BMLs 
in disease progression of knee OA.  
 
Further, we analysed the associations between changes in signal intensity alteration and 
changes in neighbouring tissues over 2 years, and found that changes of signal intensity 
alteration correlated to changes in effusion-synovitis, cartilage defects and BMLs. All this 
suggests that IPFP has potential crosstalk with neighbouring tissues such as cartilage, 
synovium and subchondral bone in the pathogenesis of knee OA [14]. An experimental study 
showed that IPFP had similar composition of immune cells from synovium [283], suggesting 
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that IPFP could act as the similar way as synovium in knee OA via releasing pro-inflammatory 
cytokines. 
 
IPFP high signal intensity alteration measures are associated with knee symptoms, knee 
structural abnormalities, the progression of ROA and incidence of total knee arthroplasty [198, 
201, 205, 263, 273], indicating the clinical importance of these measures in knee OA. In our 
current study, we found that quantitative measures of IPFP high signal intensity alteration were 
not static. Around 40% of participants had a decrease, and around 50% had an increase in all 
measures of these signal alteration. While there is no comparison data regarding the natural 
history of IPFP signal changes, we found that signal intensity alteration measures were more 
variable compared to other knee structural abnormalities [167, 178, 194]. The reason may be 
that this study included patients with active knee OA. We previously reported that this 
quantitative measurement is reproducible, and has concurrent and clinical construct validity 
[232]. Our finding suggests that high signal intensity alteration within IPFP may be reversible 
and therapeutic interventions targeting the IPFP could be considered in the future clinical 
practice. 
 
This study has several potential limitations. First, as this study is conducted as a post-hoc 
analysis within a subsample of a RCT, the treatment allocation may influence the results. Thus, 
we used the multivariable analyses considering treatment allocation as a confounder. Second, 
MRI coronal planes were used at the Victoria site, therefore we were unable to perform our 
IPFP measures on these participants; however, there were no significant differences in 
demographic factors between participants included and excluded from this study. Last, 
measurement error may influence results; however, this is unlikely because all measures had 
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high reproducibilities, and we used LSC [285] to take measurement error and the correlation 
between the baseline and follow-up measurements into account.  
 
In conclusion, IPFP high signal intensity alteration was not static in patients with knee OA. 
Changes in IPFP signal intensity alteration were age-related, independent of BMI, and 
predicted by ROA, effusion-synovitis and low cartilage volume, suggesting therapeutic 
interventions targeting the IPFP could be considered for OA treatment. 
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 9.1  Summary 
OA is the most common joint disease in the world and it is one of the most frequent causes of 
pain, loss of function, and disability in Western populations [289]. It is characterized by 
progressive deterioration of joint structures, and mostly affects the knee joint. In Australia, it 
affects around 8.0% of the population, which means over 1.8 million Australians are affected 
by this condition [290]. It costs nearly ＄1.6 billion each year in Australia, accounted for 2.5% 
of total health care expenditure. Thus, it is one of the most expensive diseases. Along with the 
aging population and rising obesity rates, the social and economic burden associated with OA 
is increasing rapidly. Furthermore, there are still no proven preventative strategies and no 
registered effective treatments for delaying the progression of this condition. TKA is the only 
effective treatment for end-stage knee OA, and it is a costly procedure. Identifying modifiable 
risk factors and developing cost-effective treatments for this disease is urgently needed. Knee 
OA has been considered as a whole joint disease affecting nearly all knee structures [1, 64]. 
IPFP is  an intracapsular but extrasynovial structure that is located in the anterior compartment 
of the knee [70]. It may be involved in the progression of knee OA [14]. MRI is an effective 
tool that can be used to assess knee structural abnormalities. This thesis has described the 
associations of semi-quantitative and quantitative measures of IPFP signal intensity alteration 
by MRI with knee pain and structural abnormalities in older populations and knee OA patients, 
as well as the natural history of these signal intensity alteration and factors associated with its 
changes. Several novel and important findings presented in this thesis are summarised below. 
 
Chapter 4 describes the associations between semi-quantitative measures of IPFP high signal 
intensity alteration at baseline and knee symptoms and structural changes in older adults. In 
cross-sectional analyses, IPFP signal intensity alteration was significantly and positively 
associated with total knee pain as well as knee cartilage defects, BMLs and knee radiographic 
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OA and negatively associated with patellar cartilage volume after adjustment for age, sex, BMI 
and/or radiographic OA. Longitudinally, baseline signal intensity alteration within IPFP was 
significantly and positively associated with increases in knee pain when going up/down stairs 
as well as increases in tibiofemoral cartilage defects and BMLs, and negatively associated with 
change in lateral tibial cartilage volume in multivariable analyses. These results suggest that 
MRI assessed IPFP high signal intensity alteration may serve as an important imaging 
biomarker in knee OA. 
 
While hyperintense signals within IPFP on T2-weighted MRI can indicate inflammation, acute 
haemorrhage and/or oedema, hypointense signals within IPFP on T2-weighted MRI may 
indicate fibrosis [239]. Chapter 5 describes the associations between hypointense signals in the 
IPFP and knee structural change and symptoms in older adults. Cross-sectionally, hypointense 
signals in the IPFP were significantly associated with a higher risk of knee cartilage defects at 
all sites, tibiofemoral BMLs and knee pain in multivariable analyses. Longitudinally, baseline 
signal abnormalities were significantly and positively associated with increases in knee 
cartilage defects, BMLs, and knee pain in multivariable analyses. The associations with 
cartilage defects remained significant after adjustment for BMLs, but the associations with 
BMLs and knee pain decreased in magnitude or became non-significant after further 
adjustment for cartilage defects. These results suggests the abnormality represented by this 
signal has a potentially important role in osteoarthritis progression. 
 
We recently established a method to quantitatively assess IPFP signal intensity alterations and 
reported that this method was reproducible, and associated with knee structural changes [232]. 
Chapter 6 describes the cross-sectional and longitudinal associations between quantitative 
measures of infrapatellar fat pad (IPFP) signal intensity alteration and knee structural 
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abnormalities in patients with symptomatic knee OA. Higher baseline sDev (IPFP), UQ (H) 
and Clustering factor (H) were associated with greater loss of tibial cartilage volume and larger 
increases in tibiofemoral cartilage defects over 2 years. Patients with high and medium tertiles 
of Clustering factor (H) had greater loss of cartilage volume per annum compared with those 
with low tertile. Baseline Percentage (H) and Clustering factor (H) were positively and 
significantly associated with increases in tibiofemoral BMLs over 2 years. Cross-sectional 
associations between IPFP measures and knee structures were similar but more consistent. 
These measurements could be used as an additional entry criteria in order to enrich for ‘faster 
progressors’ in studies of knee OA.  
 
Resistin, one of the adipokines, is a polypeptide of 105 amino acids mainly produced by white 
adipose tissue, with the ability to promote insulin resistance in mice [113] [272]. It has been 
described as an inflammatory factor associated with multiple inflammatory diseases [116, 117]. 
Chapter 7 describes the longitudinal associations of serum levels of resistin with IPFP signal 
intensity alterations and structural abnormalities in patients with knee OA. Serum resistin was 
positively associated with high signal intensity alteration measures of IPFP, as well as the 
presence and volume of effusion-synovitis in multivariable analyses. Serum levels of resistin 
was also positively associated with higher tibiofemoral cartilage defect and BML scores after 
adjustment for covariates. These results suggest the IPFP signal intensity alterations are related 
to resistin, which is an important adipokines. This suggests a potential link between IPFP 
abnormalities and knee OA. 
 
Chapter 8 describes the natural history of IPFP high signal intensity alteration and factors 
associated with its change over 2 years in patients with knee OA. Over 2 years, around 40% of 
participants had a decrease, around 50% an increase in IPFP high signal intensity alteration, 
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with around 10% having no change. In multivariable analyses, baseline age, total ROA scores 
and effusion-synovitis volume were associated with deleterious changes in IPFP high signal 
intensity alteration (ie increase intensity), while baseline cartilage volume was negatively 
associated with changes in signal intensity alteration. Changes in cartilage defects, BMLs and 
effusion synovitis were associated with changes in IPFP signal intensity alteration. There was 
no association with BMI. IPFP high signal intensity tends to fluctuate in patients with knee OA, 
suggesting it may be a potential target for intervention. Further, changes in IPFP signal 
intensity alteration were associated with a number of demographic and structural variables but 
causal pathways remain uncertain. 
 
In summary, despite the fact that pathological changes related to signal intensity alterations 
within IPFP are unclear, both high and low signal intensity alterations were associated with 
knee symptoms and structural changes cross-sectionally and longitudinally. Using semi-
quantitative and quantitative measures of these signal intensity alterations, the consistent 
results were reached, suggesting the relevant pathological changes  within IPFP may play an 
important role in the onset and/or progression in OA. These signal intensity alterations were 
associated with resistin, suggesting inflammatory adipokines may be the link between IPFP 
signal intensity alteration and knee osteoarthritic changes. IPFP signal intensity alterations 
were no static, suggesting they are treatable in knee OA patients. Future directions will be 
discussed in Section 9.2. 
 
9.2  Future directions 
OA has long been considered as a “wear and tear” disease leading to cartilage loss. Most 
recently, menisci, synovial membrane, joint capsule, ligaments, muscles and IPFP have been 
shown to be involved in the pathogenesis of knee OA, suggesting that knee OA is a “whole 
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organ” disease. IPFP, the biggest intra-articular adipose tissue in the knee, may have both 
mechanical and inflammatory contributions to the pathogenesis of this disease. Chapter 4 
highlights that semi-quantitative measures of IPFP high signal intensity alterations are 
associated with knee symptoms and structural changes of knee in older adults. These measures 
of IPFP may reflect the pathological changes such as inflammation or vascular neoformations. 
These pathological changes of IPFP may reduce the “force absorbing” effects of IPFP and/or 
release more inflammatory cytokines or adipokines, which may be two pathways of abnormal 
IPFP contributing to the initiation and progression of knee OA. Although local production of 
inflammatory mediators are well known to cartilage degradation and synovitis, the source of 
inflammation are not well understood. The confirmation of low-grade inflammation in IPFP to 
knee OA builds the foundation for future research to examine inflammatory and metabolic 
mediators releasing from IPFP as important components of the disease. 
 
Two main mechanisms, mechanical and inflammatory, are involving in the pathogenesis of 
knee OA. IPFP lower signal intensity alterations may reflect fibrosis or chronic inflammation, 
which may mechanically and biochemically contribute to the progression of knee OA. Chapter 
5 has described that hypointense signals within IPFP were associated with knee symptoms and 
knee structural changes in older adults. The fibrosis of IPFP may decrease the capabilities of 
reducing the impact loading and absorbing forces generated through the knee joint, while 
chronic inflammatory may release more inflammatory mediators that contribute to the 
degradation of neighbouring tissues within the knee. However, the exact pathological changes 
reflected by IPFP hypointense signals are still unknow. In future research, the associations 
between hypointense signals of IPFP and pathological changes of IPFP could be described to 
fully understand the mechanism that IPFP signal intensity alteration contributes to the 
progression of knee OA. Furthermore, future research on the associations between releasing 
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inflammatory mediators from IPFP and hypointense signals of IPFP are needed to enrich the 
theory of local inflammation in knee OA. 
 
IPFP has the ability of secreting pro- and anti-inflammatory cytokines and various adipokines, 
all of which may play roles in maintenance of cartilage and bone homeostasis in the knee joint 
[66-69]. Inflammation within IPFP can be assessed using non-contrast enhanced magnetic 
resonance imaging (MRI) [262]. The associations between semi-quantitative measures of IPFP 
high signal intensity alteration and knee structural changes were described in Chapter 4. There 
are currently few studies that have used quantitative measurements to evaluate IPFP signal 
intensity alterations and to describe their relationship with knee osteoarthritic abnormalities 
[264]. We recently established a method to quantitatively assess IPFP signal intensity 
alterations and reported that this method was reproducible, and associated with knee structural 
changes [232]. Chapter 6 illustrates these quantitative measures of IPFP signal intensity 
alterations were associated with MRI-assessed knee structural changes in knee OA patients. Of 
these measures, Clustering factor (H) was more consistently associated with all MRI-assessed 
knee structural changes, suggesting it may be a more useful biomarker for future research. As 
this study is conducted as a post-hoc analysis within a subsample of a RCT it may not 
generalizable to general population of knee OA and needs further confirmations in the further 
studies. Future studies is also needed to focus on the pathological changes related to these 
quantitative measures of IPFP to reveal the underlying mechanism between these abnormalities 
and knee OA progression.  
 
Obesity is a prominent risk factor for OA [269]. In addition to its contribution through 
increased mechanical loading of the joint, obesity also has a metabolic link with OA as positive 
associations between obesity and OA have not only been observed for the knee joint but also 
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for non-weight-bearing joints such as the hand [237, 270]. This link may involve factors 
originating from adipose tissue including adipokines (e.g., leptin, adiponectin and resistin) and 
cytokines which have been shown to play roles in cartilage degradation, synovial inflammation 
and bone erosions, and have a potential to predict total knee replacement [43, 107, 271]. IPFP 
is structurally similar to subcutaneous adipose tissue and located in knee joint. Chapter 7 
describes that its signal intensity alteration was associated with resistin, one of adipokines 
being associated with cartilage defects and BMLs  [211, 276], as well as synovial inflammation 
[41]. In future studies, the associations between IPFP signal intensity alterations and other 
adipokines and inflammatory cytokines could be explored to obtain a better understanding of 
the underlying metabolic link between IPFP and knee OA.  
 
Previous studies describe the significant associations of IPFP signal intensity alteration with 
knee symptoms, structural changes and inflammatory mediators. However, no study has 
examined how IPFP high signal intensity alteration changes over time, and whether it is related 
to OA risk factors and other structural measures of the disease. Chapter 8 describes that IPFP 
high signal intensity alteration was not static, with nearly 90% of signal intensity alteration 
measures either worsening or improving over the study period. These suggest that measures 
were more variable compared to other knee structural abnormalities [167, 178, 194]. The 
reason may be that this study included patients with active knee OA. Further research could 
use healthy population- based cohort studies to describe the natural history of IPFP signal 
intensity alteration. Changes in IPFP high signal intensity alteration were age-related and 
independent of BMI. Baseline higher ROA scores, less cartilage volume and more severe 
effusion-synovitis were associated with an increase in signal intensity alteration over 2 years. 
Changes in signal intensity alteration were also associated with changes in neighbouring 
structural factors (i.e., cartilage, subchondral bone and synovium) over time. This indicates that 
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abnormalities in knee local adipose tissue may contribute to the process of knee OA 
independently of obesity. Although ageing is an unmodifiable risk factor for OA, targeting the 
underlying mechanism (i.e. local adipose tissue inflammation) may not be difficult to achieve. 
In future, studies should examine treatments that target local adipose tissue inflammation to 
develop an effective therapeutic intervention. 
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Table A.1  Baseline characteristics of participants based on IPFP signal intensity 
alteration in participants with follow-up MRI data 
 
 IPFP signal 
intensity alteration 
No 
N = 136 
IPFP signal 
intensity alteration 
Yes 
N = 221 
 
 
 
P-value 
Age (year) 
Female sex (%) 
Body mass index (kg/m²) 
Medial tibial cartilage volume (ml) 
Lateral tibial cartilage volume (ml) 
Patella cartilage volume (ml) 
Medial tibial bone area (cm²) 
Lateral tibial bone area (cm²) 
Medial joint space narrowing (%) 
Lateral joint space narrowing (%) 
MTF osteophytes (%) 
LTF osteophytes (%) 
BML present (%) 
MTF cartilage defects (%) 
LTF cartilage defects (%) 
Patellar cartilage defects (%) 
Knee pain (%) 
Radiographic osteoarthritis (%) 
62.0 (7.3) 
59.6 
27.4 (4.9) 
2.3 (0.6) 
2.7 (0.7) 
3.4 (0.9) 
20.8 (3.2) 
11.8 (2.0) 
46.1 
19.5 
3.1 
0.8 
28.7 
14.0 
13.2 
25.7 
47.8 
50.8 
62.8 (7.0) 
45.2 
27.7 (4.1) 
2.4 (0.6) 
2.8 (0.7) 
3.3 (0.9) 
21.3 (2.9) 
12.4 (2.1) 
55.5 
19.4 
8.5 
3.8 
38.9 
23.5 
21.3 
43.9 
45.7 
61.1 
0.494 
0.009 
0.059 
0.162 
0.619 
0.727 
0.350 
0.826 
0.116 
1.000 
0.067 
0.161 
0.053 
0.029 
0.066 
<0.001 
0.743 
0.070 
Two-tailed t tests were used for differences between means, and χ2 tests were used for 
proportions (percentages). Significant differences are shown in bold. Mean (SD) except for 
percentages. IPFP: infrapatellar fat pat; BMI: body mass index; BML: bone marrow lesions; 
MTF: medial tibiofemoral; LTF: lateral tibiofemoral  
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Figure A.1   Association of baseline IPFP signal intensity alteration with increases in knee 
cartilage defects. 
 
 
Figure A.2   Association of baseline IPFP signal intensity alteration with increases in bone 
marrow lesions. 
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Figure A.3   Association of baseline IPFP signal intensity alteration with increase in 
WOMAC knee pain when going up/down stairs. 
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Table B.1  Associations of IPFP hypointense signals with baseline knee cartilage volume and change in knee cartilage volume over 2.6 
years 
 Multivariable*  
β (95% CI) 
Multivariable** β 
(95% CI) 
Multivariable***  
β (95% CI)  
Baseline cartilage volume 
Medial tibial 
Lateral tibial 
Patellar 
Change in cartilage volume  
Medial tibial 
Lateral tibial 
Patellar 
 
  -20.2 (-66.4, 26.1) 
-8.7 (-64.3, 47.0) 
-165.6 (-244.4, -86.7) 
 
    -6.3 (-23.2, 10.6) 
-19.7 (-35.6, -3.8) 
-15.2 (-39.6, 9.1) 
 
  17.5 (-30.2, 65.2) 
46.7 (-7.9, 101.2) 
-47.0 (-112.9, 18.9) 
 
-3.6 (-21.1, 13.9) 
-17.0 (-33.3, -0.7) 
-5.7 (-29.4, 17.9) 
 
  -10.3 (-57.0, 36.4) 
-5.4 (-61.2, 50.3) 
-154.9 (-232.7, -77.2) 
 
-5.0 (-22.1, 12.0) 
- 17.8 (-33.6, -2.0) 
-12.5 (-36.5, 11.5) 
Dependent variables: knee cartilage volume or change in knee cartilage volume per annum (mm3); independent variables: IPFP hypointense 
signals (per grade). *Adjusted for age, sex, BMI, radiographic osteoarthritis, tibial bone area, and/or baseline cartilage volume (for change in 
cartilage volume). **Further adjustment for cartilage defects. *** Further adjustment for bone marrow lesions but not for cartilage defects. 
IPFP: infrapatellar fat pat 
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Figure B.1   Association between IPFP maximum area and hypointense signals. IPFP: 
infrapatellar fat pad 
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Table C.1 Cross-sectional associations between IPFP signal intensity alteration and 
ROA 
 Univariable Multivariable* 
 β (95% CI) β (95% CI) 
sDev (IPFP) 0.58 (0.29, 0.88) 0.61 (0.31, 0.91) 
UQ (H) 0.87 (0.17, 1.56) 0.96 (0.27, 1.65) 
Percentage (H) 0.77 (0.30, 1.25) 0.65 (0.19, 1.11) 
Clustering factor (H) 0.86 (0.13, 1.59) 1.27 (0.36, 2.18) 
Dependent variable: ROA; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, sex and BMI.  
IPFP: infrapatellar fat pad; ROA: radiographic osteoarthritis; sDev (IPFP): standard deviation of IPFP 
signal intensity values; UQ(H): upper quartile value of high signal intensity region; Percentage (H): 
ratio of volume of high signal intensity region/whole IPFP volume; Clustering factor(H): clustering 
factor of high signal intensity. 
 
 
Table C.2 Cross-sectional associations between IPFP signal intensity alteration and 
cartilage defects 
 Univariable Multivariable* 
 OR (95% CI) OR (95% CI) 
Baseline tibiofemoral cartilage defects   
sDev (IPFP) 1.19 (1.06, 1.34) 1.22 (1.08, 1.39) 
UQ (H) 1.35 (1.03, 1.77) 1.40 (1.06, 1.85) 
Percentage (H) 1.44 (1.19, 1.74) 1.42 (1.18, 1.72) 
Clustering factor (H) 2.11 (1.45, 3.08) 2.18 (1.49, 3.20) 
Baseline patellar cartilage defects   
sDev (IPFP) 0.00 (-0.02, 0.02) 0.01 (-0.01, 0.03) 
UQ (H) 0.00 (-0.04, 0.04) 0.01 (-0.03, 0.05) 
Percentage (H) 0.01 (-0.02, 0.04) 0.01 (-0.02, 0.04) 
Clustering factor (H) 0.00 (-0.06, 0.06) 0.01 (-0.05, 0.07) 
Dependent variable: cartilage defects; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, sex, and BMI. 
IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of IPFP signal intensity values; UQ(H): 
upper quartile value of high signal intensity region; Percentage (H): ratio of volume of high signal 
intensity region/whole IPFP volume; Clustering factor(H): clustering factor of high signal intensity. 
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Table C.3  Cross-sectional associations between IPFP signal intensity alteration and 
BMLs 
 Univariable Multivariable* 
 OR (95% CI) OR (95% CI) 
Baseline tibiofemoral BMLs   
sDev (IPFP) 1.24 (1.06, 1.42) 1.26 (1.09, 1.45) 
UQ (H) 1.41 (1.05, 1.90) 1.43 (1.05, 1.93) 
Percentage (H) 1.43 (1.17, 1.74) 1.42 (1.16, 1.73) 
Clustering factor (H) 2.34 (1.55, 3.54) 2.36 (1.56, 3.57) 
Baseline patellar BMLs   
sDev (IPFP) 0.01 (-0.02, 0.03) 0.01 (-0.01, 0.03) 
UQ (H) 0.01 (-0.04, 0.05) 0.01 (-0.03, 0.05) 
Percentage (H) 0.01 (-0.03, 0.04) 0.01 (-0.03, 0.04) 
Clustering factor (H) 0.01 (-0.06, 0.08) 0.02 (-0.05, 0.08) 
Dependent variable: BMLs; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, sex, and BMI. 
BMLs: bone marrow lesions; IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of IPFP signal 
intensity values; UQ(H): upper quartile value of high signal intensity region; Percentage (H): ratio of 
volume of high signal intensity region/whole IPFP volume; Clustering factor(H): clustering factor of 
high signal intensity 
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Table C.4  Cross-sectional associations between IPFP signal intensity alteration and 
cartilage volume 
 Univariable Multivariable* 
 β (95% CI) β (95% CI) 
Baseline tibial cartilage volume   
sDev (IPFP) 0.08 (0.02, 0.14) -0.01 (-0.05, 0.04) 
UQ (H) 0.17 (0.04, 0.31) 0.02 (-0.08, 0.13) 
Percentage (H) -0.10 (-0.19, -0.01) -0.09 (-0.15, -0.02) 
Clustering factor (H) 0.01 (-0.14, 0.15) -0.15 (-0.28, -0.01) 
Baseline patellar cartilage volume   
sDev (IPFP) 0.01 (-0.03, 0.04) -0.05 (-0.08, -0.02) 
UQ (H) -0.01 (-0.09, 0.07) -0.09 (-0.15, -0.04) 
Percentage (H) 0.01 (-0.06, 0.07) 0.01 (-0.03, 0.06) 
Clustering factor (H) 0.03 (-0.09, 0.16) -0.05 (-0.14, 0.04) 
Dependent variable: cartilage volume; Independent variable: IPFP signal intensity alteration.  
*Adjusted for age, gender, BMI and bone area. 
IPFP: infrapatellar fat pad; sDev (IPFP): standard deviation of IPFP signal intensity values; UQ(H): 
upper quartile value of high signal intensity region; Percentage (H): ratio of volume of high signal 
intensity region/whole IPFP volume; Clustering factor(H): clustering factor of high signal intensity. 
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